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Abstract 
The production of chemicals using microbes is an area of significant interest for 
academia and industry. Significant resources are often devoted to strain development 
not only for the increase of productivity and yield but also for the improvement of 
robustness and tolerance to industrial production conditions. 
The genetic regulatory network of microbial organisms has evolved to maximize growth 
and survival in a variety of dynamic environmental conditions found in nature. Many of 
these responses can be suboptimal for the purpose of industrial manufacture of 
valuable bioproducts. A small number of methods have been developed to explore the 
effect of perturbing these networks with the objective of obtaining improved strains. 
This thesis explores the use of transcriptional regulatory network rewiring as a general 
strategy for improvement of strains used in the production of chemical compounds. 
Libraries generated using a regulatory network rewiring strategy – addition of nodes to 
wildtype background – were screened for enhanced production of a target compound 
or other phenotypes of interest. Combinatorial libraries of promoters and coding 
regions of transcriptional regulators were used to test the strategy towards the 
improvement of phenotypical limitations of M. smegmatis (growth rate) and for the 
isolation of strains with improved production of lycopene in P. pastoris. 
The method was shown to allow for the identification of potential fast growing strains in 
M. smegmatis and for the isolation of strains with improved production of lycopene in P. 
pastoris. In the lycopene project, a strain was isolated that was shown to produce 
significantly higher levels of lycopene in suboptimal aeration conditions as well as 
modest improvements in non-limited cultures, providing a hint that the strategy could 
be applied for the development of strains with large phenotypical diversity, and towards 
the understanding of complex factors limiting production of compounds of interest. 
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1. Introduction 
 
 
Summary 
Transcriptional regulatory network rewiring has been thus far explored as a strategy for 
the identification of properties associated with regulatory networks. Background is 
provided on non-rational metabolic engineering methods that can be applied to the 
inverse engineering of improved phenotypes of industrial strains, the properties of 
transcriptional regulatory networks and evolution of regulatory elements. 
The use of regulatory rewiring is thus framed in the context of metabolic engineering for 
strain improvement using non-rational methods, with the potential application to inverse 
engineering of strains through the exploration of beneficial modulation of regulatory 
networks. The evolutionary context allows for the identification of the principle of node 
addition, central to network rewiring, as an element similar to duplication and drift 
observed in regulatory evolution.  
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Socioeconomic changes at the end of the 20th century, technological advancement and 
improvement in quality of life has resulted in an historical positive trend1 in the 
worldwide demand for the production of chemicals (see Figure 1.1). 
As an alternative to the use of petrochemical sources, biological fermentation of carbon 
feedstocks has been proposed. Whilst the increased demand favours the production of 
fine chemicals through fermentation using microorganisms, aided by the specificity of 
enzymatic reactions and their increasing tractability, it also poses an opportunity for 
investment in the development of high yield strains that make bulk chemical 
biosynthesis economically sustainable in future markets. 
As the generalised biological production of chemicals becomes a realistic objective the 
issue of feedstock usage has become central – use of food crops suffers from obvious 
sustainability issues (food prices/availability) as do lower density non-crop plants (land 
usage); complexity in treatment and fermentation of high-density plants, industrial and 
commercial waste and waste gases (CO, CO2 and H2). All this results in the need for 
adaptation of processes generally developed for use with traditional carbon sources 
and the inclusion of new strains into the repertoire of industrial biotechnologists 2,3. 
The research and development of methods that allow for the engineering of industrial 
Figure 1.1 – World average per capita expenditure on chemicals by country 2010-2050 
(Adapted from Valencia, 2013:p288). 
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strains is therefore an essential step towards the emergence of new chemical supply 
chain models. 
1.1. Metabolic Engineering 
The field of Industrial Biotechnology had its greatest growth through the development 
of Genetic Engineering. 
The production of human insulin in bacteria generated a great deal of interest for the 
application of Genetic Engineering to a number of challenges related to human health, 
and whilst the production of antibiotics and fermentative products preceded its use, 
genetic modification of organisms used for this purposes allowed for a wider product 
spectrum to be explored. 
Metabolic Engineering was founded on the need to produce reliable strategies for the 
development of strains that would meet these objectives. For this purpose it organised 
the tools available for measurement of gene function and metabolic fluxes in a rational 
framework to direct the optimisation of biological processes using molecular biology 
methods. 
From the mid-1990s an essential change in technologies available to molecular 
biologists and chemical engineers enabled large scale quantitative experiments to be 
performed with large number of targets across different molecular classes such as 
proteins, RNA or metabolites4–8, resulting in the emergence of fields dedicated to their 
quantitative study, the “omics”. 
The availability of such data allowed for the first time the identification of complex 
regulatory patterns and greatly improved targeting of genetic modifications towards the 
production of chemicals in microorganisms. 
The field of Metabolic Engineering saw its early efforts in the pre-omics era, but gained 
momentum with the development of large scale measurements and modification tools: 
Having been defined as the use of recombinant technologies for the directed 
modulation of metabolic pathways for the overproduction of fuels and chemical and 
pharmaceutical products (Bailey 1991)9, it has also gained greatly from large efforts 
towards the development of algorithms capable of analysing complex metabolic and 
regulatory data for predictable strain modification. 
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While the field has provided examples of successful projects that delivered significant 
industrial results2,10,11, reliable and predictable engineering of strains that can 
consistently be scaled up to industrial level is a challenge that is the object of 
continuous research and development efforts. 
1.2. Synthetic Biology 
The abundance of data brought about by the development of the fields of the “omics” 
led to an increased understanding of biologic complexity. With this understanding came 
the need to address issues that could otherwise be dismissed with the existence of 
unknown or unmeasurable factors12. It also helped justify the shortcomings of models 
used in Systems Biology and Metabolic Engineering and the redirection of efforts 
towards the improvement of in silico solutions.  
With the advent of large scale DNA synthesis, its decreasing cost and improved 
sequence design, molecular biologists turned their attention towards the integration of 
increasingly complex genetic networks in well studied organisms, whilst attempting to 
predict and manipulate not only the behaviour of these exogenous networks but also 
the response of the native regulatory elements13–17. Together with the definition of 
operational parameters of simple genetic elements and their contextual behaviour at all 
scales, Synthetic Biology aims to deliver predictive engineering of complex phenotypes 
in microorganisms18–21. 
It draws on the need to measure (and indeed frequently re-measure) parameters 
associated with the genetic elements that play functional roles in the cell in order for 
the design of complex networks to be possible ab initio. It relies heavily on the 
advances of DNA synthesis and more traditional genetic engineering strategies (e.g. 
generation of libraries, vector mediated cloning, use of molecular reporters for indirect 
quantification of species) to allow for the exploration of design parameters and focuses 
intentionally on a small set of organisms to deliver on these objectives.  
As such it attempts to constrain the amount of resources necessary to design a new 
strain for a specific application, through component reuse and standard approaches. 
The implications for Industrial Biotechnology are that the risk and cost involved with 
R&D should decrease and new markets can be accessed as long as an appropriate 
biological chassis for the task is available. 
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1.3. Metabolic Engineering and Synthetic Biology 
It is important to mention that in the context of Industrial Biotechnology there is an 
apparent overlap between the fields. It is the opinion of the author that part of this 
overlap is a result more of the exploration of scientific opportunities created by novel 
tools from members of both communities that have similar interests and to some extent 
by the movement of members of communities “across the lines”. The expansion of 
some Synthetic Biology projects beyond the borders with Metabolic Engineering comes 
from the understanding that any model or standard approach can only be truly 
validated in a practical setting, and to that effect the most obvious and pragmatic path 
is to either compare it to existing tools or to use them to further the impact of the 
approach.  
The conjugation of methods developed in both fields should become the standard 
approach for industrial strain development in the future, with specialists from both fields 
being integrated into R&D teams22,23.  
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1.4. Pre-genomic era strain improvement 
Initial efforts for strain improvement were based on assumptions that microorganisms 
in large scale cultures could be treated as chemical systems. Basic parameters such 
as growth and total yield were studied with the use of simplistic metabolic flux models, 
and thus only in a limited number of cases could organisms with relevant phenotypical 
properties be used at an industrial scale12.  
At a genetic level, improvements could be obtained through mutagenesis (see Figure 
1.2), either by exposing a population of microorganisms to ionizing radiation (ultraviolet, 
gamma or X-rays) or to chemical mutagens (ethyl methane sulphonate, nitrosomethyl 
guanidine, etc)24. The specific phenotype of interest would be isolated by adjusting the 
mutagen dosage and by the parameters used in the screening procedure. Directed 
mutagenesis could also be achieved by generating conditions that would force an 
increased transcription rate at genes controlling production24.  
With the development of recombinant technologies came a substantial increase in the 
ability to control targets for improvement. The enzymes affecting the production of the 
desirable compounds could be more easily studied and their limitations understood, as 
well as modified to optimize their activity when they were found to be lacking9. 
Competing pathways could be more easily studied and interfered with, providing 
improved flux to those central to the biosynthesis of the target compounds. 
Overall models could be improved and more information on the system of interest 
could be gathered in a stepwise fashion. However, the complete set of regulatory 
elements that affected target pathways was in most cases impossible to identify and 
characterise, limiting the scope of successful applications12. 
Figure 1.2 – Random mutagenesis by exposure to ionising radiation or chemical mutagens. 
Time of exposure or concentration of mutagen are crucial parameters for successful isolation 
of improved strains. 
32 
 
1.5. Post-genomic era strain improvement 
The development of whole genome sequencing technologies was closely followed by 
whole transcriptome measurement tools under the form of DNA microarrays4. This 
development brought about the opportunity to understand the effects of overproduction 
of metabolites in strains and the impact of changes in culturing conditions observed not 
only during small scale studies but also throughout scale-up25–28. The availability of 
these high-throughput multi-target techniques inspired the development of further high-
throughput screening (HTS) tools for the characterization of protein and metabolite 
abundance, protein and regulatory interactions and many others.  
The integration of information obtained through the use of these tools fell within the 
remit of Systems Biology, a discipline that having preceded this revolution in molecular 
biology by decades29 gained new impetus through the “omics” age.  
The integration of Systems Biology approaches in the field of Metabolic Engineering 
(see Figure 1.3) has been referred to as Systems Metabolic Engineering, and has of 
late contributed to important advances in strain improvement30–33. 
Figure 1.3 – Integration of “omics” tools in the Metabolic Engineering process. 
Systems Biology allows for the improved prediction of targets for rational strain 
development.  ‘Extended metabolic engineering cycle.’ (Knuf and Nielsen 2012)
293
 
13-11-2014 
33 
 
Background 
1.6. Rational methods 
Whilst several advances have been made since its genesis, Metabolic Engineering has 
used Flux Balance Analysis (FBA) to guide strain development. FBA aims at the 
description of metabolism as a set of chemical fluxes described mathematically at 
steady-state, with balanced reactions and assuming that the system tends to an 
optimal phenotype (e.g. biomass). Perturbations of various natures can then be applied 
to predict flux under conditions relevant to the study34. Figure 1.4 summarises the 
application of this methodology. 
Several extensions and modifications of the process were proposed over time to 
include both improved ability to simulate cellular networks in silico and the ability to 
more extensively modify organisms of interest. 
Although of great relevance to Industrial Biotechnology, rational methods require a 
great deal of knowledge of the host strains’ genetic makeup and regulation. This 
project focuses on the development of a tool that can be applied in scenarios where 
this is not the case and where further insights into the regulatory mechanisms of the 
target strain that impact on the phenotype of interest can be obtained. Further detail on 
rational approaches can be obtained in references 30–33,35–39. 
Figure 1.4 – Use of FBA based methodologies for complemented with information gathered 
from metabolomic studies. ‘The combination of metabolomics with FBA’ (Lee et al. 2006)
34
 13-
11-2014 
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1.7. Non-rational methods 
Several library generation methods have been used in conjunction with rational 
pathway design in order to overcome issues such as enzymatic bottlenecks40,41, 
optimization of gene expression ratios42,43, substrate and co-factor specificity44,45, and 
molecular intermediate profile46,47, among others. The same principle has also been 
applied to strain improvement, where isolation of complex phenotypes is frequently too 
laborious to be achievable rationally. 
These methods are applied to bridge biological knowledge gaps, allowing requirements 
to be met where either no naturally occurring alternative is known or its use may be of 
increased risk against the engineering of a novel solution.  
1.8. Inverse metabolic engineering 
As an alternative to rational exploration of factors affecting expression, a number of 
inverse metabolic engineering strategies have been developed. These strategies rely 
on the isolation of phenotypes of interest after the application of non-targeted 
approaches, the identification of the causative factors and replication of the phenotype 
Figure 1.5 – Development of high throughput and lower cost genomics and 
transcriptomics allows for the identification of targets post random mutagenesis and 
rational strain improvement. 
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through rational engineering48(see Figure 1.5).  
Classical mutagenesis experiments addressed strain improvement blindly – whilst 
defining the experimental parameters was a complex undertaking very little information 
could be derived on the novelty of the resulting strains. This issue can now be 
addressed with the ability to cheaply sequence bacterial genomes and some 
resurgence of the technique has occurred49–53. Following the identification of mutations 
responsible for a phenotype of interest, rational modifications can be produced in non-
mutated strains that allow a similar level of improvement. The amount of novelty found 
in this strategy is however limited and other methods offer more dynamic perturbation 
of pathway regulation. 
Libraries with varying expression levels of known genes can also be used to identify 
targets for rational engineering by perturbing normal levels of expression of single (as 
seen in the ASKA collection54, using IPTG-inducible promoters) or multiple genes at a 
time (through trackable multiplex recombineering55, using promoter replacement).  
Overproduction of metabolites in an organism will in most cases result in the activation 
of a number of regulatory responses. This can be due to transient or continued stress 
due to metabolite or co-factor imbalance56, changes in external osmolarity, product or 
by-product toxicity57,58, burden on cellular machinery responsible for homeostasis59 or 
extreme variations of catabolism due to manipulation of environmental conditions in 
fermenters59. Whilst some deregulation events may be easy to identify in both scope 
and timing as they are result of human intervention, others will be the result of complex 
events that can be challenging to dissect both in the molecular and temporal 
dimensions, resulting in an increase of resources necessary for strain development. In 
order to address this, a number of evolutionary non-directed methods have been 
proposed that allow for the isolation of improved phenotypes. 
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1.8.1. ATFs 
This approach consists of the use of 
artificial transcription factors (ATFs) 
consisting of the conjugation of Zinc-
finger (ZF) with transcriptional 
activating or repressing domains 
(see Figure 1.6). The ZF domains 
allow for binding of a large number of 
DNA sequences by recognition of 
four base pairs, and so conjugation 
of several domains allows for larger 
stretches of DNA to be bound, whilst 
fusion of these with regulatory 
elements allows for modulation of 
gene expression. The application of 
this technique in Escherichia coli 
allowed for the isolation of strains 
with improved response to stress - 
heat shock, cold shock, osmotic 
pressure 60,61 - and butanol 
tolerance62, whilst in Saccharomyces 
cerevisiae strains with improved 
osmotolerance and thermotolerance 
and resistance to ketoconazole were 
identified 63.  
1.8.2. gTME 
Global transcriptional machinery engineering (gTME) was proposed as an alternative 
strategy to influence transcriptional regulation at a large scale. By generating mutant 
libraries of transcription factors or associated factors the affinity of RNA polymerases to 
a large number of regulatory sequences can be modulated, as seen in Figure 1.7. This 
perturbs the regulatory landscape of the cell allowing for regulatory novelty to arise. As 
an example, both variants of the sigma factor σ70 in E. coli 64and TBP in S. cerevisiae 65 
have shown improved tolerance to ethanol with extensive pre-programming of stress 
response genes. Importantly, analysis of sequences in the regulatory region of targets 
Figure 1.6 – Artificial zinc fingers create regulatory 
novelty. Combinations of zinc-fingers with different 
triplet affinities allow for recognition of unique DNA 
regions and fused domains allow for b) activation or 
c) repression of regulatory regions matching ZF 
recognition domains. a) original regulatory network. 
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modulated in mutants showed 
no apparent conserved region 
that σ70 would target, whilst 
the study of genes up-
regulated in ethanol tolerance 
in S. cerevisiae supported the 
hypothesis that most would 
have to be regulated by the 
mutant TBP in order for the 
selected phenotype to be 
observed. 
Together with the isolation of 
S. cerevisiae strains capable 
of growth in high amounts of 
glucose65, improved xylose 
fermentation66 and alternative 
feedstocks 67 and E. coli 
strains with improved 
production of lycopene 
(including strains previously 
rationally optimised)64, 
multiple improved phenotypes 
(ethanol and SDS)64 and later 
tolerance to butanol and other 
alcohols and production of 
hyaluronic acid and L-tyrosine 
through mutation of the RNAP 
α-subunit, a strong case was 
made for the need of methods 
that would allow for an efficient isolation of complex phenotypes through regulatory 
novelty. With the isolation of strains tolerant to low pH and high lactic acid 
concentration from rpoD mutant libraries in Lactobacillus plantarum68 and improved 
fermentation properties in Saccharomyces pastorianus69 it was also shown that the 
approach would be useful in less well studied species of industrial interest. 
Figure 1.7 – gTME allows for random perturbation of 
regulatory networks. a) A transcription factor or sigma 
regulator is selected for its known properties (maroon); b) 
epPCR is used to diversify the coding region; c) novel 
regulatory targets or modes of regulation are generated for a 
portion of the mutated elements (dark blue arrows indicate 
maintenance of upstream regulation due to use of native 
regions). 
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1.8.3. MAGE 
Multiplex automated genome engineering was developed with the objective of 
producing very large levels of variability across targeted genomic sites70(see Figure 
1.8). By using the ssDNA-binding protein β of the λ-Red bacteriophage in specific 
conditions oligonucleotides are targeted to the lagging strand during replication 
allowing for allelic replacement. Since a pool of oligos can be used, various targets can 
be affected at the same time, and in practical applications lycopene production was 
improved by generating a pool of mutants containing modified promoter regions of 24 
genes known to affect lycopene production70. Indigo production was increased after 
modulating expression of 12 genomic operons using synthetic T7 promoters71. Whilst 
this demonstrates the power of the approach it also emphasizes one of its limitations – 
the need to identify targets a priori and the limited size of modifications that can be 
made at each cycle. Regardless, the application of this method to both directly and 
indirectly affect phenotypes of interest should be possible, making this a powerful 
alternative to rational approaches in organisms where it can be implemented.  
1.8.4. Usage of exogenous regulators for transcriptomic rewiring 
Significant proteome changes were identified upon expression of irrE from 
Deinococcus radiodurans in E. coli. After characterising this gene as responsible for 
conferring a phenotype of improved radiation resistance, possible roles of this 
exogenous regulator for stress 
tolerance were explored72,73.  
Although E. coli strains did show 
enhanced stress response to 
various stimuli they failed to 
produce an improved response to 
others. In order to isolate improved 
strains responding to alternative 
stresses irrE was diversified and 
expressed with the groESL 
promoter, providing expression of 
the mutants under general stress 
response (see Figure 1.9). This 
allowed for the isolation of E. coli 
Figure 1.8 – The MAGE principle. Oligos are produced to 
target specific chromosomal locations generating 
diversity at targeted loci via recombination. ‘Multiplex 
automated genome engineering enables the rapid and 
continuous generation of sequence diversity at many 
targeted chromosomal locations across a large 
population of cells through the repeated introduction of 
synthetic DNA’, Wang et al. 2009. 
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strains with improved ethanol, butanol and acetate tolerance74. 
Studies of the transcriptomic and proteomic profiles of isolated strains revealed 
extensive modulation of the regulatory response to stress75. Whilst rational engineering 
of a similar response would be a complex task, this strategy would allow for the 
identification of possible approaches or the replication of the response by modification 
of endogenous regulators. It does provide a different avenue for strain engineering, the 
integration of regulatory elements that are foreign to the species, which could result in 
increased regulatory novelty. 
1.9. Regulatory networks 
Response to external stimuli and 
internal states in organisms requires 
the orchestration of a large number 
of molecules. The apparent 
organization of these biological 
molecules is usually abstracted 
under the form of networks, where 
elements that compose the network 
are seen as nodes and their 
interaction as edges76. This 
abstraction serves as a meaningful 
way of organizing the flow of 
information between elements in 
order for its study to be possible. 
Several classes of networks exist, 
usually involving single types of 
molecules: metabolic networks 
organise metabolites and enzymes 
responsible for their modification; 
protein-protein interaction networks 
describe the mode by which proteins 
affect the activity of other members 
of the class; gene regulatory 
networks describe the way by which 
genetic elements are regulated by 
Figure 1.9 - New phenotypes can be obtained by 
expressing exogenous TFs. b) Inclusion of an 
exogenous TF may result in specific regulatory 
changes; c) diversification of exogenous TFs may be 
necessary and sufficient to obtain new phenotypes. 
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the activity of proteins (directly) or their products (indirectly)77; or multiple types of 
molecules: signalling networks organise the flow of information in sensory systems by 
tracking protein-protein interactions, metabolite levels and gene regulation78,79. 
Identification of nodes that have central roles in organizing the network allows for the 
study of context dependent information flow and the establishment of a hierarchy80,81. 
To this effect parameters such as degree of connectivity, distance to other elements, 
diameter, clustering coefficient or betweenness can be used77 (see Figure 1.10). 
1.10. Transcriptional regulatory networks 
Maintenance of appropriate levels of mRNA is necessary for the purpose of adaptation 
to intra and extracellular conditions without excessive investment of cellular 
resources82. Regulation of transcript levels is achieved through (but not exclusively) 
transcription factors (TFs), proteins responsible for the binding of cis-regulatory 
elements in promoters and modulation of their activity. TFs can also include a domain 
that allows for regulation through the presence of small molecules, phosphorylation or 
interaction with other proteins. 
Whilst some TFs regulate a very large number of targets (global regulators) others 
interact with only a few, usually within a related process (fine tuners)77,83. The global 
regulators can be seen as 
regulatory hubs, responsible for 
the overall coordination of cellular 
responses and with overlapping 
sets of targets, whilst others will 
have a more function specific set 
of targets84. The existence of this 
property allows for the definition 
of a hierarchy of regulation.  
TRNs are then defined through 
the organisation of TFs and their 
regulatory targets. Regulation is 
defined through the directionality 
of the edge and its intensity 
(activation, repression, self-Figure 1.10 – Topological parameters. All graphs and 
formulae based on an undirected network. Adapted from 
Zhu et al. (2007) 
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regulation) both at the input and output levels, allowing for 
the analysis of information flow through the network85. A 
three layer model was proposed by Jothi et al (2009)84  
comprised by top, core and bottom layers (represented in 
Figure 1.11). Most of the regulatory targets would be 
regulated by the core layer, containing most of the 
regulatory hubs, with the top layer transcription factors being 
responsible for activation of the regulatory cascades. 
Co-regulation is statistically overrepresented versus random 
networks when considering members of just the core layer 
or mixed top and core layers. As expected, co-regulation 
with members of top and bottom layer is severely 
underrepresented. 
1.10.1. Modules 
When analysing TRNs elements that can be grouped through the biologic process they 
orchestrate or through association in specific responses may be considered as 
modules83,86. This higher level of abstraction allows for the study of subsets of TFs 
involved in a particular function and can yield relevant information on the adaptation of 
cells to specific conditions. In a way, this abstraction is the attempt to organize 
elements of a TRN in a biologically functional way. 
1.10.2. Motifs 
When considering the properties of closely related members of the network it is also 
possible to define patterns of regulation observable across different modules or even 
scales of the network87. These patterns, network motifs, show how similar modes of 
regulation can be applied to different needs in order to obtain an efficient and robust 
response. Examples of network motifs are auto-regulation (positive and negative), 
feed-forward loops, single input modules and dense overlapping regions, in order of 
increasing complexity (see Figure 1.12). The existence of motifs can be justified by the 
effects they produce in the processing of signalling inputs – detection of persistent 
signals88, faster response88–90, temporal control91,92, robustness 92–95. 
Figure 1.11 – Three layer 
model of a TRN. Adapted 
from Jothi et al. (2009). 
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1.10.3. Node identity 
In the abstraction of a network 
as a graph, edges are 
represented through 
parameters such as 
directionality and intensity or 
effect, with nodes being the 
identifiers of the elements 
taking part in an interaction84,96. 
Although these are usually 
referenced through the coding 
region associated with the 
regulatory effect, the 
underpinned interaction takes 
place through either cis- or 
trans- regulatory elements. 
1.10.4. Cis-regulatory 
elements 
Regulation of gene expression 
is dependent on the identity of non-coding regions that are usually located near the 
coding region itself. Some elements may be located remotely when considering base 
pair distance, becoming spatially close through DNA three dimensional 
arrangements97–99(see Figure 1.13). In order for a regulatory element to be considered 
as cis- acting it has to regulate directly the target gene, and as such be considered part 
of an expression module. 
Elements of relevance include promoters, enhancers, silencers, upstream activating 
sequences, intronic regions and some types of RNA elements such as riboswitches 
and iron-responsive elements.  
The existence of one or more recognition sequences for TFs, the so called transcription 
factor binding sites (TFBS), is necessary for activity of the trans-regulatory elements, 
and is frequently used to predict the existence of such elements in silico100,101. In yeasts 
and prokayotes cis-regulatory regions are mostly limited to a distance of a few hundred 
base pairs from the coding region102,103, allowing for an easier dissection of functionally 
Figure 1.12 - Commonly occurring motifs and their main 
properties 
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relevant sequences compared to 
metazoans, where these can be 
located several kb away. 
1.10.5. Trans-regulatory elements 
Diffusible molecules capable of 
modulating gene expression are 
considered to be trans-regulatory 
elements. Most noticeably transcription 
factors operate by binding recognition 
sequences in the cis- regions and allow 
for orchestrated expression across the 
genome. Proteins that interact with 
transcription factors to achieve this 
purpose can also be included in this 
class as they still perform trans- 
regulation even though this is achieved 
indirectly104. 
Other elements such as non-coding 
RNAs can also trans- regulate gene expression: miRNA105–107, piRNA108, ta-siRNA 
109,110 and long-ncRNA111 modulate gene expression by affecting mRNA stability, 
recognition and degradation. These elements will not be further discussed as only TFs 
will be addressed in this work. 
1.11. Evolution of regulatory networks 
Whilst the evolution of novel activities in functional cellular components (e.g. enzymes, 
transporters) is required for adaptation of organisms to new environmental conditions it 
is the regulatory aspect of the adaptive process that allows for a complex change in 
cellular activity to become integrated with the overall functioning of the organism112. 
The creation of a regulatory novelty potential is not necessarily dependant on the 
adaptation to new environments, as new regulatory modes can emerge through events 
such as duplication83,113, with acts as a major driving force of TRN evolution by 
supplying the organism with increased plasticity.  
Figure 1.13 – Transcriptional regulation at a 
distance.  a) An enhancer located at a distance can 
regulate transcription through b) enhancer binding 
factor recognition and c) interaction with a 
mediator complex d) resulting in spatial 
reorganization of the DNA double strand and 
interaction of the EBF with TFs.  
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Duplication events may generate copies of a transcription factor, of a target gene or 
both. Divergence from the original activity of the TF or different modulatory structure of 
the cis-regulatory elements can result in novel regulation and/or loss of previously 
existing regulatory modes114,115, as shown in Figure 1.14. 
1.11.1. Evolution of cis-regulatory elements 
Mutations in regulatory regions affecting the recognition sites of TFs may lead to 
modulation of affinity, loss of interaction or gain of interaction with different TFs116,117. 
Seeing that the impact of insertions, deletions and changes of nucleic acid identity tend 
to be relatively limited, especially in sites where no specific regulatory element is found 
(transcription-factor binding sites, enhancers, promoters, etc) it is considered that these 
regions have a large evolutionary potential117,118. However, cis-regulatory changes 
alone do not account for the evolution of all phenotypic traits across species, with 
variable contributions of cis- and trans- elements explaining better the development of 
phenotypical novelty across species119. 
Figure 1.14 – Regulatory novelty via duplication. Duplication of the a) TF coding region,b) target 
regulatory region c) or both TF coding region and target regulatory region can generate regulatory 
novelty potential. Duplicated TFs targeting the same region may generate new regulatory patterns 
by d) divergence of target binding sequence. Duplication of a TF's target region may lead to e) 
divergence of the target region leading to regulation by an unrelated TF (regulation by the original 
TF may still occur). Duplicated TF coding and target regions may evolve through f) divergence of 
one duplication pair in tandem, g) independent divergence of one coding region resulting in a TF 
with recognition for disparate target regions or h) divergence of the TF recognition sequence 
resulting in control from an unrelated TF. 
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1.11.2. Evolution of trans-regulatory elements 
The mutation of TF coding regions resulting in modified specificity tends to impact 
heavily on the ability to coordinate responses to environmental challenges through de-
regulation of critical processes120–123. Whilst evolution may occur through sequence 
divergence in the DNA binding domains it may also affect protein interaction domains 
impacting on recognition of regulatory partners or cofactors124. There are few cases of 
proven regulatory adaptations caused by trans elements in species specific adaptation, 
a consequence of the criticality of TF function, and thus most cases are linked with 
large evolutionary events 125–127. 
In the case of the mating-type locus regulation in yeasts from the Hemiascomycetes 
class (see Figure 1.15) it has been shown that a trans-regulatory element had to evolve 
in parallel with cis-regulatory elements in order for new regulatory behaviour to 
emerge116. Interestingly mutations in the regulatory protein were localised to a small 
stretch of amino acids that did not affect activity of the ancestral protein124, in a similar 
mechanism to the mutation of unconstrained sequences in the cis- region. 
1.11.3. Rewiring 
Whilst the mechanism of network evolution is 
important for the understanding of new 
behaviour acquisition, it is the endpoint of this 
process that is usually apparent in the study 
of transcriptional regulation of an organism. 
The term rewiring is used for this purpose, 
reflecting the nature of the addition of a new 
edge in the network with the maintenance of 
an existing node, be it a TF or the regulated 
gene. It should be noted that the term has 
also been used for the purpose of indicating 
changes in transcription control upon altered 
environmental conditions128,129.  
In this thesis, the use of the term ‘rewiring’ is 
restricted to a new edge in the network 
architecture, rather than the observation of 
Figure 1.15 – Changes in mating locus 
regulation across Hemiascomycetes 
species. a) Ancestral regulation of mating 
type through a2 mediated activation of the 
asgs locus in a-cells (as seen in Candida 
albicans) b) evolved towards the  α2 
mediated repression of the locus in α-cells 
(as seen in Kluyveromyces lactis) and a c) 
final state of repression of the locus in α-
cells with a2 independent activation in a-
cells. Adapted from Tsong et al. (2006). 
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the dynamic behaviour of TFs upon exposure to different signals.  For the purposes of 
evolutionary rewiring, it is considered that it has occurred if evolutionary pressures 
modify altogether the nature of the edges involved (e.g. loss of the initially known edge 
when returning to the conditions of the original observation).  
The process of rewiring is completed after a novel regulatory relationship between 
transcription factor and target gene is created. Several examples of complex and 
generalised rewiring of the transcriptome have been reported such as in the case of 
DNA damage130, introduction of exogenous transcription factors73, evolutionary 
studies86, 116,131 or cellular deregulation132. 
1.12. Regulatory perturbation as a tool for exploration of 
network parameters 
In order to understand the impact that a specific node or edge has in a TRN it is 
insufficient to observe evolutionary change or information flow in changeable 
conditions. The ability to systematically modify transcription-factor activity is required, in 
parallel with knowledge of the underlying TRN and sufficient throughput to derive 
meaningful conclusions. 
This can be achieved through the study of network behaviour after deletion or 
overexpression of genes and/or nodes. The use of libraries in E. coli and S. cerevisiae 
containing strains with genes expressed under an inducible promoter or inactivated 
allows for the determination of gene essentiality, lethality, and fitness 54,133–136. 
Modification of edge parameters and removal of nodes allows for the study of their 
relevance towards normal cellular processes, but the effective range of phenotypes 
that can be produced is limited. This is mostly due to the loss of potential in deletion 
studies and limited effects produced by linear overexpression of TFs expected from 
inbuilt robustness and buffering in TFNs. 
1.12.1. Rewiring through node addition 
Recently the concept of node addition was explored by Isalan et al. (2008)137. By 
adding combinations of transcription and σ-factors and their promoters (including 
regulatory regions) over the wild-type background of E. coli it was possible to create 
not only new nodes in the TRN but also generate edges. These edges would to a large 
extent mirror the cis-regulatory nature of the promoter regions used in terms of input 
and the trans- regulation specific to the fused TF (see Figure 1.16). 
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Although artificial and disconnected from further mutation, rational rewiring mimics to 
some extent the events that follow duplication and result in adaptive/evolutionary 
rewiring, providing a method to address the questions of network robustness and 
adaptation to new conditions. 
It has resulted from this study that improved phenotypes were isolated, such as 
optimized growth in specific media conditions, survival in stationary phase and heat 
resistance. In the case of these last two conditions, the same re-wiring event was 
identified (promoter: rpoS, ORF: ompR), showing that a single re-wiring event may be 
key to a positive response of the cells in multiple conditions.  
Another relevant result was that most combinations (72%) resulted in over-expression 
of the ORFs over background when expressed from a plasmid, as monitored by 
expression of GFP included downstream of the ORF. The hierarchy of the ORF within 
the TRN correlated with expression (higher in the hierarchy means higher expression 
levels) whilst the promoter region did not show any trend, supporting the concept that 
expression of lower-tier TFs is likely to be under more strict control.  
This result points out that the engineering of cellular responses must take into account 
limitations imposed by the TRN as they may produce responses that at this point 
cannot be predicted in silico, and that engineered systems that perturb the cell will be 
affected by such limits unless adequate strategies can be adopted. 
Figure 1.16 – Rewired node addition generates regulatory novelty. Driving the 
expression of a master regulator (g6) with the promoter of a low-tier regulator (p11) 
results in its expression under conditions that would normally lead to repression. 
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1.13. Motivation 
Currently the ability to predict cellular responses upon overproduction of metabolites is 
still limited. One of the factors that will affect cellular behaviour is the perception of 
metabolic fluctuations and the resulting regulatory adaptation imposed by the TRNs, 
which will affect processes differently at different levels of industrial strain development. 
The use of rational approaches towards engineering TRN responses is thus an open 
challenge that will require extensive understanding of the dynamics of regulatory 
networks and the identification of design rules. 
Tools that may inform future strain design through the understanding of the effect of 
addition and modification of a single TF (gTME and introduction of exogenous TFs) and 
the modulation of regulatory responses through addition of nodes of an entirely 
engineered nature (ATFs) are already available. However these strategies rely on 
either stepwise exploration of nodes or the use of non-natural elements that may 
subvert the study of network architecture by implementing regulation that is 
disconnected from the TRN and to some extent orthogonal. This last element can 
become of extreme interest once the design principles become known and 
implementation of artificial control feasible. 
Among the factors that can inform future design are the changes in network hierarchy - 
how new nodes interact in coordination with pre-existing levels of regulation; the 
changes in mode of regulation - what type of regulatory pattern is favoured when 
specific types of processes are established; the depth and breadth of the changes that 
occur and their correlation with the essentiality or orthogonality of the new process. 
The strategy implemented by Isalan et al. (2008) has the potential of allowing the 
exploration of parallel rewiring events by node addition and the posterior study of their 
impact on the TRN structure. 
It should also allow for the exploration of the regulatory landscape of less well 
characterized species: TFs are known to be organized in well conserved families and 
their identification is thus made simpler. Limitations in genetic tractability of these 
species is therefore the largest obstacle to pursuing this strategy. In principle, 
expressing the promoter-TF fusions should allow for the isolation of phenotypes of 
industrial relevance, such as tolerance to stress and improved growth in alternative 
feedstocks. 
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Considering the results obtained using the previously described methods, it should also 
be possible to perturb the TRNs in a way that allows for the improved production of 
metabolites in strains containing heterologous pathways. For this purpose a library of 
promoters and TFs should be tested in strains producing the compound of interest. 
This thesis addresses the exploration of such a method for the improvement of strains 
producing metabolites of industrial interest, where the knowledge of transcriptional 
control is limited. Initial work in Mycobacterium smegmatis explored the use of 
transcriptional regulatory network rewiring for the purpose of obtaining general 
phenotypes of interest and Pichia pastoris was used to validate the method towards the 
isolation of rewired strains overproducing the carotenoid lycopene. Five unique strains 
with improved lycopene yield and productivity versus non-rewired control were isolated 
and validated from a combinatorial library containing 2814 variants and tested at flask 
scale. One of the isolated strains revealed a novel pattern of lycopene expression 
under poor aeration conditions supporting the method’s applicability to the selection of 
phenotypes not only for industrial applications but also gene regulation studies. 
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2. Methods 
2.1. Strains and plasmids 
2.1.1. E. coli specific 
E. coli strains used throughout this work are described in Table 2.1. 
 
Table 2.1 – E. coli strains used in this study 
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2.1.2. M. smegmatis specific 
M.smegmatis strains used throughout this work are described in Table 2.2. 
2.1.3. P. pastoris specific 
P.pastoris strains used throughout this work are described in Table 2.3. 
 
Table 2.2 – M. smegmatis used in this study 
Table 2.3 – P. pastoris used in this study 
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2.1.4. Plasmids 
Table 2.4 includes all plasmids produced or used throughout the work here described.  
Table 2.4 – Plasmids used in this study 
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2.2. Media  
2.2.1. Miller Lysogeny Broth (LB) Medium 
LB medium was prepared by dilution of 1% (w/v) Peptone from casein (Sigma-Aldrich 
UK, Gillingham, UK), 0.5% (w/v) Yeast Extract (Sigma-Aldrich UK, Gillingham, UK) and 
1% (w/v) NaCl (Sigma-Aldrich UK, Gillingham, UK) in 30% of the total volume to be 
prepared of ddH20, and addition of ddH20 up to the total volume. Agar plates were 
produced by addition of 1.5% (w/v) agar (Sigma-Aldrich UK, Gillingham, UK). 
2.2.2. Sauton Medium 
Sauton medium was prepared by dilution of 0.05% (w/v) Monopotassium phosphate 
(Sigma-Aldrich UK, Gillingham, UK), 0.05% (w/v) Magnesium Sulphate heptahydrate 
(Sigma-Aldrich UK, Gillingham, UK), 0.2% (w/v) Citric acid (Sigma-Aldrich UK, 
Gillingham, UK), 0.005% (w/v) Ferric Ammonium (Sigma-Aldrich UK, Gillingham, UK), 
6% (v/v) Glycerol(Merck, Nottingham, UK), 0.4% (w/v) Asparagine (Sigma-Aldrich UK, 
Gillingham, UK) and 0.05% (v/v) Tyloxapol in 30% of the total volume to be prepared of 
ddH20, and addition of ddH20 up to the total volume. Agar plates were produced by 
addition of 1.5% (w/v) agar. 
2.2.3. Yeast Extract Peptone Medium (YPD) 
YPD medium was prepared by dilution of 1% (w/v) Yeast Extract, 2% (w/v) Peptone 
from casein and 2% (w/v) Dextrose in 30% of the total volume to be prepared of ddH20, 
and addition of ddH20 up to the total volume. Agar plates were produced by addition of 
2% (w/v) agar. 
2.2.4. Minimal Dextrose Medium (MD) 
MD medium was prepared by dilution of 1.34% (w/v) Yeast Nitrogen Base (Sigma-
Aldrich UK, Gillingham, UK), 4x10-5% (w/v) d-Biotin (Sigma-Aldrich UK, Gillingham, 
UK), 2% (w/v) Dextrose (Sigma-Aldrich UK, Gillingham, UK) in 30% of the total volume 
to be prepared of ddH20, and addition of ddH20 up to the total volume.  
2.2.5. Minimal Methanol Medium (MM) 
MM medium was prepared by dilution of 1.34% (w/v) Yeast Nitrogen Base, 4x10-5% 
(w/v) d-Biotin, 0.5% (w/v) Methanol (Merck, Nottingham, UK) in 30% of the total volume 
to be prepared of ddH20, and addition of ddH20 up to the total volume. 
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2.2.6. Regeneration Dextrose Medium (RD) 
RD medium was prepared by dilution of 18.6% (w/v) Sorbitol (Sigma-Aldrich UK, 
Gillingham, UK), 1.34% (w/v) Yeast Nitrogen Base, 4x10-5% (w/v) d-Biotin, 2% (w/v) 
Dextrose and 0.005% Amino Acids ) in 30% of the total volume to be prepared of 
ddH20, and addition of ddH20 up to the total volume. Agar plates were produced by 
addition of 2% (w/v) agar. 
2.2.7. Amino Acid Stock Solution (0.5%) 
Amino acid stock solution was prepared by dilution of 0.5% (w/v) L-glutamic acid 
(Sigma-Aldrich UK, Gillingham, UK), L-methionine (Sigma-Aldrich UK, Gillingham, UK), 
L-lysine (Sigma-Aldrich UK, Gillingham, UK), L-leucine (Sigma-Aldrich UK, Gillingham, 
UK) and L-isoleucine (Sigma-Aldrich UK, Gillingham, UK) in 70% of the total volume to 
be prepared of ddH20, and addition of ddH20 up to the total volume. 
2.3. Molecular Biology 
2.3.1. Plasmid DNA isolation 
Plasmids were isolated from E. coli and M. smegmatis cultures using QIAprep Spin 
Miniprep Kits (Qiagen, Hilden, Germany) and according to the manufacturer’s 
instructions. 
2.3.2. Isolation of yeast genomic DNA 
gDNA was isolated using Wizard® Genomic DNA Purification Kits (Promega, Madison, 
USA) and according to the manufacturer’s instructions. 
2.3.3. DNA quantification 
Measurements were performed using 1µL of solution in a Nanodrop™ 1000 UV-Vis 
(ThermoScientific, Pittsburgh, USA) spectrophotometer. 
2.3.4. Gel Extraction 
Gel extractions were performed using the Wizard™ SV Gel and PCR Clean-Up System 
(Promega, Madison, USA) and according to the manufacturer’s instructions. 
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2.3.5. Restriction Digests 
All restriction enzymes were obtained from New England Biolabs (Hertfordhsire, UK) 
and digestions were performed according to the manufacturer’s instructions.  
Plasmid linearization for transformation was performed for 1h and a clean-up 
procedure was performed using the Wizard™ SV Gel and PCR Clean-Up System 
protocol with parameters similar to those for PCR clean-up. 
2.3.6. Circular Polymerase Extension Cloning 
All reactions were performed according to Quan and Tian (2009) with some 
adaptations. Reaction volumes used were of 25µL, with 200ng of linear vector and 
equimolar amounts of insert. Denaturation was performed at 98°C for 1 minute, 
annealing at 55°C for 30 seconds and extension at 20s per kb of final product. 1.25µL 
of Phusion DNA polymerase (New England Biolabs, Hertfordhsire, UK) was used per 
reaction. 
2.3.7. One-pot isothermal assembly 
Gibson assembly was performed according to Gibson et al. (2009). 6mL 5x Isothermal 
Reaction Mix was prepared using 3mL 1M Tris-HCl (pH 7.5) (Sigma-Aldrich UK, 
Gillingham, UK), 300μL 1M MgCl2 (Sigma-Aldrich UK, Gillingham, UK), 60μL 100mM 
dGTP (Bioline, London, UK), 60μL 100mM dATP (Bioline, London, UK), 60μL 100mM 
dTTP (Bioline, London, UK), 60μL 100mM dCTP (Bioline, London, UK), 300μL 1M DTT 
(Sigma-Aldrich UK, Gillingham, UK), 1.5 g PEG-8000 (Sigma-Aldrich UK, Gillingham, 
UK), 300μL 100mM NAD (Sigma-Aldrich UK, Gillingham, UK) and ddH20 up to the final 
volume. 1.33x Gibson Master Mix was prepared by mixing 50µL Taq DNA ligase 
(40u/µL) (New England Biolabs, Hertfordhsire, UK), 100µL 5x isothermal buffer, 2µL T5 
exonuclease (1u/µL) (New England Biolabs, Hertfordhsire, UK), 6.25µL Phusion DNA 
polymerase (2u/µL) and 216.75µL ddH2O.  
Assembly reactions were prepared on ice using 15µL of 1.33x Gibson Master Mix and 
5µL of solution containing 100ng of the largest DNA fragment to be assembled and 
equimolar amounts of all other fragments. 
All reactions were performed for 1h, with the exception of library assembly where 
components were allowed to react for 8h. 
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2.3.8. Agarose Gel Electrophoresis 
DNA separation was performed using 1% (w/v) agarose gels. Fragments up to 8kb 
were separated by applying a constant 110V field for 27 minutes. Fragments above 
8kb were separated by applying a constant 95V field for 45 minutes. TAE buffer was 
used (0.484% (w/v) Tris Base (Sigma-Aldrich UK, Gillingham, UK), 0.1142% (v/v) 
Glacial Acetic Acid (Sigma-Aldrich UK, Gillingham, UK) and 10% (v/v) of a 500mM 
EDTA (pH 8.0) solution) (Sigma-Aldrich UK, Gillingham, UK) to dissolve agarose and 
heating was applied until it melted.  
Agarose was poured into moulds at approximately 60°C and SYBR® Safe(Invitrogen, 
Paisley, UK) was diluted 1:20,000 for gels used for gel extraction procedures, whilst 
GelRed (Biotium, Hayward, USA) was diluted 1:10,000 for gels used for sizing. 
6x Loading buffer (10mM Tris-HCL ph7.6, 0.15% orange G (w/v) (Sigma-Aldrich UK, 
Gillingham, UK), 60% glycerol (v/v) and 60mM EDTA) was diluted in DNA samples and 
loaded into gels. For sizing purposes 3µL GeneRuler™ 1kb DNA Ladder 
(ThermoScientific, Pittsburgh, USA) was typically used. 
Agarose gels were imaged using a Gel Doc XR System (Bio-Rad, Hemel Hempstead, 
UK) with emission of trans-UV at 302nm. Gel Extractions were performed using a Visi-
Blue™ Transilluminator (UVP, Cambridge, UK). 
2.3.9. Primer design 
All primers were designed with a GC clamp where possible. Melting temperatures were 
determined using the IDT OligoAnalyzer tool (Integrated DNA Technologies, Leuven, 
Belgium) with target as DNA, oligo concentration of 0.5µM, Na+ concentration of 0, 
Mg2+ concentration of 1.5mM and dNTPs concentration of 0.3µM unless stated 
otherwise. Hairpin structures, self-dimerisation and hetero-dimerisation with primer pair 
were also verified using the tool and primers adapted where issues could arise. 
Assembly primers were designed to allow for a minimal ΔTm between primers and Tm 
above 55°C.  
Library primers were designed so as to achieve a Tm between 60°C and 65°C, primer 
pair ΔTm below 2°C and minimal length. 
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Sequencing primers were designed to allow for amplification starting at -100bp of the 
sequencing target and a Tm of 55°C using the IDT OligoAnalyzer tool with target as 
DNA, oligo concentration of 0.25µM, Na+ concentration of 50mM, Mg2+ concentration of 
0mM and dNTPs concentration of 0µM. 
2.3.10. Polymerase Chain Reaction (PCR) 
PCR reactions were performed in 0.2mL PCR tubes (VWR, Lutterworth, UK) in either 
Mastercycle Gradient (Eppendorf UK, Histon, UK), Veriti® (Applied Biosystems, 
Waltham, USA) or GS482(G-Storm, Catcombe, UK) thermal cyclers. Phusion DNA 
polymerase was used for all reactions, with the provided 10µL Buffer HF/GC, 1.5µL 
dNTPs, 2.5µL forward primer, 2.5µL reverse primer, 0.5µL of polymerase, 5µL of 
template and 28µL of ddH20 for a reference mix totalling 50µL. Concentration of 
template varied according to product size and source. Reactions containing betaine 
(Sigma-Aldrich UK, Gillingham, UK) or DMSO (Sigma-Aldrich UK, Gillingham, UK) 
were prepared by dilution of stock solutions, with 7.5% DMSO being achieved by 
addition of 3.75µL of DMSO to a 50µL reaction. 
PCR parameters as follow: 1m30s initial denaturation at 98°C, 30 seconds 
denaturation at 98°C, 30 seconds annealing at the highest primer Tm of the pair, 15 
seconds per kb for plasmid template/ 30 seconds per kb for genomic DNA extension at 
72°C, and final extension for double the extension period at 72°C. 25 cycles were used 
for all normal reactions. 
Reactions used to amplify rewiring library constructs used the follow parameters: 3 
minutes initial denaturation at 98°C, 30 seconds denaturation at 98°C, 30 seconds 
annealing at the highest primer Tm of the pair, 3m30s extension at 72°C, and final 
extension for 10 minutes at 72°C. 31 cycles were used. 
Oligonucleotides were synthesised by Integrated DNA Technologies (Leuven, 
Belgium), and a list can be found in Table 16.1, Table 16.2 and Table 16.5. 
2.3.11. Electroporation of E. coli 
Electrocompetent DH10b cells (Invitrogen, Paisley, UK) were prepared by inoculation 
of 10mL LB from a single colony and growth overnight at 37°C and 225rpm in a MaxQ 
6000 incubator (ThermoScientific, Pittsburgh, USA), inoculation of 1L of LB in a 2L 
flask by 1:100 dilution followed by growth to an OD600 of 0.5 using the same conditions, 
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centrifugation at 4000rpm for 15 minutes in a Sorvall RC 6+ centrifuge 
(ThermoScientific, Pittsburgh, USA) after 30 minutes of chilling the culture on ice, 
resuspension of only the pellet in 800mL ddH20, centrifugation at 4000rpm for 15 
minutes, resuspension in 40mL of ddH20, centrifugation at 4000rpm for 15 minutes, 
resuspension in 4mL pre-chilled 10% glycerol and finally aliquoting in 50µL volumes. 
Aliquots were then flash-frozen in dry ice and stored at -80°C. All centrifugation steps 
were performed at 4°C and cells were maintained on ice at all times after incubation. 
Transformations were performed by addition of 1.5µL to an aliquot and transference of 
the full volume to a pre-chilled 0.2cm gap electroporation cuvette (Bio-Rad, Hemel 
Hempstead, UK) and pulsing using a MicroPulser electroporator (Bio-Rad, Hemel 
Hempstead, UK) with the EC2 setting (2.5kV). 
2.3.12. Electroporation of M. smegmatis 
Electrocompetent mc2155 cells (ATCC) were produced by inoculation of 5mL Sauton 
from a single colony and growth overnight at 37°C and 225rpm in a MaxQ 6000 
incubator, inoculation of 500mL of Sauton in a 2L flask by 1:100 dilution followed by 
growth to an OD600 of 0.8-1.0, centrifugation at 3000g for 10 minutes using a 5810R 
centrifuge (Eppendorf UK, Histon, UK) after 1h30m of chilling the culture on ice, 
resuspension of only the pellet in 100mL 10% glycerol, centrifugation at 3000g for 10 
minutes, resuspension in 25mL of 10% glycerol, centrifugation at 3000g for 10 minutes, 
resuspension in 5mL pre-chilled 10% glycerol and finally aliquoting in 200µL volumes. 
Aliquots were then flash-frozen in dry ice and stored at -80°C. All centrifugation steps 
were performed at 4°C and cells were maintained on ice at all times after incubation. 
Transformations were performed by addition of 1µg to an aliquot and transference of 
the full volume to a pre-chilled 0.2cm gap electroporation cuvette after incubation on 
ice for 10 minutes and pulsing using a Gene Pulser electroporator (Bio-Rad, Hemel 
Hempstead, UK) with 2.5kV, 25µF and 1,000Ω. Recovery performed in 5mL Sauton 
media for 2h30m at 37°C. 
2.3.13. Electroporation of P. pastoris 
Electrocompetent GS115 (Invitrogen, Paisley, UK) cells were produced by inoculation 
of 5mL YPD in a 50mL Falcon™ tube (Corning Life Sciences, Tewksbury, USA) from a 
single colony and growth overnight at 29.5°C and 225rpm using a MaxQ 6000 
incubator, inoculation of 50mL of YPD in a 500mL flask at an OD600 of 0.2 followed by 
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growth to an OD600 of 0.8-1.0, centrifugation at 500g for 5 minutes, resuspension in 
9mL of ice-cold BEDS solution (10 mM bicine-NaOH, pH 8.3 (Sigma-Aldrich UK, 
Gillingham, UK), 3% (v/v) ethylene glycol (Sigma-Aldrich UK, Gillingham, UK), 5% (v/v) 
(dimethyl sulfoxide) DMSO, and 1 M sorbitol) with 1mL 1.0M dithiothreitol (DTT), 
incubation for 5 minutes at 100rpm at 29.5°C, centrifugation at 500g for 5 minutes, 
resuspension in 1mL of BEDS solution and aliquoting in 40µL volumes. 
Transformations were performed by addition of 300ng to an aliquot and transference of 
the full volume to a pre-chilled 0.2cm gap electroporation cuvette  and pulsing using a 
MicroPulser electroporator (Bio-Rad, Hemel Hempstead, UK) with the Sc2 setting 
(1.5kV). 
2.3.14. Bradford assay for protein quantification 
Protein content in cell lysates was quantified using the Bradford assay, with a 
calibration curve being produced using BSA (Sigma-Aldrich UK, Gillingham, UK) as 
standard. 
5µL of sonicated sample was incubated for 5 minutes after addition of 95µL of Bradford 
reagent, followed by quantification of protein concentration in a NanoDrop® 1000 using 
2µL of the incubated mixture.    
2.3.15. SDS-PAGE Protein Gels 
Typical samples containing 20µg of protein were prepared by quantification of total 
protein content using the Bradford assay, dilution into a 2x Sample Loading Buffer 
containing 1% (w/v) Sodium Dodecyl Sulfate (Sigma-Aldrich UK, Gillingham, UK), 20% 
glycerol, 0.01% (w/v) Bromophenol Blue (Sigma-Aldrich UK, Gillingham, UK), 0.125M 
Tris HCL pH6.8, 5% (v/v) 2-β Mercaptoethanol (Sigma-Aldrich UK, Gillingham, UK) and 
denaturation at 98°C for 10 minutes. 
Protein samples were loaded into 4-20% Precise™ protein gels (ThermoScientific, 
Pittsburgh, USA) by with 1x Tris-Hepes-SDS Running Buffer containing 1.21% (w/v) 
Tris Base, 2.38% (w/v) HEPES (Sigma-Aldrich UK, Gillingham, UK) and 0.1% (w/v) 
SDS being used for running gels for 1 hour at 125V. NuPAGE® (4–12%) Bis-Tris/MES 
ladder (Life Technologies, Paisley, UK) was used for determination of protein mW. 
Gel staining was performed using GelCode™ Blue Safe Protein Stain 
(ThermoScientific, Pittsburgh, USA) according to the manufacturer’s instructions. 
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Washing was performed with three 5 minute 100mL ddH20 washes, followed by 
staining for 1 hour at room temperature using 25mL of solution and finally washing for 1 
hour with 200mL of ddH20. 
Gels were documented using a Gel Doc XR System with epi-white light emission. 
2.3.16. Western Blot 
SDS-PAGE gels were transferred to nitrocellulose membranes using a Trans-Blot SD 
Semi-Dry Electrophoretic Transfer Cell (Bio-Rad, Hemel Hempstead, UK) running at 
25V for 27 minutes using the Bjerrum and Schafer-Nielsen transfer buffer (0.582% 
(w/v) Tris Base, 0.293% (w/v) Glycine (Sigma-Aldrich UK, Gillingham, UK), 50% (v/v) 
Methanol). 
A WesternBreeze™ Chromogenic Immunodetection Kit (Life Technologies, Paisley, 
UK) was used for protein detection according to the manufacturer’s manual. 10mL of 
blocking solution was used with incubation for 30 minutes on a rotary shaker, followed 
by rinsing of the membrane for 5 minutes with 20mL of water (twice), incubation of the 
membrane with the Primary Antibody Solution for 1h, three 5 minute washes with 
Antibody Wash solution, incubation of the membrane with 10mL of Secondary Antibody 
Solution for 30 minutes, three 5 minute washes with Antibody Wash solution, rinsing of 
the membrane with 20mL of water for 2 minutes (twice), addition of 5mL of the 
Chromogenic Substrate and development for 1 hour and finally removal of excess 
substrate by rinsing the membrane twice for 2 minutes using water.  
Gels were documented using a Gel Doc XR System with epi-white light emission. 
2.3.17. Sonication of M. smegmatis cultures 
Cultures were grown in Falcon™ 14mL tubes (Corning Life Sciences, Tewksbury, 
USA) with 5mL of Sauton media being used for this purpose. Cultures were grown at 
37°C to an OD600 of 1.2 and then induced for 24 hours. 1mL of culture was then 
centrifuged at 12,000g in a Model 5424 centrifuge (Eppendorf UK, Histon, UK), 
resuspensed in 200µL PBS (Life Technologies, Paisley, UK) followed by sonication for 
3 cycles at maximum amplitude with 1min ON 30 second OFF cycles with a Vibra 
Cell™ VCX130 sonicator with a Piezoelectric lead zirconate titanate crystals converter 
and 2mm probe (Sonics, Newtown, USA).  
61 
 
The exception to the described procedure was during the optimisation of the sonication 
process – for this 0, 3 and 10 cycles were tested, as well as the amount of cells to be 
used, with 500, 250 and 125 µL of culture at OD600 1.0. 
2.3.18. Sequencing 
Samples submitted for sequencing by Source Bioscience (Nottingham, UK) sequencing 
services were prepared by dilution of plasmid DNA to a total of 5µL at 100ng/µl and 
separate preparation of primers at 3.2pmol/µl in 5µl. 
Samples submitted for sequencing by Eurofins MWG (Anzinger, Germany) sequencing 
services were prepared by dilution of plasmid DNA to a total of 15µL at 100ng/µl and of 
primer to 1.33pmol/µL. 
2.3.19. Pairwise alignment 
Sequences were aligned using the BLAST 138 algorithm against vectors when using 
sequencing results, against the M. smegmatis genome when identifying M. smegmatis 
rewiring clones and against the P. pastoris genome when identifying P. pastoris 
rewiring clones. 
2.4. Strain maintenance 
2.4.1. Long-term storage of E. coli strains 
E. coli strains were grown to an OD600 of approximately 0.8 to 1 and diluted at a 1:1 
ratio with 50% glycerol, followed by mixing by pipetting. Stocks were stored at -80°C. 
2.4.2. Long-term storage of M. smegmatis strains 
M. smegmatis strains were grown to an OD600 of approximately 0.8 and diluted at a 1:1 
ratio with 30% glycerol, followed by mixing by pipetting. Stocks were stored at -80°C. 
2.4.3. Long-term storage of P. pastoris strains 
P. pastoris strains were grown to an OD600 of approximately 1.0 and diluted at a 2:1 
ratio with 60% glycerol, followed by mixing by pipetting. Stocks were stored at -80°C. 
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2.4.4. Antibiotic selection 
Strains of E. coli carrying plasmids conferring antibiotic resistance were grown in media 
containing 100µg/mL of Ampicillin, 170µg/mL of Chloramphenicol, 50µg/mL of 
Kanamycin or 200µg/mL of Hygromycin as appropriate. 
Strains of M. smegmatis carrying plasmids conferring antibiotic resistance were grown 
in media containing 50µg/mL of Kanamycin or 50µg/mL of Hygromycin as appropriate. 
2.5. Alkane/alkene specific methods  
2.5.1. GC-MS sample preparation 
Cultures for GC-MS were grown in Falcon 14mL with 5mL of Sauton media being used 
for this purpose. Cultures were grown at 37°C to an OD600 of 1.2 and then induced for 
24 hours.  
Extraction of hydrocarbons was performed using equal parts of culture and ethyl 
acetate (Sigma-Aldrich UK, Gillingham, UK) to a total volume of 1mL, with the 
supernatant being recovered for analysis after centrifugation at 12,000g for 3 minutes. 
GC-MS procedures after this point were handled by the Mass Spectrometry Core 
Facility, part of the Centre for Integrative Systems Biology at Imperial College 
(CISBIC). 
2.5.2. Growth and induction of reporter strain 
E. coli DH10B cells transformed with plasmid pASK-IBA3C-LuxAB gifted by Dr. Eric 
Davidson (Imperial College London) carrying an expression construct consisting of the 
LuxAB genes of the V. fischeri bacterial luciferase were used as reporters for the 
luminescence assay. 
Cultures were grown in LB overnight at 37°C in 50mL tubes and induction was 
performed by inoculation of cultures at 37°C and growth to an OD600 of 0.5, followed by 
addition of ATC (Clontech, Saint-Germain-en-Laye, France) to 200ng/mL and 
incubation for 3 hours at 30°C. Cultures were then diluted with 50% glycerol (1:1 ratio) 
and aliquots of 15mL were stored at -80°C until necessary.  
Cultures were thawed on ice previous to use in assays. 
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2.5.3. Aldehyde production and detection 
2.5.3.1. M. smegmatis cultures growth and induction 
M. smegmatis cultures were induced by as described for GC-MS sample preparation, 
with the exception of optimisation experiments (time/induction series). 
Samples were assayed by addition of 100ul of the reporter strain to 50ul of sample 
prior to analysis.  
In order to assess the effect of quenching samples were re-suspended in PBS, diluting 
the culture 5 fold and luminescence was compared against the use of growth media. 
All measurements were performed using a POLARstar Omega microplate reader (BMG 
labtech, Aylesbury, UK) in Luminescence mode without filters, maximum gain and 10 
seconds shaking at 300rpm before each cycle. LuminNunc™ 96 MicroWell™ 
(ThermoScientific, Pittsburgh, USA) plates were used for all measurements. 
2.5.3.2. P. pastoris cultures growth and induction 
After a 48h outgrowth period in MD media cultures were centrifuged and washed with 
200µL of MM media. Induction followed by addition of 250µL of MM media, with further 
incubation of samples at 700rpm, 29.5°C in a Microtron shaker incubator (Infors HT, 
Reigate, UK) for 48 hours. 
For cultures grown in 50ml Falcon tubes, 5ml of MM was used and shaking was 
performed in a MaxQ 6000 incubator at 225rpm. 
2.5.3.2.1. Testing of cultures 
20µL of individual cultures were then transferred to LumiNunc 96-well microplates 
(ThermoScientific, Pittsburgh, USA) containing 130µL of PBS per well for screening by 
addition of 150µL of the E. coli based LuxAB reporter strain and sampling of 
luminescence levels. 
2.5.3.2.2. Testing of spent media 
Microplates were centrifuged for 5 minutes at 1500g and 100µL of supernatant was 
transferred to LumiNunc 96-well microplates per culture. The screening procedure was 
similar to the one described above.  
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2.6. Methyl halides specific methods 
2.6.1. Testing of a free chloride assay 
The protocol described by Jӧrg and Bartau(2004)139 was optimized for bio-
dehalogenation processes and only to detect free chloride in cell-free media. The 
reported concentration of perchloric acid used in assays (23 M) was seemingly 
incorrect, as this concentration is not achievable with this acid.  As such the correct 
concentration had to be determined. 
Optimization of reagent concentration was performed by testing perchloric acid (Sigma-
Aldrich UK, Gillingham, UK) at 230mM, 23mM and 2.3mM and Iron (III) Nitrate (Sigma-
Aldrich UK, Gillingham, UK) at 200mM, 20mM and 2mM. 
In order to analyse the chloride content of samples 95µL of HClO4 solution, 20µL of 
Fe(NO3)3.9H20 solution and 65 µL of water were added to 20µL of samples and 
absorbance was measured at 340nm using a Synergy HT multi-detection microplate 
reader (Bio-Tek, Potton, UK). 
2.6.2. Localization of tagged GFP 
An Eclipse Ti microscope (Nikon, Amstelveen, Netherlands) was used to obtain initial 
evidence of GFP localization into the vacuole.  
5ml of YPD in 50ml tubes were inoculated with single colonies and incubated at 30°C 
for 48h at 225rpm in a MaxQ 6000 incubator. 
10µL of cultures were pipetted onto glass slides and covered with slips. Cells were 
observed using a 60x oil objective and 1.5x digital zoom, and overlays of fluorescence 
and bright field images produced. 
2.7. Lycopene specific methods 
2.7.1. Flask cultures of lycopene producing cultures 
Initially production of lycopene was tested at flask level by inoculation of 50mL of YPD 
in 500ml flasks (VWR, Lutterworth, UK) using a single colony and incubation for up to 
96h at 30°C and 225rpm in a MaxQ 6000 incubator. Changes in culture colour were 
observed visually and registered in order to assess endpoints of similar experiments. 
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2.7.2. HPLC analysis of lycopene samples 
Lycopene (Sigma-Aldrich UK, Gillingham, UK) standards were prepared by the dilution 
of 1mg in 50mL of ethyl acetate to a final concentration of 20µg/mL.  
5mL cultures of cells expressing the lycopene pathway and wild type controls were 
grown for 72h in YPD media in 14mL snap-cap tubes and were collected via 
centrifugation at 3000g for 5 minutes. Lycopene was extracted using the protocol 
described by Bhataya and Schmidt-Dannert (2009)140, with the replacement of hexane 
for ethyl acetate and the re-suspension of dried sample in ethyl acetate. 
Samples were then analysed in a Surveyor HPLC (ThermoScientific, Pittsburgh, USA) 
using a C18 ODS-2 Hypersil column (ThermoScientific, Pittsburgh, USA). The solvent 
system was as described in the previously referenced paper, with a flow of 0.5mL/min. 
2.7.3. Lycopene absorbance spectra 
Absorbance scans of lycopene samples were obtained using a Spectronic Helios Alpha 
UV-Visible spectrophotometer (ThermoScientific, Pittsburgh, USA) with samples placed 
in a narrow gap quartz cuvette and collection of OD scans from 400nm to 530nm. 
2.7.4. Identification of visible wavelengths appropriate for the quantification of 
lycopene  
P. pastoris cultures producing lycopene were mixed with non-producing cultures with 1, 
0.75, 0.5, 0.25, 0.1 and 0 ratios after inoculation of 96-well plates at an OD660 of 0.1 
and growth for 72h. 
200ml of each culture was transferred to Costar 96-well flat bottom cell culture plates 
(Corning Life Sciences, Tewksbury, USA) and absorbance spectra from 300nm to 
700nm was obtained using a POLARstar Omega microplate reader in absorbance 
mode (100 flashes per well). 
Lycopene was extracted using 50µL of culture in a 1.5ml centrifuge tube (VWR, 
Lutterworth, UK) with addition of approximately 300µL of acid-washed glass beads 
(0.5mm diameter; Sigma-Aldrich UK, Gillingham, UK) resuspended in water and 500µL 
of acetone (Sigma-Aldrich UK, Gillingham, UK), followed by vortexing for 10 minutes, 
centrifugation at 12,000g for 5 minutes, removal of acetone into a clean tube and 
addition of 300µL of hexane (Sigma-Aldrich UK, Gillingham, UK), followed by vortexing 
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for 10 minutes, centrifugation at 12,000g for 5 minutes and removal of hexane into the 
sample tube. Extractions with hexane were repeated until no colour could be observed 
in pellets. The acetone/hexane mixtures were dried by using a continuous nitrogen 
stream and resuspended in 1mL hexane. 
100ml of each extraction were transferred to Costar 96-well flat bottom cell culture 
plates and absorbance at 502nm was obtained. Background subtraction was 
performed using the extract from the culture without lycopene producing cells.  
Correlation between absorbance at each wavelength of the cultures and OD502 of the 
extracted lycopene in hexane was obtained using the Excel 2010 (Microsoft, Redmond, 
USA) CORREL function, whilst variance across cultures at each wavelength was 
obtained using the VAR function. 
Lycopene concentration of samples was estimated using the extinction coefficient of 
lycopene in hexane at OD502 (ε=1.72×10
5 L.mol−1.cm−1), the values of OD502 obtained 
from extracts after path length correction to 1cm, and the formula 
[lycopene]=εlycopene502nm x 1(pathlength) x OD502. 
Measurements of lycopene (OD484) absorbance were converted to 1cm pathlength 
using a second order polynomial with forced intercept at (0,0). 
Linear regression was used to correlate corrected OD484 measurements to 1cm path 
with lycopene concentration.  
2.8. Rewiring library specific methods 
2.8.1. Rewiring M. smegmatis 
2.8.1.1. Identification of potential regulators to be included in the M. smegmatis 
library 
Elements for inclusion in the library were identified by using the advanced query 
interface of the Uniprot website (www.uniprot.org). Parameters used included a search 
filter for organism with the identifier 246196 (Mycobacterium smegmatis, strain ATCC 
700084 / mc(2)155) and search terms including “Sigma factor”, “Transcription 
regulator”, “Regulator” and “Oxireductase”. 
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2.8.1.2. Assembly of the M. smegmatis rewiring library 
Libraries of selected promoters and transcription factors were assembled into the 
shuttle plasmid pSE100 by Ginkgo BioWorks (Boston, USA). A test library was made 
available by the company, consisting of 16 promoters and 28 transcription factors. 
2.8.1.3. Competitive growth experiment 
Transformation of the library into M. smegmatis strain mc2155 was followed by serial 
passaging over a period of 2 months, corresponding to 16 passaging rounds.  
Small volumes of cultures (10µL in the first 3 rounds, 100µL in the following) were 
transferred to 100mL of fresh Sauton media and grown for 2-3 days, resulting in OD600 
of 0.8 to 1.6. 
Samples from all passaging steps were collected and plasmid DNA isolated to allow for 
future study of the populations. 
2.8.1.4. Optimization of growth of M. smegmatis in HTS formats 
Growth of M. smegmatis cultures using 96-well format was performed using Costar 96-
well flat bottom cell culture plates.  
Sauton medium with a range of concentrations of Tylaxopol from 0.05% to 0.5% was 
tested in order to optimize growth without the formation of biofilm. 200µL of culture was 
used in all occasions. 
Identical tests were used to optimize growth in Costar 24-well flat bottom cell culture 
plates. Other parameters tested included shaking (from 200 to 300 rpm), total culture 
volume (0.75-2mL) and the use of Breathe-Easy™ sealing films (Diversified Biotech, 
Dedham, USA). 
2.8.1.5. Determination of growth rate 
Growth rate was calculated as (ln Nt – ln N0)/(t-t0) where Nt is the OD600 at a time near 
the end of the exponential growth phase (t), N0 it the OD600 at a time at early 
exponential growth phase (t0). Empty pSE100 containing cultures were used as 
reference for each plate and used for normalisation of growth rate, with growth rate 
variation being presented as percentage of pSE100 containing strains’ rate. 
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2.8.1.6. Identification of M. smegmatis rewiring clones 
Plasmids were isolated from M. smegmatis and submitted for sequencing to Eurofins 
MWG sequencing services. Primer RR_pSE100_FWD was used for identification of 
ORFs and pBlueScriptKS for the identification of promoters. 
2.8.2. Rewiring P. pastoris 
2.8.2.1. Clone screening probability 
The probability of screening a specific clone was obtained by calculation of the 
binomial distribution probability for not screening an element (number of successes = 
0) and its subtraction to 1, thus obtaining the probability of any given number of 
successes to occur.  
For the variation of probability considering number of library elements and fold 
coverage the number of trials was defined as “no. library elements x fold coverage” and 
the probability of the successful event defined as the inverse of the number of library 
members (equal probability). 
For the variation of probability considering fold coverage and the probability of an 
element to be included in the sampling (success probability) the number of library 
elements was fixed at 3000, the number of trials was defined as “no. library elements x 
fold coverage” and the probability of success varied from 0.2-10x “equal probability”. 
Values were obtained using the Excel 2010 BINOM.DIST function. 
2.8.2.2. Identification of potential regulators to be included in the P. pastoris 
library 
Elements for inclusion in the library were identified by using the advanced query 
interface of the Uniprot website (www.uniprot.org). Parameters used included a search 
filter for organism with the identifier 644223 (Komagataella pastoris (strain GS115 / 
ATCC 20864) (Yeast) (Pichia pastoris)) and search terms including “Transcription 
factor”, “Regulator”, “Regulation”, “Stress Response” and “Oxireductase”. 
2.8.2.3. Assembly of the P. pastoris lycopene rewiring library 
42 genes and 67 promoters amplified with compatible overhangs were assembled into 
pSM-crtEBI after digestion of the plasmid with SmaI using Gibson Assembly. 80ng of 
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plasmid were assembled with 15ng of promoter pool and 30ng of ORF over a period of 
8h. 1µL of Gibson mix was then transformed into 100µL DH10B electrocompetent cells 
per transformation, and the resulting colonies counted using a Gel Doc XR System. 
Plates were then washed with LB media followed by plasmid DNA isolation. 
2.8.2.4. Colony picking 
Colonies of rewired strains picked manually using sterile toothpicks by collection of 
cells from the growing edge and inoculation of 200µL of MD media in pre-sterilised V 
bottom clear 500µL 96-well plates (Corning Life Sciences, Tewksbury, USA). Colonies 
selected using the QPix2 colony picker (Molecular Devices, Sunnyvale, USA) were 
obtained using the wide picking pins and a protocol for colony recognition based on low 
brightness and high contrast settings that allowed for partial differentiation of lycopene 
producing colonies and was adjusted according to plate variation. Colonies were 
transferred to V bottom 96-well plates after picking by inoculation of 200µL of MD 
media per well using the picking pins. 
2.8.2.5. Library cultures outgrowth 
Cultures were incubated for 72h in MD media at 29.5°C and 700rpm in a Microtron 
incubator using Breathe-Easy® membranes to limit evaporation. Long-term stocks 
were produced by centrifugation of plates for 5 minutes at 500g using a 5810R 
centrifuge, removal of media and resuspension of a MD solution with 20% glycerol, 
followed by shaking in the incubator for 10 minutes and finally storage at -80°C. 
2.8.2.6. Library culture screening 
V bottom 96-well plates containing 240µL of YPD were inoculated from glycerol 
stocked cultures using the QPix2 colony picker replication tool and incubated for 48 or 
72h (as appropriate for each screening set) at 29.5°C and 700rpm in a Microtron 
incubator using white rayon membranes (ThermoScientific, Pittsburgh, USA)  to allow 
for good sample oxygenation. 72h incubated samples had media reconstituted at 48h 
using 120µL of ddH20. 
At endpoint samples were visually inspected and cultures showing a strong red colour 
were transferred to a new V bottom 96-well plate, with the coordinates for sample 
position and plate reference being registered for future reference.  Wells without growth 
or showing no detectable lycopene production were also counted to allow for coverage 
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and picking efficiency calculations. Centrifugation for 5 minutes at 500g followed, 
media was removed, samples were washed with 300µL of PBS and finally 
resuspended in 300µL of PBS. 40µL of resuspended sample was transferred to a 
Costar 96-well flat bottom cell culture plate containing 160µL of PBS. Absorbance was 
measured at 484 and 660nm in a POLARstar Omega microplate reader using 100 
flashes per well. 
2.9. Candidate validation methods 
2.9.1. Replication of screened cultures 
Cultures selected for absorbance readings were re-arrayed into new plates and 
incubated as described for the initial outgrowth. Testing of cultures was performed as 
for the library cultures screening procedure. 
2.9.2. Selection of candidates 
Standard scores for cultures assayed during screening and validation were obtained 
after normalisation of OD484 using OD660 and use of the scale() function in R (version 
2.15.1)141. Candidates were selected where standard scores on both runs were above 
0.5. 
2.9.3. Identification of P. pastoris rewiring clones 
Plasmids were isolated from P. pastoris and submitted for sequencing to the Source 
Biosciences sequencing services. Primer RR_Lib_Rev was used for identification of 
ORFs and RR_Lib_Fwd for the identification of promoters. 
2.9.4. Growth and testing of master plates for candidates 
96 clones were picked from RD agar plates for each candidate and used to inoculate 
200µl of MD media in V bottom 96-well plates. After incubation for 72h at 29.5°C, 
glycerol stocks were produced as described for the library culture outgrowth. 
Testing of the clones was performed as described for library screening, with an 
incubation period of 72h. 
71 
 
2.9.5. Growth and testing of candidates at 5ml scale 
The top 3 clones were used for inoculation of 5ml YPD in 50mL tubes (one per tube) 
and incubated overnight at 30°C and 225rpm. 5ml of YPF in 50mL tubes were then 
inoculated at an OD660 of 0.1 and incubated for 72h in the same conditions. Sampling 
was performed by collection of 200µL of culture and the protocol for assaying 
screening cultures was employed. 
2.9.6. Growth and testing of candidates at flask scale 
The top clone of each candidate was tested using a protocol similar to that used at 5ml 
scale, with the exception that 50mL of YPD was used in 500mL flasks. 
2.9.7. Growth and testing of candidates at 200µl scale 
The four clones with normalised expression levels immediately above the third quartile 
were used to inoculate 5ml YPD in 50mL tubes (one per tube) and incubated overnight 
at 30°C and 225rpm. 5ml of culture were prepared at OD660 of 0.1 and 200µL were 
transferred to V bottom 96-well plates and incubated at 29.5°C and 700rpm for 48h 
using white rayon membranes. 
2.9.8. Testing of growth conditions 
96 clones from the non-rewired lycopene producing strain GS115-SMGAP-crtEBI were 
used to produce a master plate by inoculation of wells containing 50µL of MD. 10µL of 
culture was used to inoculate plates containing 190µL of MD (2) and plates containing 
190µL of YPD (2). One plate of each type of media was sealed with a Breathe-Easy ® 
or a white rayon membrane. After growth for 72h at 29.5°C and 700rpm (cultures with 
white rayon membranes had 120µL of ddH20 added after 48h) cultures grown with 
white rayon membranes were replicated into 96-well plates containing 200µL of YPD 
using the QPix2 replication tool and then subjected to the glycerol stocking protocol 
previously described. 
Cultures directly inoculated and inoculated from glycerol stocks (using 200µL YPD) 
were incubated for 48h at 29.5°C and 700rpm. Results were recorded after visual 
observation. 
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2.9.9. Growth of candidate populations 
48 clones of each candidate and non-rewired strain were picked and incubated for 72h 
in 240µL of YPD at 29.5°C and 700rpm using white rayon membranes. Only the first 
half of each 96-well plate was used for this purpose. Cultures were then centrifuged at 
500g for 5 minutes, had the media removed and were re-suspended in 300µL of YPD. 
Replication using the QPix2 tool was performed into 96-well plates containing 240µL of 
YPD and using a candidate plate to inoculate the leftmost 48 wells and the control plate 
to control the rightmost 48 wells. Incubation for 72h followed using the same conditions 
as before and cultures were assayed using the same protocol as for screening with the 
exception that absorbance was recorded from 400 to 700nm. 120µL of ddH20 was 
added to cultures at the 48h mark in both circumstances.  
2.9.10. Identification of red/white cultures 
In order to identify red and white cultures a SVM algorithm was employed. A training 
dataset was produced by selection of clones tested and seen to have very clear 
phenotypes. 
The “e1071” R package was used, with the tune.svm() function being used to obtain 
the gamma and cost parameters by means of optimization of the parameters between 
10-6 to 10-1 and 10-1 and 101 respectively. 
A model was obtained using the svm.model() function with a radial kernel and the 
parameters obtained from the previous step. Samples classified as white were 
removed from the dataset to allow for further analysis. 
2.9.11. Statistical significance of samples 
Normalised lycopene production obtained from all cultures with exception of population 
tests were tested for statistical significance using the Excel 2010 T.TEST() function 
with one tailed distributions and unequal variance. Normalised lycopene production of 
clonal populations were tested for significance using the t.test() function in R with the 
same parameters. 
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2.10. Scale-up methods 
2.10.1. Preparation of inoculum for flask scale candidate tests 
60 clones of each candidate were picked from transformation plates and streaked onto 
YPD plates. After incubation at 29.5°C for 48h single colonies were used for inoculation 
of 240µL of YPD in 96-well plates and incubated for 48h at 29.5°C and 700rpm using 
white rayon membranes. 40µL of each culture were pooled into a 50mL tube, vortexed 
and 100µL of culture was transferred to a new 50mL tube containing 5mL of YPD. 
Following overnight incubation at 29.5°C and 225rpm 20mL or 200mL of culture with an 
OD660 of 0.1 were prepared by dilution into YPD, for 500mL and 2L flask runs 
respectively.  
YPD used in the flask cultures was prepared by filtration using 250mL or 1L vacuum 
filter systems with bottle (Corning Life Sciences, Tewksbury, USA) as appropriate, and 
90% of the total volume was dispensed into autoclaved flasks. The final 10% volume 
was added using the cultures afore mentioned, producing a final OD660 of 0.01.  
2.10.2. Incubation of flask cultures 
Incubation of flasks was performed at 29.5°C and 185 rpm in a New Brunswick 
Innova® 44 (Eppendorf UK, Histon, UK), for 96h. Sampling was performed by removal 
of 2mL of sample at every 24h.  
2.10.3. Assaying of samples and statistical significance 
Assays were performed as described for screening and statistical significance was 
calculated as described for flask cultures. 
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Part 1  
Preliminary Work in M. smegmatis 
  
75 
 
3. Introduction 
 
 
Summary 
M. smegmatis is used as a genetics workhorse for research involving pathogenic 
members of the Mycobacterium genus. The species is presented as a target for 
regulatory rewiring due to its relevance as a disease model organism, limited 
knowledge of the transcriptional regulatory network makeup and interaction and 
uncommon fatty-acid synthesis. 
Recent developments that increased the genetic tractability of the organism are also 
described, along with its potential use for the production of biofuels from simple carbon 
sources. 
A two gene pathway for the production of alkanes and alkenes is proposed for 
expression in M. smegmatis that could allow for validation of regulatory network 
rewiring through isolation of strains overproducing the compounds. 
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3.1. M. smegmatis 
Mycobacterium smegmatis is 
a non-pathogenic acid-fast 
Gram-positive bacterium from 
the Mycobacterium genus 
(see Table 3.1).  
Similarities to pathogenic 
bacteria from the genus such 
as M. avium, M. tuberculosis 
and M.leprae, together with 
fast growth makes this 
species a valuable model for 
molecular research in the 
diseases they cause. 
Study of the mycobacterial 
cell wall is one of the areas 
where M. smegmatis is used as it displays a complex structure similar to pathogenic 
members of the genus. Importantly the cell wall contains a high percentage of mycolic 
acids bound with arabinogalactan and peptidoglycan that prevents staining through 
standard techniques and protects cells from the activity of several antibiotics152. 
3.1.1. Use of alternative carbon sources 
M. smegmatis has been shown to be flexible in the use of single carbon sources for 
growth, such as sugars (glycerol, D-xylose, D-ribose, L-arabinose, D-fructose, D-
glucose, Trehalose)153, acetate154, cholesterol155, methanol156, carbon monoxide156, 
pyruvate157, or carbon dioxide (in the presence of H2) 
157. 
Growth requirements are also minimal, with the use of simple nitrogen sources, citrate 
and minerals being enough in conjugation with carbon sources to provide growth to 
moderate densities. 
3.1.2. Fatty-acid synthesis in M. smegmatis 
The M. smegmatis genome encodes two types of fatty acid synthase (FAS), FASI and 
FASII158. The co-occurrence of both enzymes is uncommon, as FASI is mostly found in 
Species 
Doubling time 
(h) 
Pathogenicity 
M. smegmatis 2-3142 n.a. 
M. avium 10-12143 
Immunocompromised 
humans144 
Ruminants145 
M. bovis 22-24146 
Humans 
(tuberculosis) 
Wide range of 
mammals147,148 
M. tuberculosis 22-24149 
Humans  
(tuberculosis) 
Wide range of 
mammals150 
M. leprae 336151 
Humans151 
Nine banded 
armadillos151 
Primates151 
Table 3.1 – Doubling time and pathogenicity of 
members of the Mycobacterium genus. 
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parasites, fungi and all higher eukaryotes but only rarely in bacteria159. This 
multidomain enzyme is encoded in a single large polypeptide responsible for the 
synthesis of saturated fatty acids from C16 to C24160.  
The biosynthesis of mycolic acids requires the condensation of two modified long-
chained fatty acids produced by the fatty-acid synthases FASI and FASII152. Modulation 
of fatty acid synthesis has been shown through the use of 3-O-methyl-d-mannose-
containing polysaccharides (nMMPs) and 6-O-methyl-d-glucose-containing 
(lipo)polysaccharides (nMG(L)Ps). These molecules have been shown to be 
responsible for an early termination of fatty-acid synthesis in FASI by providing 
modified escape kinetics from the enzyme’s active site158,161, altering the product chain-
length profile it produces. 
3.1.3. Use of M. smegmatis in industrial biotechnology 
M. smegmatis has been used in the past for the production of xylitol from D-xylulose 
with 70% efficiency162, having been superseded by other organisms capable of 
conversion at higher rates.  
Although no current industrial process makes use of this species, previously mentioned 
features of its natural metabolism can be relevant for future processes. 
3.1.4. Available mycobacterial molecular biology tools 
With the recent development of a number of methods for molecular biology research in 
M. smegmatis the feasibility of the engineering of biochemical pathways is increasing in 
this species.  
The most relevant advancement is perhaps the isolation of the hyper-transformable M. 
smegmatis strain mc2 155163 allowing for transformation with reduced amounts of DNA 
and higher experimental throughput. This advance complemented the identification of 
an origin of replication (pAL5000) that can be used for the construction of plasmids that 
are readily maintained in Mycobacteria164. 
Inducible/repressible promoters are an important tool for the controlled expression of 
proteins of interest, especially when a product has deleterious effects during the growth 
phase – tetracycline and acetamide controlled promoters are now routinely employed 
in Mycobacterial research 165,166 Although limited in their dynamic range, they provide 
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an initial platform for controlled expression that could be complemented in the future 
with the development of promoter characterization and diversification efforts. 
Finally, integration of genetic constructs is a requirement for successful deployment of 
industrially relevant GMOs. Although mechanisms for homologous recombination are 
available and illegitimate recombination has been shown to occur at low frequencies167, 
mycobacteriophage based methods remain the most efficient for directed genomic 
integration. The latter have evolved greatly over the last decade, with methods for 
improved single-site 168–170 and sequential recombination systems171. In 2007, the first 
recombineering strain was produced, providing a simpler and more efficient alternative 
to phage based methods149. 
3.2. Selection of the target metabolite 
Selection of a metabolic pathway for method validation should be weighed between the 
use of a pathway known to be operational in the target species and the opportunity of 
presenting progress on one that has not been previously known to produce a specific 
metabolite. 
In this project a number of pathways were considered following evaluation of three 
parameters – viability, suitability for validation and industrial interest (see Figure 3.1). A 
more viable pathway would be one previously described in literature as working in the 
target species, whilst a pathway that validates the method for a class of molecules will 
be regarded as more suitable than one that only validates improvements in the 
production of an end molecule (not a known precursor). Industrial interest is considered 
mostly as an exclusion factor for systems that have foreseeable application, such as 
molecular reporters. 
Whilst selection of organism and pathway 
may be considered separately they tend to 
be coupled – compatibility of the existing 
metabolic profile of an organism with a 
target metabolite is required, as developing 
a complete expression platform is in itself a 
matter for individual research. 
Figure 3.1 – Factors affecting selection of a 
target metabolite. 
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3.2.1. High-throughput screening 
Suitability of the target compounds for HTS is a necessary condition as the workload 
and equipment requirements associated with hard-to-screen compounds could 
drastically increase during the validation effort. As such the compounds used in this 
project had to be either screenable in vivo, easy to extract from cells or be 
exported/diffuse to the growth media. In any of these cases the assays used for 
screening could have a moderate level of noise but should have good discretization 
properties at the top end of the range of the signal: noise can act as a cut-off filter to 
some extent if most positive clones produce below its level and only higher than normal 
production can be detected; as for good assay signal properties at the top end of the 
assay range, this can ensure that samples producing strong signals can be 
appropriately measured and ranked according to production of the target compound 
(see Figure 3.2).  
3.2.2. Expected impact on the cell 
An important consideration to have in the process of pathway selection is the overall 
impact on the cell that production of a specific metabolite might have. This may to a 
large extent determine what type of rewiring will be effective in producing a desirable 
phenotype. Considering the nature of a metabolite, if the target is or has as a precursor 
a primary metabolite it is probable that alternative metabolic modes or other 
Figure 3.2 - Minimal requirements for assay use in HTS. Samples below noise 
levels (red line) would not be measured, impacting on the number of samples 
to be quantified. This would be an issue in a study where the parameter was to 
be related to a specific clonal variable, but would act as an useful filter in a 
study where only the highest values are of interest. Inset – The ability to 
correctly discriminate samples above noise level is required in large studies so 
as to isolate candidates at the top range. 
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compensation mechanisms will be linked with rewired strains showing good levels of 
production. This inference is based on the ability to compensate for disruptions caused 
by modifying the normal metabolism of the cell. 
Secondary metabolites are less likely to affect the normal function of the cell and 
provide more flexibility in the controlled environment that is provided in laboratory 
settings. Adaptations should come from compensatory mechanisms to the drain of 
pathway specific metabolic pressures (co-factors, reducing equivalents, by-product 
effects) or the deregulation of elements that would normally limit production of the 
compound or its precursor. 
As for the mode of production, it may be necessary to engineer regulatory modulation 
of strains in order to produce substantial amounts of a target compound. This is 
because change of metabolic fluxes elicits a regulatory response to avoid deregulation 
of the cell and will counter the effort. Overproduction of a compound will also create 
stress in the cells whilst coordination with normal metabolism may offer improved 
conditions16,172,173. This targeted approach can be expensive in terms of resources, but 
successful. 
Considering the validation of the method it was considered that a non-optimized strain 
should be used for validation as an alternative to rational methods or as a means for 
the identification of regulatory targets to modulate. This does not mean that rewiring of 
the regulatory network cannot bring benefit to already optimized strains, as it may bring 
further improvements through regulatory novelty, such as seen through the use of 
gTME64. 
3.2.3. Production of long-chain alkanes and alkenes 
Production of biofuels is the subject of heavy academic and industrial research efforts 
that aim to realise a sustainable global energy market. However, many of the solutions 
put forth by the community suffer from issues such as the impossibility to use the 
existing distribution structure and combustion technologies, the requirement of large 
areas of land and of specific conditions of sunlight exposure. These limitations may 
result in a continued dependency of countries on imported energy sources. 
 The use of drop-in fuels produced from non-photosynthetic sources could provide an 
alternative to complement photosynthetic strategies.  
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A pathway for the biosynthesis of 
alkanes - major components of 
transportation and aviation fuels - was 
initially described by Schirmer et al. 
(2010)174. In that paper a number of 
Acyl-ACP reductases and aldehyde 
decarbonylases capable of producing 
alkanes in E. coli were identified and 
individual yields quantified. Although 
the maximum yields obtained were 
symbolic (300mg/L over 72h) when 
industrial applications are considered, 
the published work described a non-
optimized system in a species not 
characterized as being a producer of 
fatty acids at high titres (see Figure 3.3).  
3.2.4. Production of alkanes and alkenes in M. smegmatis as a benchmark for the 
re-wiring strategy 
The reduced size of the pathway was ideal for the implementation of optimization 
strategies and the aldehyde intermediates produced by the Acyl-ACP reductase 
(henceforth referred to as Reductase) of Synechoccus elongatus (PCC7942) was 
compatible with HTS methods as they serve as substrate for the bacterial luciferase of 
Vibrio fischeri, allowing for screening by luminescence. The luminescence 
measurements would serve as a midpoint in the isolation of improved producers of 
alkanes, as strains would have to be retested with a plasmid including the aldehyde 
decarbonylase (henceforth referred to as Decarbonylase) of Nostoc punctiforme 
(PCC73102) to ensure levels of aldehydes and alkanes were correlated. 
M. smegmatis was selected for the initial work for (1) its relevance as a model 
organism in mycobacterial research; (2) its fatty-acid synthesis pathway and high fatty-
acid cell wall content; (3) recent developments in mycobacterial molecular biology 
methods that provide opportunity for its use as a chemical production platform; and (4) 
the limited amount of experimentally confirmed transcription factors. 
In terms of (1), any work that allows for a better understanding of this species 
regulatory network could impact on research towards the elucidation of mycobacterial 
Figure 3.3 – Choice of alkanes and alkenes as 
target metabolites. Heterologous expression had 
only been demonstrated in E. coli, increasing the 
risk of lengthy optimization of expression 
conditions. Expansion of the pathway to validate 
the general applicability of the method towards 
complex pathway improvement would be limited. 
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pathogenesis and antibiotic resistance, and knowledge gathered from the use of the 
promoter/transcription factor libraries could enable this.  
(2) and (3) create the conditions for the implementation of the pathway and its 
optimization using Synthetic Biology and Metabolic Engineering strategies. Although 
the aim of the project was not to develop a highly optimized pathway, it could allow for 
a comparative study of the re-wiring effect pre- and post-optimization as for its 
efficiency and suitability in aiding the design of a rational approach. 
As for (4) the lack of experimental confirmation of TF provides an insight on the 
applicability of the strategy to less well characterized species. 
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4. Assembly of an alkane and alkene pathway 
 
 
Summary 
Validation of transcriptional regulatory network rewiring as a strategy to improve 
phenotypes of strains overproducing metabolites requires a pathway of interest to be 
established in the parent strain (before rewiring). In this chapter, the cloning of a two 
gene pathway for the production of alkanes and alkenes into an E. coli-M. smegmatis 
shuttle plasmid is described, as well as the production of variants used to test 
production of intermediates and expression. Work towards the development of a 
method compatible with HTS is also described. Results suggested that the method 
would be compatible with screening at high-throughput although consistent production 
of pathway products and intermediates could not be fully established. 
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4.1. Aims 
In order to use this pathway as a model for rewiring-based strain improvement it is 
necessary to (1) demonstrate production of aldehydes in M. smegmatis and (2) 
demonstrate conversion of aldehydes to alkanes and alkenes. 
4.2. Experimental strategy 
Alkane and alkene production in M. smegmatis was engineered such that the pathway 
could be used for validation of the rewiring strategy. Independent validation of 
transcriptional regulatory network rewiring towards the isolation of improved 
phenotypes could be achieved by applying selection pressure to rewired populations 
and this was attempted in parallel, as discussed in the next chapter. 
In order to test aldehyde production, constructs were assembled containing the 
Reductase gene under the control of an M. smegmatis inducible promoter. Detection of 
aldehyde production was performed using an E. coli reporter strain expressing the V. 
fischeri luxAB genes, resulting in a luminescence signal (see Figure 4.9). For verifying 
conversion of aldehydes to alkanes and alkenes, constructs containing the 
Decarbonylase under the same promoter as the reductase were produced, as well as 
individually expressed using a constitutive promoter. Cloning of the reductase gene for 
co-expression with luxAB should provide information about the production of aldehydes 
in real time. 
Genes were obtained by chemical synthesis using the original sequence reported in 
Schirmer et al. (2010)174. 
Protein expression was assessed via SDS-PAGE or Western Blot. Aldehyde 
production was assessed using a luminescence assay, while aldehyde, alkane, and 
alkene production could be assessed using GC-MS. 
4.3. Results 
4.3.1. Assembly of the Reductase gene using pUV15tetORm as vector backbone 
pUV15tetORm is a mycobacterial shuttle plasmid containing GFP expressed under a 
strong tetracycline inducible promoter175. The Reductase gene (sequence provided in 
section 16.3.1) was amplified from the original vector supplied by Mr. Gene 
(Regensburg, Germany) resulting in a product of 1.1kb.  
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Attempts to amplify the vector backbone with overhangs for assembly were performed 
using several different annealing temperatures, Touchdown PCR and additives, namely 
dimethyl sulfoxide (DMSO) and betaine. Amplification of the plasmid was only 
successful with supplementation of 7.5% of DMSO, but the resulting plasmid was 
shown to have been altered by the process when sequenced.  
Analysis of the plasmid revealed a GC-rich region that spanned over 75 base pairs with 
a GC content of 94.7%, possibly explaining the difficulty in amplifying the vector. The 
target construct was isolated using restriction sites flanking the region of insertion, and 
re-cloned into the target vector. The process is summarised in Figure 4.1. 
4.3.2. Re-synthesis of the Reductase gene by DNA2.0 
A second version of both genes was synthesized and sequence optimized by DNA2.0 
(Menlo Park, USA) after a possible secondary structure impacting on the translation of 
the reductase gene was detected. This was following extensive testing of the 
expression constructs, to be described within this chapter. 
4.3.3. Assembly of the Reductase and Decarbonylase genes using pMIND-Lx and 
pMEND-Lx as vector backbones 
pMEND-Lx and pMIND-Lx plasmids were selected for assembly of expression 
constructs for this project, as they lacked very high GC content regions and allowed for 
inducible expression in M. smegmatis at both medium and high levels176. The TetR(Z) 
repressor in pMEND contains a single amino acid substitution in relation to pMIND that 
allows for reduced basal level of expression and increased fold induction, albeit with a 
lower maximum level of expression176. 
Figure 4.1 – Assembly of pUV15tetORm-R. a) assembly strategy used; b) Lanes 1,3 and 5 – 
plasmids linearized with Pst1, lanes 2,4 and 6 digested with PstI and SpeI for insert sizing.   
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All plasmids were confirmed by gel electrophoresis after assembly (for plasmids 
assembled using Circular Polymerase Extension Cloning (CPEC) – Mr.Gene version of 
the Reductase gene) and after cPCR of colonies obtained post-transformation (for 
plasmids assembled by the Gibson method – DNA2.0 version of the reductase gene) 
and sequencing.  
The pMEND and pMIND pair will be referred to as pMXND. 
4.3.4. pMXND-R assembly  
The assembly of these plasmids was performed by insertion of both the Reductase 
gene and the transcriptional terminator rrnB T2 in a single fragment substituting luxA.  
For this purpose rrnB T2 was part of the primers used for extraction of the Reductase 
gene from the plasmids provided by the gene synthesis companies avoiding an extra 
PCR step. The amplification of these components resulted in a 1.1kb long product, 
whilst the addition of overhangs to the vector resulted in a 7.8kb product. Assembly by 
CPEC and Gibson methods resulted in 8.8kb plasmids, as summarised by Figure 4.2. 
4.3.5. pMXND-RD assembly  
Assembly of this construct was performed by insertion of the Reductase gene in the 
position of luxA and of the Decarbonylase gene and rrnB T1 transcription terminator 
replacing luxB. 
Figure 4.2 - Assembly of pMXND-R. a) strategy used for assembly. The plasmid of origin for the 
Reductase gene described is the one provided by DNA2.0. b) 3 Reductase construct assembly. 
Lane 1 – Reductase gene amplified with overhangs; Lane 2 – pMIND-Lx amplified with primers that 
excise LuxA and provide compatible overhangs for insertion; Lane 3 – pMIND-R. 
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Amplification of the Reductase gene resulted in a 1.1kb product whilst the 
Decarbonylase gene and rrnBT 1 were amplified as a single fragment with a final insert 
size of 0.8kb. The vector with overhangs had a final size of 6.8kb resulting in an 8.5kb 
plasmid after assembly of all components. Assembly is summarised in Figure 4.3. 
The region separating luxA and luxB was preserved in this assembly to allow for 
modular cloning. 
4.3.6. pMXND-R-D assembly 
Assembly of the plasmid was performed by amplifying the Decarbonylase gene using a 
previously amplified product containing the psmyc promoter as forward primer and a 
second primer compatible with the vector backbone. This resulted in a 0.4kb product, 
whilst the promoter and Decarbonylase gene product was 1.1kb long. 
The final amplification product was compatible with the Reductase product used for 
Figure 4.3 - Assembly of pMXND-RD. a) assembly strategy; b) Operon construct assembly.  Lane 1 
– Reductase gene amplified with overhangs; Lane 2 – Decarbonylase gene amplified with 
overhangs; Lane 3 – pMIND-Lx amplified with primers that excise LuxA and LuxB and provide 
compatible overhangs for insertion. Lane 4 – pMIND-RD. 
Figure 4.4 - Assembly of pMXND-R-D. a) assembly strategy; b) Assembly of pMXND-Lx-R. Lane 1- 
Decarbonylase and psmyc; Lane 2 – pMIND-Lx amplified with primers that excise LuxA and LuxB 
and provide compatible overhangs for insertion. Lane 3 – pMIND-R-D. 
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cloning of pMXND-R allowing for the assembly of the full construct using the two 
inserts. 
The vector amplified for pMXND-RD was also compatible with the inserts. The final 
assembly step resulted in a 9kb long product. Figure 4.4 summarises the process. 
4.3.7. pMXND-Lx-R assembly 
These constructs were obtained by independent amplification of the promoter and an 
upstream transcriptional terminator, resulting in a 0.5kb product, and the Reductase 
gene and downstream transcriptional terminator, resulting in a 1.2kb product. The 
vector was amplified with compatible overhangs producing an 8.9kb product. Figure 4.5 
describes the fragments used and the assembly order.  
Assembly using the Gibson method resulted in a 10.3kb circularized product. 
4.3.8. Hexa-histidine tagging of constructs 
In order to confirm expression of the genes 6-His tags were added in all constructs 
allowing for Western Blotting of samples. 
As all constructs but pMXND-Lx-R had already been assembled and the tags selected 
(HHHHHSSG for Reductase, SSGHHHHHH for Decarbonylase) were small in size the 
strategy used was to amplify the vector using primers containing the tag itself and the 
use of a Gibson assembly mix to allow for re-assembly of the vector. 
Figure 4.5 - Assembly strategy for pMXND-Lx-R.  
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As for the pMXND-Lx-R the primers 
used for its assembly were compatible 
with the cloning of the His-tagged 
version of pMXND-R into the final 
construct, not requiring the design of 
new ones. 
4.3.9. Optimisation of cell lysis for 
protein expression analysis 
Samples were sonicated with a variable 
number of cycles (0,3,10) and culture 
volumes (125,250 and 500µl). 
The SDS-PAGE gel produced for this 
optimisation step (Figure 4.6) shows an increase of the number of proteins visible with 
increased sonication, albeit a very similar profile is visible for samples sonicated for 3 
and 10 cycles. Non-sonicated samples still presented a very complex profile, but some 
proteins are not visible, mostly above the middle of the spectrum (>36.5 kDa) and 
require a larger volume of culture to produce good signal. Sonicated samples also 
presented more proteins with lower kDa when using smaller volumes of culture, 
supporting that the sonication step is not only required but also efficient. 
The use of 3 cycles of sonication and 250ul of cell culture were therefore used for 
processing samples for protein analysis.    
Figure 4.6 - SDS-PAGE gel representing the 
optimization of the cell lysis step and culture 
volume. Marker labels represent molecular weight 
in kDa, values below number of cycles represent 
culture volume 
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4.3.10. Protein expression 
4.3.10.1. SDS-PAGE  
In order to confirm expression of the Reductase and Decarbonylase genes SDS-PAGE 
gels of induced vs. non induced samples were produced for both Mr. Gene and 
DNA2.0 versions of the Reductase gene. 
Cultures of the operon containing strain and wild-type were also sampled at 0, 30 and 
150 minutes after induction, producing the results shown in Figure 4.7. Apparent 
expression of the Decarbonylase gene can be seen at the expected molecular weight 
and Reductase expression could not be verified. It should be noted that an increase in 
production was not visible in induced samples. 
4.3.10.2. Western Blot 
Samples of pMXND-R and pMXND-RD had the Reductase His-tagged, and of pMXND-
RD had the Decarbonylase His-tagged. 
Samples were processed as for SDS-PAGE gels and a purified His-tagged GFP 
sample was obtained from Dr James Chappell at the laboratory to use as a control for 
sample transfer and anti-body recognition. 
The SDS-PAGE gel was also stained after transfer to ascertain the level of efficiency of 
the transfer process. 
Figure 4.7 - SDS-PAGE of cutures carrying the operon construct. Molecular weight of: reductase – 
37.5kDa; decarbonylase – 27.36kDa. Values below strain and plasmid name represent sampling 
time. NI – not induced, I –induced. Note that cultures used as wt were partially contaminated with 
pMIND-R containing plasmids. Red arrows indicate suggested Decarbonylase expression. Noise 
was partially removed by band passing high frequencies after converting pixel data using the 
fourier transform. Marks shown in white represent the expected position of reductase and 
decarbonylase proteins. 
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Although the transfer appeared to have been efficient in terms of the amount of control 
protein, a significant amount of protein remained in the SDS-PAGE gel (Figure 4.8). 
This may explain the lack of a clearly visible signal on the Western Blot, although 
image manipulation hints at the possibility that some tagged protein may be present. In 
the case of the pMXND-RDdh samples it is also possible to observe a band in the Mw 
region where the Decarbonylase is expected to migrate to. 
4.3.11. Analysis of gene product activity  
4.3.11.1. By GC-MS 
Knowledge of the chain-length distribution of aldehydes and alkane produced using the 
Reductase and Decarbonylase enzymes was necessary in order to direct the initial 
steps of product optimization. GC-MS was used to characterize products from the 
constructs containing the Mr. Gene Reductase version. Total ion current 
chromatograms of the samples are available in Figure 16.1. 
It was impossible to identify any products within the aldehyde or alkane series which 
supports the possibility that the genes were not active in these constructs.  
4.3.11.2. By luminescence  
An E. coli reporter strain expressing the luxAB genes kindly supplied by Dr Eric 
Davidson (Imperial College London) was used for detection of aldehyde production 
(see Figure 4.9).  
Figure 4.8 – Western Blot of 6-His tagged protein samples. Lane 1 mc
2
 155; Lane 2 pMEND-Rh; 
Lane 3 pMEND-RDrh; Lane 4 pMIND-RDrh; Lane 5 pMEND-RDdh; Lane 6 pMIND-RDdh; C positive 
control, His-tagged GFP (30 kDa). a) Stained SDS-PAGE post transfer; b) Resulting Western Blot; 
c) Western Blot image with decreased levels of brightness and increased contrast. Red arrows 
indicate suggested Decarbonylase expression. 
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Attempts to detect aldehyde production by constructs containing the Reductase gene 
version synthesized by Mr. Gene failed, with no signal being obtained from either the 
use of cell cultures induced with 200ng/ml of ATC or supernatant as sources of 
substrate.  
Tests performed with the version synthesized by DNA2.0 induced at the same 
concentration of ATC resulted in a detectable signal, but only with the addition of cell 
culture to the reporter strain, as attempts to use supernatant at any 
supernatant/reporter cell ratio failed to produce relevant signal. 
Testing of reporter/producer culture ratios between 1:1 to 4:1 in duplicate were 
performed with 2:1 providing the best signal to noise ratio (data not shown). 
Concentration of ATC used for induction was optimised, resulting in the profiles seen in 
Figure 4.10 (n=2). 
Increasing induction levels in pMEND-R samples did not correspond to an increased 
signal, but in the case of pMIND-R samples induction at 1µg/ml ATC produced a level 
of maximum luminescence comparable to 1.50µg/ml ATC, with visible increased signal 
of both when compared to 500 µg/ml ATC.  
Figure 4.9 – Detection of aldehydes by luminescence. E. coli cultures expressing the luxAB genes 
produce luminescence in the presence of aldehydes produced by M. smegmatis expressing the 
reductase gene. Induced cultures were mixed in 96-well plates after induction and production of 
aldehydes was monitored over time in a microplate reader in luminescence mode. 
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This experiment also resulted in the determination of levels of background expression 
of the enzyme that are high enough to produce a luminescence signal that is stronger 
than a third of the maximum level in pMIND-R and half the maximum level for pMEND-
R. 
Expression constructs assembled with the DNA2.0 version of the Reductase gene 
were tested after induction with 1µg/ml of ATC using both cultures and re-suspension 
of cell cultures in PBS with a 1:5 dilution to minimize quenching of luminescence. 
Results obtained from the luminescence assays (see section 16.5 - Detection of 
aldehydes in two culture systems) showed the expected behaviour for samples with 
pMEND-based constructs with lower luminescence levels than pMIND (the exception 
being pMEND-RD), as well as operon constructs with lower levels of expression than 
Reductase alone.  
Use of PBS to re-suspend the cell culture resulted in luminescent signals similar to 
those obtained using medium, with decaying levels after a period of 40 minutes of 
increasing luminescence. 
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Figure 4.10 – Production of aldehydes by strains expressing the Reductase gene. Concentrations 
refer to the inducer, ATC. Error bars – standard deviation. 
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The signal present in the mc2 155 samples (Figure 16.2 and Figure 16.7) was due to 
contamination, and further testing of the wild type strain resulted in no signal detectable 
above noise levels. 
 As an alternative for the use of the two cultures system pMXND-Lx-R was assembled. 
These constructs should have provided a more immediate luminescence signal as the 
diffusion of molecules towards LuxAB would be limited to the cytoplasm. However, no 
signal was detected when cells were tested after induction of LuxAB regardless of ATC 
concentration. 
4.4. Discussion 
4.4.1. Gene synthesis 
Genes were synthesized by Mr.Gene prior to the beginning of this project in E. coli 
codon optimized versions and part of the work in M. smegmatis described here makes 
use of them. A second version of the Reductase gene was synthesized by DNA2.0 as 
the first version lacked any measurable activity. A hairpin-like structure being formed 
within the mRNA was then identified, being the probable cause for the lack of activity. 
4.4.2. Plasmid selection 
Vectors were selected that contained expression constructs so as to allow for the 
swapping of genes and improved screening properties. 
pUV15tetORm was chosen as the swapping of GFP for the Reductase gene would 
provide not only a valid expression construct but also the means to partially screen 
unmodified colonies by fluorescence. 
Attempts to assemble constructs using pUV15tetORm required a number of 
optimization steps in order to obtain amplification products from the vector. However, 
the resulting construct was shown to have rearrangements of parts of the vector, 
prompting the search for the underlying reasons that resulted in this event.  
Regions of high GC content were identified in the plasmid, with an extreme case of 
94.7% over 75bp. Although high GC content in vector shuttles was expected as the M. 
smegmatis genome’s GC content is of 66%, it was initially not clear that it would impact 
so severely in their amplification.  
95 
 
pMIND-Lx and pMEND-Lx – a version of pMIND-Lx with a single amino acid change 
resulting in lower background expression and higher fold-induction but lower maximum 
expression levels - were selected as backbone for the following reasons:  
1) the LuxAB expression construct present in the plasmids could be used as a reporter 
for the production of fatty-aldehydes and as a screening tool; 
2) the different background and fold-induction levels could be used to understand the 
effect of expression levels towards the efficiency of the pathway; 
3) no regions of the plasmids showed very high GC content; 
4) versions for integration into the M. smegmatis genome were available and were 
compatible with the existing expression platform. 
However, the construct carried by the plasmids did not contain a transcriptional 
terminator following the luxAB operon thus requiring the insertion of such element. 
4.4.3. Assembly of expression constructs  
An expression construct containing only the Reductase gene was produced to allow for 
quantification of the aldehyde intermediates in the two gene alkane pathway. As these 
molecules serve as substrate for LuxAB it also presented an opportunity for screening 
of libraries. 
The cloning of both the Reductase and Decarbonylase genes as an operon provided a 
platform for the production of alkanes and characterization of product carbon chain 
length distribution. It was also expected that by using a subtractive approach in the 
analysis of luminescence data it would be possible to, and without the use of GC-MS, 
determine if the Decarbonylase gene product was indeed functional.   
In order to understand further the activity of the Decarbonylase an alternative construct 
was designed containing both genes with the Decarbonylase gene being expressed 
constitutively from a strong mycobacterial promoter and transcriptionally insulated from 
the Reductase gene, which was in turn expressed from a tetracyline inducible 
promoter. 
As an effort to further characterize activity of the Reductase gene product, an 
expression construct was also assembled with the Reductase gene following the 
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original luxAB operon with a strong constitutive promoter. By producing aldehydes 
throughout a long period of time and inducing LuxAB while screening was ongoing it 
was expected to be possible to understand the profile of production of these molecules. 
4.4.4. Analysis of gene expression 
Due to conflicting descriptions of cell lysis methodologies found in literature165,175,177,178 
and the requirements of sufficient cell wall disruption for cytoplasmic protein content 
analysis posed by M. smegmatis it was necessary to optimize the cell lysis step using 
sonication. 
In order to do so a variable number of sonication steps and culture volumes were used 
so as to determine an approximate number of cycles that would allow for a minimal 
amount of culture to be lysed efficiently with minimal loss of signal. Having determined 
these parameters, cultures were processed for the purpose of confirming expression of 
the Reductase and Decarbonylase genes. 
Gels using both versions of the Reductase gene had bands of the expected molecular 
weight (Mw), but no distinction could be made against controls hinting at the migration 
of at least one protein produced by the wt cultures at the same Mw. Bands at the 
expected Mw for the Decarbonylase protein could be seen in gels, supporting the 
possibility that this protein was being expressed at relevant levels in the cultures. 
As an attempt to further verify the identity of the bands in gels and to understand if 
shorter periods of growth after incubation could be used prior to sample sonication, 
SDS-PAGE gels were also produced for cultures expressing the pMIND-RD construct.  
The resulting gel allowed for the clear identification of the Decarbonylase gene product, 
but did not produce a distinguishable signal for a Reductase gene product of the 
expected Mw, as similar bands (albeit more undefined) were produced in that region in 
the wt samples. It is possible that the protein migrated with lower apparent Mw in which 
case light banding can be seen in the operon samples closer to 36kDa. What is more 
relevant to point out is that there is no visible difference between induced and non-
induced samples, which could be explained by a significant level of background 
expression allowed for the tetracycline inducible promoter version of pMIND. 
Results obtained from SDS-PAGE gels, luminescence assays and GC-MS analysis 
could not confirm the expression of the Mr.Gene version of the Reductase gene 
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product, leading to a number of attempts to modify induction conditions and sampling 
time. It was through parallel work taking place within the group in E. coli (the organism 
for which the nucleotide sequence had been optimized) that the hypothesis of incorrect 
or no expression of the gene gained more experimental support, prompting its re-
synthesis by a different company. 
At this point expression of the Decarbonylase gene was apparent from results obtained 
from SDS-PAGE gels, but without the formation of intermediate products any 
conclusions were delayed until a working version of the Reductase gene could be 
used. 
Constructs containing the DNA2.0 version of the Reductase gene were assembled 
using the Gibson method, but SDS-PAGE gels of induced cultures could not provide 
absolute confirmation of expression.  
Luminescence assays provided initial support for the activity of the gene product, 
allowing for the optimization of the assay. In order to verify the expression of the genes, 
constructs were modified to include hexa histidine tags thus allowing for the use of 
Western Blots. 
The attempt to use Western Blot to confirm protein identity has led to signal below the 
expected levels, possibly due to incomplete transfer of SDS-PAGE contents as the 
control sample confirms that the blocking and detection steps had been successful. 
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5. Rewiring M. smegmatis for an improved growth 
phenotype 
 
 
Summary 
Validation of the strategy for strain improvement required the design and 
implementation of a rewiring library in a suitable species and knowledge that the 
screening of this library could yield phenotypic diversity. In this chapter, the process of 
rewiring library design in M. smegmatis and an attempt to isolate rewired strains with 
an improved phenotype is described. A rewiring library was produced and tested 
towards the isolation of strains with improved growth rate. Two distinct rewired strains 
were isolated and the identity of their promoter and open reading frame was defined. 
Feasibility of the species and the selected pathway for validation of the method are 
also analysed in view of the observed results. 
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5.1. Introduction 
Limited knowledge of the M. smegmatis’ regulatory network was available, even though 
the species had been used extensively to characterise regulatory proteins of members 
of the genus. Identification of elements to be included in the regulatory network rewiring 
effort were therefore limited to genes that had been annotated as regulators through 
recognition of conserved protein motifs. More detailed study of regulatory elements of 
the pathogen M. tuberculosis could allow for more accurate inference of the effect of 
rewiring in M. smegmatis, and possibly provide the opportunity to transfer knowledge 
gained through this process into research efforts on that organism. 
As transcriptional regulatory network rewiring had only been described at the scale 
present in this study in E. coli137 and no attempts to apply it to strain improvement had 
been made, this would also allow for the exploration of the potential of applying the 
method to less well characterised species. In order to do so, the design of a rewiring 
library, its assembly and screening would have to be performed and the resulting set of 
candidates would have to be confirmed as being responsible for the phenotype 
selected for.  
An initial attempt to test the use of transcriptional regulatory rewiring for strain 
improvement should be done at a small scale. This would allow the identification of 
issues related with library preparation, production of sufficient number of clones, 
screening protocols and design of experiments that would allow for appropriate 
validation of the method. 
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5.2. Aims 
Considering the limited amount of published work related with the strategy outside of 
traditional model organisms, and for the purposes of strain improvement, there was a 
need to (1) validate M. smegmatis for the purpose of regulatory network rewiring and 
(2) test rewiring as an appropriate strategy for strain improvement. 
5.3. Experimental strategy 
Cloning and assembly of the rewiring library was performed by Gingko Bioworks 
(Boston, MA), with constraints being placed only on the target vector and identity of 
elements to be included. This was so that the cloning process could be optimized using 
their proprietary assembly method. 
In order to confirm the possibility of using this species for the isolation of phenotypes of 
interest, a test library containing a subset of the full library elements was constructed. 
This work was performed in parallel with efforts to confirm production of aldehydes, and 
served to explore possible issues with experimental throughput. 
Initially rewiring strains were sought that would result in enhanced growth rate - the 
slow-growing nature of the species was a limiting step to research and faster growing 
E. coli rewired strains had been obtained by Isalan et al. (2008). 
Serial culturing of a mixed rewired population should allow for the isolation of strains 
that become dominant over time. Whilst the dominant effect may not be due only to 
faster growth, this could be assessed throughout a validation stage.  
5.4. Results 
5.4.1. Selection of elements for library assembly 
Library elements were selected by querying 
the Uniprot KB database using specific terms, 
and then defining subsets within the results 
obtained. 
The terms focused on the main categories that 
were expected to produce phenotypical 
changes, such as “Sigma factor” or 
Table 5.1 - Search terms used for 
identification of candidate genes and 
number of elements selected for test 
library 
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“Transcription regulator”. 
Search terms can be found in Table 5.1, along with the number of elements selected 
for a test library produced by Ginkgo Bioworks (Boston, MA) and cloned in to a pSE100 
backbone. Considering identity of elements used for promoters and ORFs 20 were 
unique to the ORFs list, 7 to the promoters and 8 were found in both. 
The full list of initially identified 50 promoter regions and 42 ORFs selected for a full 
rewiring library with descriptions are available in Table 16.3. 
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Figure 5.2 - Identity of promoters found in rewired strains sequenced throughout the competitive 
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Figure 5.1 -- Identity of rewired strains sequenced throughout the competitive growth experiment 
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5.4.2. Analysis of population constitution through sequencing 
In order to study any initial tendency for specific rewired strains to become dominant, 
sampling was performed during the serial passaging experiment. This experiment was 
performed by inoculating medium (100mL) with strains carrying rewiring plasmids, 
incubation for 2 to 3 days until an OD600 between 0.8 and 1.6 was obtained, followed by 
inoculation of fresh media using 10-100µl of culture. This was repeated over a period of 
2 months, with initial samples being obtained at day 1,4,10 and 15 of the experiment. 
After plasmid isolation and retransformation eight single colonies from each sampling 
point were sequenced. 
A noticeable increase in the number of clones without a rewired construct over time 
was observed, as well as no dominance of a specific rewired strain (see Figure 5.1). 
Similar results were obtained for promoters (Figure 5.2) and ORFs (Figure 5.3).  
5.4.3. Isolation of fast growing individuals in M. smegmatis strain mc2 155 
Dominant strains of rewired M. smegmatis were isolated from serial passaging of 
cultures after 16 rounds. 
Plasmid DNA from the last serial passaging step was retransformed into M. smegmatis 
for isolation of single clones, followed by the characterization of their growth in liquid 
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Figure 5.3 - Identity of ORFs found in rewired strains sequenced throughout the competitive 
growth experiment 
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medium. Due to the need of a significant sample of the population to be analysed, 
optimization of growth in HTS format was performed. Figure 5.4 describes the process 
used throughout the experiment. 
Attempts to grow cultures in 96-well format resulted in the production of suspended 
biofilms in all conditions, resulting in inconsistent absorbance readings. This showed 
that the format was unsuitable for growth curve experiments. However, it was 
determined that samples could grow to high densities, providing a practical platform for 
growth of large numbers of samples. 
The use of 0.75% Tyloxapol, 1.5ml of medium and 225rpm resulted in growth without 
the formation of biofilm and the use of Breathe-Easy membranes reduced the 
evaporation of media over long periods of growth in 24-well plates.  
Growth at higher shaking speeds was also efficient, but an appropriate plate shaking 
incubator was not available. An alternative system had to be built using available 
materials. Therefore, the slowest speed that resulted in no biofilm formation was used. 
Growth with lower volumes of media would also be possible but would limit the ability to 
grow cultures for extensive periods of time due to media evaporation even when 
membranes were used.  
Figure 5.4 – Protocol used to isolate strains showing improved growth.  
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85 directly comparable growth curves were obtained for isolated clones. Normalisation 
of values obtained for generation time using internal standards (plasmid backbone, 
pSE100) present within each 24-well plate, lead to the identification of 22 candidates 
with potentially lower generation time.   
Results are summarised in Figure 5.5. 
Figure 5.5 - Growth rate change in samples grown in 24 well plate format. Values were obtained by 
normalizing against an internal reference (plasmid backbone - pSE100). Higher values should be 
interpreted as slower growing cultures. 
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5.4.4. Sequencing of clones with apparent improved growth  
Clones isolated from the final population of the 
competitive growth experiment were isolated and 
sequenced. Ordered results for 6 clones can be 
seen in Table 5.2. Unexpectedly, the tendency for 
the dominance of empty vector clones persisted 
throughout the experiment  
5.4.5. Growth curves of clones with apparent 
improved growth 
After the identification of the two clones harbouring rewiring constructs, their growth 
curves were analysed. As these clones were originally incubated in separate 24 well 
plates Figure 5.6 and Figure 5.7 include the reference control sample from the 
respective plate. Sample names reflect the predicted function of the proteins driven by 
the isolated promoters and of the ORFs identified. 
In the case of sigH-like::sigJ strain, the apparent accelerated growth in the last time 
interval impacted greatly on the value of generation time obtained. The effect was not 
observed in other wells in that plate, and no issues were observed during the 
experiment that could have affected the well in question. 
Table 5.2 - UniprotKB ID of proteins 
encoded by the source gene 
Figure 5.6 - Growth of a sigH-like::sigJ rewired strain versus control. First 
measurement made 17h after inoculation at 0.1 OD600. 
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As for the sigF::lytS-like strain the growth curve is more similar to that of the empty 
plasmid control. The slower growth at the first two intervals of pSE100 resulted in the 
difference between generation times. 
  
Figure 5.7 – Growth of a sigF::lytS-like rewired strain versus control. First 
measurement made 17h after inoculation at 0.1 OD600. 
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5.5. Discussion 
5.5.1. Isolation of fast growing clones in M. smegmatis 
Growth curves obtained from members of the re-wiring library in M. smegmatis had 
shown that most of the population had grown at a rate similar to that of controls 
(pSE100 plasmid), with most of the individuals behaving outside that rate growing 
slower. This was expected considering the complexity associated with the phenotype in 
case – the process of chromosomal replication and binary fission requires complex 
orchestration and a single rewiring step must impact severely on the process in order 
for it to occur at a faster pace179–181. 
Although the experiment was designed to isolate fast growing individuals a number of 
factors could explain the selection of fast growers, such as adaptation to growth in 
fresh media, enhanced production of biofilm, enhanced co-operative growth or 
improved growth at low cell densities. The number of serial passaging steps may also 
not have been enough to differentiate these individuals from the rest of the population, 
in which case a more prolonged experiment could be used to validate the hypothesis. 
The number of fast growing individuals supports the previous argument, as they 
comprise only 24.7% of the population. The existence of different levels of growth was 
expected as only a very small proportion of re-wiring events could provide advantage in 
growth rate considering it is regulated by multiple pathways in the cells. 
Sequencing of clones derived from the serial passaging population did not however 
provide a clear indication of its progression towards dominance of rewired strains. It 
also showed that with the progress of the experiment most isolated plasmids did not 
contain rewiring constructs. This may be explained by the burden imposed on cells 
expressing the rewiring constructs from several plasmid copies, which may outweigh 
gains produced by rewiring the TRN of M. smegmatis. 
Attempts to isolate rewiring strains at the endpoint of the experiment led to sequencing 
of mostly empty constructs with the exception of the fastest growing clone, harbouring 
rewiring construct sigH-like::sigJ (A0QXG9-A0QT05)and the 4th fastest sigF::lytS-
like(A0QTD8-A0R2L6). Whilst isolation of clones containing rewiring constructs and 
with faster growth is a positive result, the fact that two thirds of those isolated retained 
empty vectors limits its positive scope. It also shows that in the pursuit of complex 
phenotypes it may be necessary to evaluate both the use of plasmid based and 
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integrated copies of the rewired construct in order to obtain the right level of TRN 
perturbation. 
Elimination of empty plasmid from construct pools could also be addressed in order to 
avoid domination in competitive growth experiments, but this could be not only difficult 
due to the complexity of combinatorial library generation but also prejudicial as it could 
bias the experiment to the point of not providing a base line. 
5.5.1.1. sigH-like::sigJ 
Considering the faster growing rewired strain, the promoter for the SigH-like protein 
encoded by MSMEG_3296 has been shown to be expressed at very low levels in 
varied growth conditions, upon stress and in the presence of cell wall biosynthesis 
inhibitors. It is however upregulated through Isoniazid mediated inhibition of the FAS-II 
elongation pathway of mycolic acid biosynthesis182. The ORF of this pair, SigJ is an 
alternative RNA polymerase sigma factor whose M. tuberculosis homologue has been 
shown to be active in the stress response against reactive oxidative species183 and to 
be highly expressed in late stationary phase and in persistent cultures after rifampicin 
treatment184. 
This rewiring construct may provide an improved response to stresses related to 
adaptation to culture density.  
5.5.1.2. sigF::lytS-like  
The second rewired strain isolated, SigF has been show to regulate adaptation to heat 
and oxidative stress (via production of protective carotenoids) as well as to stationary 
phase185, whilst a lytS homologue in S. aureus has been shown to be involved in 
regulation of cell wall synthesis186–188. It is possible that this rewired strain may also 
have improved response to cell density change. However the lack of a more closely 
related characterised homologue for lytS limits the scope of this suggestion. 
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6. Conclusions - M. smegmatis rewiring (Part 1) 
 
 
Summary 
Following completion of the competitive growth experiment it was necessary to 
evaluate project progress and commitment to the production of a full rewiring library for 
use in M. smegmatis. A number of issues identified throughout this phase of the project 
are described. 
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6.1. High GC content PCR 
In the case of PCR, review of the literature in respect to the use of additives and 
enzyme processivity under non-standard conditions lead to the recognition that even 
one of the cornerstones of molecular biology, the process of in vitro DNA replication, is 
context dependent and not fully understood. It was however possible to identify 
strategies to address the issue that was presented and eventually some level of 
success was obtained. More importantly it produced an opportunity to identify some 
relevant parameters of plasmid design and also understand that PCR based methods 
for DNA assembly may be limited in applicability. 
6.2. Limitations in gene synthesis 
Regarding the issue of gene synthesis, the approach to in silico optimization can result 
in completely different outcomes for the client’s research, and in this particular case the 
difference between activity or complete loss of signal of an essential enzyme. From the 
experimental point of view, the process of testing the initial version of the Reductase 
gene was lengthy and required substantial work to eliminate possible approach related 
issues. It did however allow for the improvement in manipulation of M. smegmatis 
cultures and to address most issues related to growth at smaller scales. 
6.3. Production of alkanes and alkenes in M. smegmatis 
Initial efforts to produce signal from the initial version of the Reductase gene did not 
result in any signal. Attempts to verify expression of the gene were made using SDS-
PAGE gels to no effect. Activity was tested through luminescence assays and GC-MS 
without identification of relevant products being achieved. Performing these 
experiments without any progress over a significant period of time delayed the project, 
although parallel work was performed in order to minimise the impact. 
Even with the re-synthesis of the gene a definitive confirmation of expression of both 
the Reductase and Decarbonylase could not be achieved. The results obtained through 
luminescence assays suggested that production of alkanes and alkenes was occurring 
and signal obtained from Western blotting experiments supported this. 
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6.4. Improving growth rate through rewiring 
The M. smegmatis regulatory network rewiring effort had provided preliminary results 
that show improvement of a desired phenotype (growth rate) through a single round of 
re-wiring. However, a large number of the clones sequenced proved to contain an 
empty vector, which suggests that the library contained failed assembly products that 
eventually became dominant in the population. The existence of empty vector in the 
library was known through a quality control report based in sequencing produced by 
Gingko Bioworks, in which 2 out of 48 clones sequenced were identified as not 
containing a rewiring construct. Three other reads were inconclusive or failed. This was 
considered as of a good enough standard for the purpose of testing the approach. 
Two of the fastest growing clones did contain rewiring constructs and their identity does 
indicate that a stress-response may be involved in providing improved adaptation to the 
experimental conditions. Two clones containing an empty vector outperformed one of 
the rewired strains indicating this could have been a false-positive. Further testing 
would be required to confirm this and to validate that the faster rewired clone did have 
an improved growth/stress response phenotype. 
The optimal method for testing growth rate would have been the isolation of single 
clones and production of individual growth curves, as performed for the 85 clones used 
to quantify growth rates after the competitive growth experiment. This would require 
sufficient coverage of the library in order to ascertain that most members were 
assessed. This strategy should eliminate the effects of stress produced by the series of 
dilutions and nutrient depletion cycles but isolation of non-rewired clones could still 
present a challenge. However with the increased experimental complexity of the full 
library obtaining growth curves for all members would be a challenging prospect, 
requiring automation at a scale that was not available. 
6.5. Feasibility of the species and pathway for validation of the 
method  
Considering the objective of the project, it was necessary to review the results obtained 
in light of method validation towards real world applications. Whilst the selection of M. 
smegmatis was appropriate for the purpose of testing the method in a less well 
characterized organism, its growth requirements severely restrained the experimental 
set-up. Technical issues and delays with the assembly of the test library also revealed 
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that progress could be hindered through external factors, and steps that included DNA 
manipulation could lead to future issues.   
Tests performed towards the identification of fast growers and expression of aldehydes 
allowed for the identification of crucial bottlenecks to the screening of a library 
containing the alkane/alkene pathway: Screening of aldehyde production is complex 
from the sampling manipulation perspective; An unmeasured amount of empty vector is 
part of the test library, which could be difficult to exclude with the complete version; 
biofilm formation in microwell plate formats above 24 wells would severely affect 
experimental throughput; and difficulties in manipulating sequences originated from the 
species may lead to unexpected delays. 
Overall the choice of this pathway and organism was valid and could allow for 
successful completion of the main objective of this project but taking into account 
existing limitations in terms of time, resources and technical requirements at the time it 
was decided that a new approach should be taken. 
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Part 2  
Rewiring P. pastoris for improved 
production of the carotenoid lycopene 
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7. Introduction 
 
 
Summary 
P. pastoris is considered a strong platform for the production of recombinant proteins, 
but examples of its use for metabolite overproduction are rare. There is limited 
knowledge of its regulatory network, making it a candidate for regulatory rewiring in the 
scope suggested in this work. Elements relevant to the genetic tractability and 
examples of use of the species for the production of chemicals are described. 
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7.1. Pichia pastoris 
P. pastoris is a yeast from the Saccharomycetaceae family with particular 
characteristics that make it an excellent platform for the industrial production of proteins 
and enzymes189. 
Its ability to grow non-fermentatively on sugars eliminates ethanol-based toxicity, and 
under controlled media conditions the toxicity profile of growth by-products is mostly 
eliminated. This results in the achievement of very high cell densities at the fermenter 
scale, with examples of as high as 200gCDWL
-1 on glucose190 and 170 gCDWL
-1 on 
methanol191 having been reported in the literature.  
Capable of producing post-translational modifications such as glycosylation, proteolytic 
processing and disulphide-bonding, this species has become widely used for 
expression of therapeutic proteins, with “humanized” strains being available for 
expression of products with decreased probability of an immune response192,193. 
Although of great industrial importance, knowledge of P. pastoris’ genomic organization 
and regulation are still in its infancy. Only a small amount of high-throughput 
experiments have been reported in open repositories, with no available commercial 
microarray platform being available as of the time of writing. 
A case was made by Dikicioglu et al. (2014) towards an increased effort in genome 
annotation with high quality community curating as a means to make this species a 
more widely used platform both academically and industrially194.  
7.2. Genetic tractability  
P. pastoris can be considered generally as a tractable organism for the expression of 
heterologous proteins and pathways. This has mostly been realised due to the interest 
in industrial protein production and the general applicability of principles used in 
research with S. cerevisiae. 
7.2.1. Episomal vectors 
Episomal vectors have been reported for P. pastoris 195–197 but their adoption has been 
limited to directed evolution libraries198–201 and generation and screening of plasmid 
libraries202–204. The main advantage of using these plasmids is the possibility of easy 
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recovery and subsequent modification of members of libraries for further improvement, 
as stability of expression over long periods is yet to be demonstrated. 
7.2.2. Genomic integration 
Most of the published work in P. pastoris relies on integration of expression cassettes 
into the genome. A number of auxotrophic markers have been produced with variable 
use, mostly propelled by the needs of specific strain engineering projects. Amongst 
these are the HIS4205, MET2206, ADE1207, ARG4207, URA3207, URA5208, ARG1209, 
ARG2209, ARG3209, HIS1209, HIS2209, HIS5209 and HIS6209 markers, which require full 
complementation for survival in selective media. HIS4 is by far the most widely used 
marker for its historical precedence and wide availability of vectors. Figure 7.1 includes 
a simplified graphical representation of integration into this locus. 
An alternative approach to auxotrophic complementation was taken by Du, Battles & 
Nett, using ADE1 and ADE2 markers with truncated promoters driving their expression, 
resulting in the need for multi-copy integration. It also results in a pink color which 
allows for distinction against ade- clones and to some extent number of gene copies210. 
Antibiotic based selection markers are also available, allowing for integration of 
constructs in environmental isolates and selection of multi-copy clones by successive 
increase in antibiotic concentration (posttransformational vector amplification – PTVA; 
see Figure 7.2)211. This method requires the use of a resistance mechanism that relies 
on the production of sufficient amount of protein to escape antibiotic action, such as 
Zeocin212, G418 sulphate213 and hygromicin214. 
Figure 7.1 – Genomic integration in P. pastoris using auxotrophic markers. Example of integration 
integration into the his4 locus: the linearization of a vector containing a gene of interest (GOI) 
using a restriction enzyme specific to the functional copy of HIS4 allows for the recognition of the 
mutated genomic copy. A functional and a non-functional copy will flank the expression cassette 
if the vector is integrated into the correct site. 
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Along with antibiotics such as blasticidin215 and nourseothricin216, selection markers 
have been shown to allow for appropriate selection in P. pastoris. The use of antibiotic 
based selection allows for the integration of multiple constructs, both for multi-copy 
integration and for strain engineering. 
A known issue with P. pastoris is the lack of efficiency in the integration process. This 
is mostly due to the prevalence of the non-homologous end joining (NHEJ) pathway 
over the homologous recombination pathway during integration. This results in the 
need for large stretches of homology in linearized DNA and even then a reduced 
fraction of clones express the genes of interest correctly. A strain with a single knock-
out of the essential NHEJ pathway protein KU70 allows for the use of much smaller 
integration cassettes and a much higher fraction of clones expressing the target 
construct217. 
7.2.2.1. Note on the use of multiple gene copies 
Use of multiple gene copies for increased production of proteins of interest is common 
practice in P. pastoris. Multiple strategies have been designed but copy number 
instability is a common issue that arises over time and can be difficult to manage in 
Figure 7.2 – Increasing copy number through PTVA. Multi-copy strains may be obtained by 
direct plating of transformations onto media containing high antibiotic concentration, but 
this may require a very large number of trials until suitable clones are obtained. Plating of 
cells onto a gradient of antibiotic concentration may be used to identify a concentration 
suitable for selection, and restreaked colonies may then be subject to an increasing 
concentration of antibiotic, resulting in the isolation of strains at much higher concentration 
and therefore with increased copy number. 
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industrial settings. The use of multiple gene copies was deemed inappropriate for the 
purpose of the work here described as it could introduce bias through gene copy 
fluctuation. For an excellent review on the subject see Aw and Polizzi (2013)218. 
7.2.3. Protein secretion 
The existence of efficient native machinery in P. pastoris for protein secretion is of 
great interest for the production of industrial proteins and protein characterisation 
efforts. A number of secretion signals have been identified for this purpose but the 
most commonly used is the α-MF secretion signal of S. cerevisiae219. Some limitations 
occur due to the saturation of secretory capacity or three dimensional conformation of 
the signal peptide when expressed with the protein, and this is a subject for 
optimization in projects related to industrial applications. 
7.2.4. Inducible promoters 
7.2.4.1. AOX1  
The alcohol oxidase promoter is the most frequently used in P. pastoris due to its high 
levels of expression and very low basal level220. One characteristic of this promoter is 
the strong repression by glucose and high levels of induction with methanol, with 
moderate levels of expression upon de-repression221.  
Considering the popularity of the promoter, its tight on-off regulation, and the need for 
promoters exploring a wider level of expression levels, a library for improved control 
was produced by Hartner et al. (2008)222. This library enabled expression from 6 to 
169% of the wt promoter, and modified regulatory modes in some of the promoters. 
7.2.4.2. DAS  
The dihydroxyacetone synthase promoter has similar levels of expression similar to 
those of AOX1. However, although it also shows induction by methanol and repression 
by glucose, no expression is associated with the process of de-repression221. 
7.2.4.3. FLD1  
The formaldehyde dehydrogenase promoter is strongly induced by methanol as carbon 
source or methylamine as nitrogen source223. 
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It has been shown to produce the same level of expression using only methylamine as 
inducer as the AOX1 promoter in methanol224. However, the adaptation to methylamine 
as nitrogen source is apparently slower than to methanol as carbon source leading to a 
long lag period (55h) in the case of adaptation to sorbitol-methylamine versus 8h for 
the methanol-ammonium pair224.  
7.2.4.4. ICL1  
The isocitrate lyase promoter is strongly induced by ethanol and repressed by glucose. 
High levels of expression can be achieved on ethanol or in conditions of absence of 
glucose225. This promoter is active during stationary phase, consistent with the use of 
ethanol produced during growth once glucose is depleted. 
7.2.4.5. CUP1  
The CUP1 protein from S. cerevisiae was shown to be regulated by copper in a 
concentration dependent fashion in P. pastoris. Induction of approximately 28 fold at 
200µM of Cu2+ can be achieved by media supplementation226.  
7.2.4.6. ADH1 and GUT1 
The promoters for alcohol dehydrogenase adh1 and the glycerol kinase gut1 genes 
have been described in a 2012 patent by Cregg & Tolstorukov227 but further detail is 
not provided due to the lack of peer reviewed material. 
7.2.5. Constitutive promoters 
7.2.5.1. GAP 
The Glyceraldehyde-3-phosphate dehydrogenase promoter is a widely used 
constitutive promoter in P. pastoris228. It shows a high level of expression in glucose 
and 30% of the maximum expression level with glycerol229, making it an important 
alternative when compared to the AOX1 promoter, due to lower safety requirements 
(such as the flammability of methanol) and overall lower complexity at the industrial 
production scale230. Whilst using this promoter in fed-batch processes, maintenance of 
cultures at the limit of aerobic to fermentative metabolism can improve specific 
production rate231  
A library of GAP promoters was also produced in order to allow for fine-tuning of 
expression levels, producing promoter variants spanning 0.17 to 19.58 fold 
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improvement in eGFP fluorescence against the wildtype GAP promoter and spanning 
more than a 400-fold range in mRNA levels for three distinct transcripts228 
7.2.5.2. TEF1 
The translation elongation factor 1-alpha promoter is capable of producing high 
expression levels during growth, especially in carbon-limited fed-batch cultures232. Its 
expression levels are also more correlated with growth than GAP with decreased 
activity when stationary phase is reached, whilst producing earlier detectable activity. It 
also achieves high levels of activity at high glucose concentrations232. 
7.2.5.3. YPT1 
The YPT1 promoter has been characterized as a moderate constitutive promoter by 
Sears et al. (1998). The data made available from use of the GUS protein as reporter 
system suggests that it has constitutive low expression with glucose, methanol and 
mannitol as carbon sources233. 
7.2.5.4. PGK1  
The 3-phosphoglycerate kinase gene has been shown to be functional in glucose, 
glycerol and methanol, with higher activity in glucose234. Comparative data against 
commonly used promoters is not available. 
7.2.5.5. GCW14 
The promoter of a potential glycosyl phosphatidyl inositol (GPI)-anchored protein has 
shown higher expression levels in glucose, glycerol and methanol when compared with 
the GAP and TEF1 promoters, and 2/3 expression level when compared to the AOX1 
promoter in methanol. The tests were however limited to flask scale, with no data 
available on large scale production235. 
7.2.5.6. G1(GTH1)  
The promoter of a glucose transporter with high affinity was identified from microarrays 
produced from fermenter cultures using conditions similar to those in industrial 
fermentation of proteins driven by pGAP. G1 is very tightly repressed by glucose, with 
production of protein starting only at 0.5g/L. It also allows for very high expression 
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levels, improves over pGAP in multicopy tests and showed general improved 
properties236. 
7.2.6. Transformation methods 
For the purpose of transformation a number of techniques can be used, including 
spheroplast generation237, polyethylene glycol treatment238, alkali treatment239 and 
electroporation240,241.  
The level of complexity associated with the methods described varies widely, with 
electroporation methods being well balanced in transformation efficiency with both 
auxotrophic and antibiotic markers, protocol complexity, and multicopy integration, as 
seen in Table 7.1. 
7.3. Production of chemicals using P. pastoris  
Very few applications have been reported for P. pastoris in the field of metabolic 
engineering, as its engineering has been hindered by the lack of tools and precise 
knowledge on gene identity and regulation. 
Production of cyanophycin grana peptides (cgp), using cphA from Synechocystis sp. 
Strain PCC 6308 has been demonstrated in the species242. There a number of potential 
uses in biotechnology, with the most obvious being as a biodegradable polymer 
(polyaspartic acid) and as intermediate towards urea or acrylonitrile242. S. cerevisiae 
has been reported with wild-type yield at 6.9% (wt/wt)243 and 15.3%(wt/wt)244 in strains 
defective in arginine biosynthesis. In P. pastoris, up to 10.4%(wt/wt) was recovered 
from wildtype strains in 2L fermentors after optimisation of media, temperature and pH.  
Fed-batch with glycerol of a truncation mutant of the CphA protein resulted in 
accumulation to 23.3% (wt/wt). 
Table 7.1 - Comparison of transformation methods. Adapted from Lin-Cereghino et al. (2005)
240
 and 
Cregg & Russell (1998)
294
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Polyunsaturated fatty acids (PUFA) such as arachidonic and eicosapentaenoic acids 
have also been reported in P. pastoris after cloning of Marchantia polymorpha genes. 
These PUFA are produced in plants, and the requirement of native linoleic acid and α-
linolenic acid fatty acids could not be met in S. cerevisiae but was native to P. 
pastoris245,246. 
The production of riboflavin, a precursor to flavin mononucleotide has been achieved 
by inclusion of a single gene from S. cerevisiae, RIB1. Identification of a homologue in 
P. pastoris and its overexpression also led to the accumulation of riboflavin, with further 
improvements being obtained by overexpression of multiple RIB genes from the same 
strain, achieving an yield of 175 mg/L in fed-batch cultures247. 
Production of carotenoids such as lycopene and beta-carotene have also been 
reported, with yields matching those found in literature of initial stages of strain 
engineering in E. coli and S. cerevisiae 140,248. 
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8. Selection of a target pathway for strain improvement 
 
 
Summary 
The main objective of this project was to achieve validation of transcriptional regulatory 
network rewiring for the improvement of strains overproducing metabolites. The need 
for a working pathway in the target species with the requirement of HTS compatibility 
has already been noted, and was subject of research in P. pastoris. 
Three types of metabolite were targeted and the ability to meet minimal requirements 
considered. Alkanes and alkenes could be used for HTS using a luciferase producing 
strain as a reporter but consistent production of the measurable intermediates 
(aldehydes) could not be achieved; methyl halides were considered of interest but the 
need to develop a quantitative assay for HTS and potential health and safety issues 
made screening of the rewiring library a complex issue; lycopene demonstrated 
properties likely to assist HTS and its production in P. pastoris had been reported. 
Lycopene was selected as the target compound and a suitable assay was developed. 
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8.1. Candidate pathways 
Selection of a pathway followed the principles described in Section 3.2, namely 
viability, suitability for validation and industrial interest. As such three target metabolite 
classes were considered: carotenoids, alkanes / alkenes, and methyl halides. 
8.1.1. Production of carotenoids 
Lycopene is the metabolic precursor of carotenoids, being a part of that family. 
Applications of these compounds can be found in the medical, food and cosmetics 
industries. P. pastoris natively produces farnesyl-pyrophosphate, a precursor required 
for the production of the molecule249. 
The selection of the pathway for lycopene production described by Bhataya et al. 
(2009)140 was based on: its small size (three Erwinia uredovora genes: crtE, crtB and 
crtI); ease of screening of cultures, as lycopene has a characteristic red colour; 
substrate used, farnesyl diphosphate (FPP) which is relevant for a number of other 
pathways, such as steroids, prenylated quinones, dolichols and hemes; and to its direct 
industrial application, as mentioned before.  
Heterologous expression in P. pastoris had also been demonstrated with relevant 
yields, expansion of the pathway had also been reported and a large number of 
products could be obtained through inclusion of other members of carotenoid 
biosynthesis pathway. There was a mild interest in obtaining strains capable of 
producing lycopene in large amounts, but other compounds such as astaxanthin would 
be of outstanding interest. Figure 8.1 denotes how the selection parameters were 
perceived for this compound 
Figure 8.1 – Choice of lycopene as target metabolite.  
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8.1.2. Production of methyl halides 
Methyl halides are naturally produced by 
plants and microorganisms as means to 
regulate intracellular pools of halides. 
The economic and environmental 
relevance of these compounds comes 
from their use in the organic chemistry 
industry as a substrate for alkylation 
reactions, being part of processes for 
the production of both fine and bulk 
chemicals250. Some methyl halides are also used in agriculture as fumigants, although 
there are concerns about the effect of such chemicals on the ozone layer and human 
health. 
Methyl halide transferases (MHTs) catalyse the formation of methyl halides by 
methylation of free halides in the presence of S-adenosyl methionine. This metabolite 
is ubiquitous in nature, and in S. cerevisiae 80% can be found in the vacuole251. 
The highly efficient Batis maritima methyl halide transferase (MHT) (Bayer et al., 2009) 
was selected for this project as an example of bioconversion. In particular, these 
molecules are toxic when produced at high concentrations, producing a considerable 
stress to strains expressing the gene. 
Heterologous expression had not been demonstrated in P. pastoris, but good yields 
had been reported in S. cerevisiae. The use of an MHT would likely only validate the 
method for bioconversion and inclusion of a pathway down-stream would be 
considerably risky. The use of high-density cultures of P. pastoris could be of great 
interest in industry for this bioconversion step, whilst the compound itself is relevant for 
organic chemistry pipelines. Perception of these elements is abstracted in Figure 8.2. 
8.1.3. Production of long-chain alkanes and alkenes 
As no report of successful expression of these genes in eukaryotes existed, this 
pathway allowed for the validation of the method in this domain. The lower viability of 
this pathway was considered to be offset by the importance towards the validation of 
the method and the high industrial relevance of a potential strain. 
Figure 8.2 – Choice of methyl-halides as target 
metabolites.  
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8.2. Aim 
Determination of a phenotype for strain improvement was a requirement for the 
successful validation of the method. The work here described aimed at the selection of 
a model pathway that would allow for efficient screening. 
8.3. Experimental strategy 
Pathways were initially cloned into the vector that had been selected for use with the 
rewiring library in order for their activity to be tested.  
Production of lycopene could be recognised by eye, with spectroscopy and liquid 
chromatography allowing for confirmation of its production. A HTS compatible assay 
was also developed to allow for the use of the pathway for validation of the method.  
Production of methyl halides could not be determined in HTS format and thus an assay 
for this purpose was required. Targeting of the enzyme to the vacuole was also 
attempted as it had been demonstrated in S. cerevisiae that this would result in higher 
activity. 
Production of alkanes and alkenes was assessed using the assay described in Part 1 
for M. smegmatis, which already provided a platform for HTS. 
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8.4. Results 
8.4.1. Alkane/Alkene pathway 
8.4.1.1. Assembly 
The Acyl-ACP Reductase 
encoded by orf1594 of S. 
elongatus PCC7942 was 
optimized for expression in 
S. cerevisiae and 
synthesized by DNA2.0, as 
well as the Aldehyde 
Dehydrogenase encoded by 
the orf1593 of N. 
punctiforme PCC73102.  
Versions of the P. pastoris 
pAO815 vector with either 
or both genes were 
produced in order to test 
functionality of the pathway (see Figure 8.3). 
The reductase and decarbonylase were amplified with primers containing specific 
homology with the AOX promoter and terminator in the target vector. For the version 
containing both genes the full expression cassettes were amplified with an intermediate 
linker. All constructs were sequence verified. 
8.4.1.2. Testing at tube scale 
After testing of multiple clones at 96-well plate scale, 24 were selected for testing in 
50ml falcon tubes with a final culture volume of 5ml. Three replicates were used per 
construct and supernatant was tested after 48 hours of induction with methanol. 
Figure 8.3 – Assembly of expression constructs for aldehyde 
and alkane/alkene production. 
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Samples were tested with the reporter strain using both spent media and culture, but 
no signal could be obtained from spent media alone. The results seen in Figure 8.4 
could not be replicated under similar incubation conditions using other clones. 
Detection of product from spent media and cells using GC-MS also failed to provide 
any confirmation, even though a number of pAO815-R clones were assessed (data not 
shown). 
8.4.2. MHT 
8.4.2.1. Assembly of MHT into pSM vector 
The MHT from B. maritima was synthesised and optimized for P. pastoris expression 
by DNA2.0.  
The gene was amplified using primers with homology to pSM and assembled using the 
one pot isothermal method. The resulting plasmid had similar structure as those 
described previously and was sequenced for verification of correct assembly. 
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8.4.2.2. Development of a methyl halide assay 
The need for an assay that could be used for HTS led to its attempted development 
prior to in vivo testing. 
A free chloride quantification method in aqueous solutions had shown that chloride 
concentration could be measured in ranges relevant to the system – transfer of methyl 
groups to free chloride would reduce signal and therefore allow for the detection of the 
enzymes’ activity.  
Several concentrations of both perchloric acid and iron (III) nitrate were tested to 
produce a measurable iron-chloride complex, but only at 23mM and 20mM respectively 
did the assay produce enough linearity. 
This assay was time dependent and so both addition of reagents and equipment delay 
during readings would affect the values obtained. This can be seen in Figure 8.5, 
where the delay in pipetting the solution whilst using a multichannel pipette caused 
significant change in signal at the time of sampling, noticeable between the 45 and 
50mM samples. 
8.4.2.3. Targeting of MHT to the vacuole 
Attempts to target the protein to the vacuole were made using a known S. cerevisiae 
vacuolar targeting sequence (Carboxypeptidase Y)252, a sequence obtained through 
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Figure 8.5 - Absorbance at 340nm obtained using the free chloride assay. Attempt 
to obtain a calibration curve with addition of developing reagents to sodium iodide 
solutions. 
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alignment of this VTS with the homologous protein in P. pastoris (QMPM) and an 
extended sequence containing four extra amino acids (IGLSQMPM). Versions of GFP 
tagged with these sequences were observed by fluorescence microscopy, resulting in 
the images seen in Figure 8.6. From these images it was impossible to confirm 
localization of GFP in vacuoles, as the fluorescence appeared to be located in the 
cytoplasm.  
8.4.2.4. Testing of MHT expressing clones 
MHT expression in S. cerevisiae was used to test if the methyl halide assay could be 
applied in vivo. Although not completely validated, the assay supported removal of free 
halides from the media (see supplementary Figure 16.8). 
Attempts to replicate the results with P. pastoris clones in minimal media did not result 
in clear reductions of OD340 against empty plasmid controls when incubation periods of 
48h were used post induction. 
  
Figure 8.6 - Overlay of fluorescence and bright field images of P. 
pastoris strains expressing yEGFP. a: yEGFP; b: yEGFP tagged with 
the QRLP sequence; c: yEGFP tagged with the QMPM sequence; d: 
yEGFP tagged with the IGLSQMPM sequence. 
131 
 
8.4.3. Lycopene 
8.4.3.1. Assembly of crtE, crtB and crtI into pSM 
The genes for the lycopene pathway were synthesized and optimized for expression in 
P. pastoris by DNA2.0. crtE, crtB and crtI were amplified from their original pJ905 
vectors with their promoters (GAP) and terminators (AOX). Linkers were designed into 
the primer overhangs so as to allow for appropriate assembly into pSM, resulting in a 
10534bp vector (see Figure 8.7). The final vector was sequenced with full expression 
construct coverage. 
8.4.3.2. Confirmation of lycopene production 
Colonies expressing lycopene were selected visually for testing and incubated for 72h 
in a volume of 5ml, followed by extraction of lycopene into ethyl acetate. Absorbance 
measurements and HPLC analysis of the organic extracts and standard confirmed 
production of lycopene (see Figure 8.8). It was observed that red colour was only 
developed in cultures after a long period of time (above 36h), as exemplified in Figure 
8.9.  
  
Figure 8.7 – Assembly of the crtEBI expression construct. The target vector was amplified with 
exclusion of the existing expression cassette components and crtE, crtB and crtI were amplified 
from the original pJ905 vector with compatible overhangs. 
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8.4.3.3. Development of an in-vivo assay 
Lycopene absorbance scans displayed specific patterns on strains producing lycopene 
(see Figure 16.12). Normalisation for all scans was performed using OD660 (see Figure 
16.13), as interference of lycopene absorption would impact readings at OD600 in 
samples with high concentrations, when using some light sources and these 
wavelengths correlated well (see Figure 16.10). 
Attempts to correlate extracted lycopene absorbance with mixed populations producing 
lycopene showed high correlation across tested wavelengths (see Figure 16.14). 
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In order to allow for the selection of specific wavelengths, variance was calculated 
across all samples and wavelengths to determine those most informative (see Figure 
16.15). 
Having combined variance and correlation data, OD484 was selected for lycopene 
production monitoring. 
Using the reference absorbance of hexane extracted cultures (OD502; see Figure 16.16) 
and the extinction of coefficient for lycopene, OD484 was correlated with lycopene 
concentration of samples (see Figure 8.10).   
Figure 8.9 - Production of lycopene in flasks with 50ml of culture. a) after incubation for 24h; b) 
after incubation for 56h. Inset – Cell pellet obtained after 56h. 
y = 0.6558x - 4.8187 
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Figure 8.10 - Correlation between lycopene concentration (calculated from lycopene extinction 
coefficient at 502nm in hexane) and OD484 measurements corrected to a 1cm pathlength. 
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8.5. Discussion 
8.5.1. Production of alkanes and alkenes 
Production of long-chain alkanes and alkenes using the pathway identified by Schirmer 
et al. (2010)174 had never been reported in yeasts. Whilst assembly and expression of 
constructs in yeasts did not result in toxicity or other unexpected negative effects, the 
absolute identification of clones producing the target compounds was mostly 
unsuccessful.  
Whilst the complexity of the pathway was low and the number of colonies screened for 
each construct within a reasonable number, only a single positive clone for each of the 
constructs was isolated, with limited success and without the ability to reproduce the 
results.  
Alternatively, the level of expression of aldehydes may have been low and the reporter 
system not sensitive enough for adequate detection. GC-MS was used to investigate a 
number of clones but none provided hints of production of the target compounds. 
Possible explanations for the results obtained are the targeting of the proteins, - 
especially the Acyl-ACP Reductase - for degradation, the existence of post-
translational modifications that may affect the protein’s activity or potential incorrect 
folding.  
Considering the difficulty in isolating and reproducing signal from positive clones, it was 
decided that continuing efforts towards the use of this pathway for library screening 
would carry excessive risk. 
8.5.2. Production of methyl halides 
The most important step to establish feasibility of the synthesis of these compounds 
using the chosen MHT was the optimization of the screening procedure for free 
chloride.  
Even though direct detection of methyl halides would be more suitable for high 
throughput screening of a library, no reasonable method was found in published work. 
As such, measurement of the substrate was pursued as it had been addressed for 
other purposes139. 
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Initial testing with aqueous solutions of sodium chloride demonstrated that intervals of 
linearity were feasible for biologically relevant concentrations of free chloride.  
Possible interference of methyl chloride with the assay was not tested. This was due to 
the highly toxic nature of high concentrations of the chemical, and its high vapour 
pressure253. Although undesirable, this property of the product could help minimise 
interference with the method, as heating the samples to a temperature of 60°C for a 
prolonged period of time in a fume hood should decrease the amount of this compound 
found in solution.  
Screening carried some concerns as whole libraries would require incubation of a 
number of 96-well plates for a few hours until a relevant amount of free chloride was 
consumed by the cultures. The ability to ensure safety in the working environment 
could be an issue as non-breathable membranes would have to be applied to plates 
with a high degree of precision. 
As no reference to vacuolar targeting sequences could be found for P. pastoris in the 
literature, a number of possible tags derived from the Carboxypeptidase Y252 of this 
species were tested after alignment against the S. cerevisiae homolog. The reasoning 
behind the choice of the tags was the homology with a recognised sequence from S. 
cerevisiae (QRLP, also tested), resulting in the choice of the QMPM amino acid 
sequence and a larger segment of the propeptide resulting in the IGLSQMPM 
sequence, matching a region of homology with the carboxypeptidase. Interest in this 
targeting sequence was also linked to its potential importance for scientists that use P. 
pastoris as a model system in the study of protein degradation due to its use of micro- 
and macro-autophagy pathways. 
Overall, work for this class of targets was halted as the complexity of the tasks 
necessary previous to any library screening was considered too high. 
8.5.3. Production of lycopene 
Early success in pathway assembly and production of lycopene in P. pastoris led to 
further work in the project to be dedicated to this pathway. Even though the same 
promoters and transcriptional terminators had been used for all three genes, the 
construct was reported stable for long periods in culture248 and test at flask scale 
reinforced this observation. 
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Confirmation of lycopene in samples was obtained using absorbance readings of crude 
samples and via HPLC against a standard.  
No high throughput screening assay for lycopene was found in published literature, as 
most projects involving the molecule relied on the visual identification of clones 
producing the compound and extraction into organic phase previous to quantification. 
The amounts of lycopene produced in the test strains required the use of multiple 
extraction steps until all was recovered in organic phase, with the use of glass beads 
for this purpose as reported by Araya-Garay et al. (2012)248. Seeing that this procedure 
would require a large amount of effort and resources for use in a library screening 
process it was decided that an alternative assay had to be developed. 
Considering the nature of the molecule, absorbance-based detection was considered. 
Full visible light spectrum of cultures was used to verify the presence of lycopene 
specific peaks and determine candidate wavelengths. Observations of possible 
interference in absorbance of cell density at OD600 by lycopene led to the need to select 
a different wavelength for cell density normalisation. OD660 was chosen as an 
alternative as it correlated with cell density as measured by the typical wavelength (see 
Figure 16.10). 
Extracts of cultures in hexane with varying amounts of lycopene producing cells were 
produced in order to attempt correlation of OD502 (lycopene reference peak in hexane) 
with wavelengths obtained from culture spectra. The resulting plot showed high level of 
correlation across most of the wavelength range, which should be related with the 
nature of the molecule. As such it was necessary to isolate a wavelength that could not 
only correlate both measurements, but also allow for discrimination of lycopene 
production levels throughout cultures. 
The parameter that was considered for this was variance. By analysing variance across 
the spectra obtained from afore mentioned cultures (see Figure 16.15), it was possible 
to isolate wavelengths that could be used for the purpose of measuring lycopene 
accumulation in vivo. 
OD484 was selected for this purpose and an approximation to the concentration of 
lycopene in a culture was produced from the correlation of OD484, OD502 and extinction 
coefficient.   
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A relevant observation was that cultures at different stages of growth may produce 
signals that do not correspond to observed phenotypes. As such use of the assay 
quantitatively should be restricted to cultures that comply with the conditions used to 
produce the described relationships.  
The most important implication of this is that screening of libraries would require long 
culture incubation times to allow for inoculations at lower cell densities to achieve high 
enough densities for lycopene content to be measured.  
Considering that a HTS compatible assay could be used, that the pathway was 
confirmed to be active in P. pastoris strain GS115 and that it was a precursor to a 
number of other pigments (this could be useful to explore if the selection of a precursor 
overproducer would result in overproducers in more complex pathways) this compound 
was selected as target for phenotypical improvement.  
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9. Library design and implementation 
 
 
Summary 
Prior to the assembly of a rewiring library it was necessary to gather requirements, 
define parameters and strategy for the production of the physical library and its testing 
in the target species. The design principles used for generating the library are 
described, as well as the assembly strategy used for production of rewiring pairs in a 
combinatorial fashion. Quality control by sequencing of clones post-assembly (in E. 
coli) and gel electrophoresis post-transformation into the target species is also 
described. A working regulatory network rewiring library was produced and shown to 
be suitable for use for method validation purposes. 
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9.1. Introduction 
9.1.1. Library design 
The use of genetic libraries in biotechnology can be loosely grouped in two categories 
– (i) generation of diverse versions of a genetic component and (ii) exploration of 
genetic search spaces for elements with a desirable function. 
Common to both problems is the need to define and constrain the search space. Whilst 
a number of studies on the subject focus on improving the throughput of the search254–
257 or reduce as much of the search space as possible258,259, in practical terms the 
search space exploration should be limited according to requirements defined prior to 
the experiment.  
The object of this work - the determination of the suitability of regulatory network 
rewiring for eliciting favourable phenotypes for industrial applications - poses the 
problem that it can be classed in both categories of library, as the phenotype of interest 
is only loosely defined (increased metabolite production may arise from a number of 
different paths) posing a novelty problem, and the components that generate these 
phenotypes may do so in a graded way depending on the conjugated promoter and 
ORF elements.  
Added complexity is provided by the fact that the model species chosen for this study is 
not as thoroughly studied as others (such as S. cerevisiae or E. coli). The information 
regarding regulatory networks is limited to a small number of seminal studies usually 
focused on parameters of interest for the expression of a specific protein or condition 
generally relevant to production of proteins at the industrial scale194 (with autophagy 
being an exception260–264).  
The underlying limitation is that identification of regulatory elements is done mainly 
through homology to known sequences of yeasts. Although this approach should help 
identify targets for rewiring successfully, it may ignore evolutionary novelty and loss of 
relevant targets in P. pastoris.  
After considering the search space and the identity of regulatory elements, the 
generation of a physical library must be taken into account, as it further impacts the 
potential library size and screening workflow. 
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9.1.2. Library Assembly 
The assembly of a library should be considered as a problem of reduction of search 
space, insertion of bias and introduction of non-desirable/non-expected elements. 
As much as possible, bias should be minimised to allow for minimal departure from 
equal screening probability of all library variants. Production of individual clones for 
each combination, with confirmation of identity via sequencing would be optimal. 
However, even with current state of the art automation and sequencing, costs could be 
prohibitive and experimental complexity would be taken to a level that very few projects 
may benefit from.  
With relatively large target libraries, combinatorial assembly becomes a more suitable 
option. Different approaches exist for the production of DNA fragments encoding library 
elements and for the production of rewiring clones in the target strain. 
Table 9.1 – Summary of DNA assembly techniques. Full circle – Applicable; Empty circle – 
Requires adaptation. Adapted from Ellis, Adie and Baldwin (2011)
295
 and extended to include 
Golden Braid, MASTER, MODAL, LCR, LCR-SOC, DNA assembler and E. coli RecET mediated 
recombination 
296–302
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9.1.2.1. DNA assembly strategies 
A number of strategies exist that have been proven to successfully produce libraries. 
Restriction enzyme based cloning has been used successfully to produce libraries; 
however the reduction in efficiency caused by ligation of multiple parts tends to limit the 
number of elements that can be combined in a single reaction. This leads to multiple 
sequential cloning steps and the precision in part ligation may be limited by the number 
of bases produced as an overhang after restriction. 
These limitations and the availability of high-fidelity DNA polymerases have led to the 
development of methods that rely on long overhang homology to allow for precise 
assembly. Within this class, methods can be distinguished by their reliance on one or 
more enzymes' activity (such as exonuclease, DNA polymerase and/or ligase activity), 
thermal cycling and inclusion of non-DNA basepairs with reliance on in vivo or in vitro 
assembly.  
If part of the diversity in a library is focused on the ends of the fragments to be 
assembled, these methods alone will fall short as they cannot fully address this issue 
unless linker regions are produced – alternatively a hybrid approach could be a valid 
strategy, in which case the overall efficiency should be judged according to the specific 
case. 
A summary of properties relevant to current DNA assembly methods can be seen in 
Table 9.1. 
9.1.2.2. Quality control 
Preparation of DNA for library assembly is a multi-step process, providing the 
possibility for bias and erroneous assembly of parts. Steps such as vector restriction, 
normalization of DNA fragment concentration, assembly of fragments in size-based 
tiers or transformation, all have the potential to impact the variability and quality of the 
library (see Figure 9.1). 
As such, steps should be included to ascertain that the library meets experimental 
requirements and can proceed to the screening phase. 
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Considering libraries in which a base level of signal is expected from a significant 
proportion of clones, the first step should be to verify that this is the case as loss of 
signal could indicate issues during assembly: sequencing should ultimately be used to 
verify if the assembly process was successful and variability has not been affected.  
 
9.2. Aims 
Generation of a working rewiring library required the (1) determination of the rewiring 
library size, (2) generation of a list of targets to be included in the library, (3) production 
of a working rewiring library in a vector containing the lycopene pathway and finally (4) 
the verification of existence of diversity on the transformed library. 
9.3. Experimental strategy 
The nature of the screening workflow limits the size of libraries. An upper limit for 
library size and screening coverage were determined to assist the process of library 
element selection. 
Figure 9.1 – Example of operations that may lead to library bias. a) Inclusion of uncut vector may 
occur during gel extraction due to incomplete digestion or close migration (larger vectors will be 
more affected); b) Dilution of PCR products prior to pooling may lead to over or 
underrepresentation of an element in the library; c) Creation of tiers for parallel PCR of elements 
is arbitrary by nature and may increase the probability of bias due to b) as conditions may be 
suboptimal in some cases; d) transformation efficiency of different constructs may vary due to 
size or identity of the DNA sequence. 
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Choice of assembly method required appropriate design of the rewiring expression 
cassette and allowed for constraints to be placed on primer design. The resulting 
primers were evaluated for deviation to the constraints and the library elements were 
obtained from genomic DNA. 
Post-assembly variability was evaluated by sequencing the promoters in E. coli clones. 
Genomic DNA of P. pastoris clones was amplified to determine variability of the ORF 
elements. 
9.4. Results 
9.4.1. Determination of library size 
The effect of library size and possible screening coverage were investigated by 
calculating the probability of an element to be selected for screening according to a 
binomial distribution. 
Assuming equal probability of selection for screening for every member of the library 
the surface seen in Figure 9.2 is obtained. Increase in number of elements 
homogenizes the probability curve as the skew of the distribution decreases and it 
approaches normality. Plotting the probability derivative shows that screening depth 
gains decrease quickly. The typical use of 3-fold coverage (number of clones screened 
equaling three times the size of the library) is thus indicative of an attempt to include at 
least 95% of the variants in the sampled population. This however does not include any 
bias in the selection probability for each clone to be picked. 
Considering the scope of the project a library size above 1000 can be assumed, and 
the parameter to be investigated thus becomes selection probability, as it can be 
affected during assembly, transformation or colony picking process.  
Given a large enough library (3000 members) and equal odds, each variant in the 
library would have a selection probability of 1/3000 (3.33x10-4). Halving the probability 
(1.67x10-4) of a variant to be selected would result in a decrease in screening 
probability to 77.7% at 3-fold coverage. 
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In Figure 9.3, the effects of varying the probability of a clone being assayed are shown. 
Considering that an increase in selection probability will further ensure screening of a 
library member, mostly decrease in selection probability was investigated. Decreasing 
the probability of a clone being assayed creates an effect similar to fold coverage 
decrease. This is most obvious from the calculation of the probability slope, where it 
can be seen that decreased selection probability negatively affects the effect of 
increased screening coverage. Overall screening coverage above 2.75 to 3 fold 
coverage will result in reduced gains.  
9.4.2. Impact of number of variants in the screening process 
Considering the need to establish a limit of number of elements to be chosen and the 
assumption of 3x coverage, the number of clones to be screened was calculated 
considering an equal number of promoters and ORFs (see Figure 9.4). This exercise 
mostly shows the amplification that occurs through library coverage on the 
combinatorial growth in number of samples to be treated, and considering logistic 
Figure 9.2 - The probability of screening a clone given the size of the library and screening 
coverage considering equal probability each individual clone to be assayed. Inset – Gain in 
screening probability by increasing library coverage 
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limitations the final number of elements should not exceed approximately 60 (60 ORFs 
and their promoters), or 10800 clones screened at 3x coverage. 
9.4.3. Selection of library elements 
UniProt’s UniProtKB database was used to select elements for this library. Queries 
were built by limiting results to the target species, P. pastoris (strain GS115; Taxon 
identifier: 644223) and filtering using the general search term of interest (e.g. 
“Transcription Factor”).  
Considering the limitation previously mentioned it was decided that a different number 
of promoters and ORFs were to be chosen. This was done taking into account that 
hierarchical changes should impact more extensively the TRN265, and that including an 
increased number of promoters should produce this effect. 
Figure 9.3 - The probability of screening a clone given screening coverage and 
probability of a clone to be assayed. Inset – Gain in screening probability by 
increasing library coverage. 
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Table 9.2 includes the 67 proteins selected for the database, be it for use of their ORF 
or promoter region. A larger number of promoters were selected (67) when compared 
to ORFs (42). This resulted in a total library size of 2814 variants, which should require 
8442 clones to be selected for screening, below the limit previously set.  
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Figure 9.4 – Effect of number of library elements in the number of 
clones to be screened to obtain 3x coverage. 
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Table 9.2- Elements selected for the library. Dark grey background indicates the element was 
included as its promoter (-1000 to 0 bp) or ORF. 
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9.4.4. Library Assembly 
9.4.4.1. Definition of target regions 
Components in the ORF pool were defined as the complete coding sequence for the 
genomic entry at NCBI gene, whilst promoter regions were considered to be the 
1000bp upstream of the genomic gene location (as seen in Stadlmayr et al. 2010)266, 
taking into account strand directionality. 
Target sequences were extracted from NCBI using the Entrez geneID associated with 
the UniprotKB entries selected in the previous section. Mapping of IDs is available in 
Table 16.4. 
9.4.4.2. Expression cassette  
In order for the rewiring constructs to be functional and to insulate their effects from 
read-through of plasmid elements, a strategy had to be devised for linking the promoter 
and ORF components as well as for the addition of a terminator. 
Individual variant assembly would require the design of primers specific to each 
promoter-ORF pair, resulting in a specific set being produced per variant, 5737 
(2814x2 +42 +67) primers in total. Assembly using a variant-independent linker would 
require 208 primers (42*2 + 67*2), resulting in a more acceptable number of reactions 
Figure 9.5 – Assembly of the rewiring expression cassette. Promoters were amplified 
individually with homology to the vector and to a linker region to allow for combinatorial 
assembly with the ORF fragment. ORFs and transcriptional terminator were amplified 
individually and combined in an intermediate reaction using a linker region. The 
terminator included homology to the vector. 
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to be processed. 
Homologous overhangs were 
added for one-pot promoter-ORF 
pair assembly – the promoter’s 
reverse primers and ORF’s 
forward primers included a 40bp 
linker region as overhang to 
allow for random annealing of 
these components and use in 
Gibson assembly. 
The AOX terminator was 
selected for use in the cassettes, 
with its assembly being done by 
individual amplification and 
addition to the ORF fragments in 
an independent PCR reaction. 
Figure 9.5 summarises the 
procedure. 
Regions flanking the promoter 
and terminator contained recognition sites for the restriction enzyme SmaI and 
homology with the target vector, so as to allow for both assembly and easy 
confirmation of cassette insertion through SmaI digestion. 
9.4.4.3. Primer design 
The main parameters considered for primer design were melting temperature between 
60°C and 65°C, primer pair ΔTm below 2°C, inclusion of a GC clamp and minimal 
length. 
Compliance with the parameters is summarised in Figure 9.6. 
Figure 9.6 – Compliance of primers with the predefined 
parameters 
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9.4.4.4. Preparation of component pools 
9.4.4.4.1. Promoters 
All promoters were amplified as expected producing bands with 1080bp. The pool was 
prepared by addition of elements in an equimolar fashion to prepare an initial pool at 
50ng/µl with further dilution to a working concentration of 20ng/µl. 
9.4.4.4.2. ORFs 
ORFs were amplified separately by 1kb size bands. The pool was prepared by 
equimolar addition of elements to prepare an initial pool at 30ng/µl. The average 
sequence length of the pool was 1711bp. 
9.4.4.4.3. Preparation of vector 
The vector pAO815 (Invitrogen) was modified to reduce its size by removing a 1370bp 
fragment containing the 3’ AOX region between the pUC19 origin of replication and the 
HIS4 marker. A recognition site for SmaI was added for cloning of the rewiring 
cassette. The resulting vector was digested using SmaI and gel purified for assembly. 
9.4.5. Library assembly and transformation into E. coli 
The assembly reaction was performed with the 
recommended component concentration (100ng linearized 
vector, equimolar amounts of promoter and ORF pools). The 
reaction mix was kept at 50°C for 8 hours to allow for 
complete assembly of the library. 
Transformation by electroporation of the library resulted in 
approximately 9800 colonies. These were washed from agar 
plates and plasmids were isolated, with the exception of ten 
clones that were isolated for sequencing of the promoter 
region to verify clonal variability. 
The 10 clones produced the sequencing results seen in 
Table 9.3.  
Table 9.3 – Identity of 
promoters sequenced 
from E. coli library 
clones. 
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9.4.6. Transformation into P. pastoris 
Transformation in P. pastoris using the condensed high efficiency electroporation 
method produced variable clone counts per ng of library DNA. Throughout a number of 
transformation cycles it was possible to identify the following factors as being relevant 
to the success of the protocol: 
1. Aliquot age: aliquots stored at -80°C suffered from loss of competence, likely due to 
variations in storage temperature; 
2. Preparation of media: filtered YPD improved clone number versus autoclaved YPD; 
RD agar prepared with components diluted on the day improved clone number versus 
use of stored components. It was observed that agar depth variations due to viscosity 
of the recovery media can severely impact growth of clones at low levels. 
3. Growth at 29°C: this temperature did not produce higher number of clones but 
allowed for accumulation of lycopene at smaller colony size, aiding isolation. 
In total 13000+ P. pastoris clones showing a red colour were picked for screening. 
Amplification of the rewiring construct from 10 individual clones was performed to 
confirm the existence of genetic variability in the library, with the resulting gel being 
seen in Figure 9.7. 
Figure 9.7 – Rewiring constructs amplified from P. pastoris clones. Lanes 1-10 contain PCR 
products from individual colonies showing red colour after transformation. L indicates ladder, 
GeneRuler 1kb DNA ladder (ThermoFisher, USA). 
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9.5. Discussion 
9.5.1. Screening coverage 
One parameter that was considered for quantifying the number of elements to include 
in the library was the number of clones that would be screened to achieve sufficient 
coverage. Assuming a perfectly balanced library of genetic components with equal 
transformation probability, 3x coverage during screening is required to test 
approximately 95% of the variants at least once. It is also relevant to notice that 
increasing coverage above 2.25x results in a small return in terms of percentage of the 
library screened, with this level of coverage producing at least one screenable clone for 
90% of the library. 
By including non-specific selection bias in the analysis, it is possible to understand that 
a large deviation from equal screening probability of specific individuals of the library is 
needed in order for coverage to be affected. Further decrease in the selection 
probability produces a decrease in the steepness of the coverage vs screening 
probability, as is expected.  
Although bias is expected from sample handling, transformation efficiency, and/or 
plasmid assembly (in cases of combinatorial assembly) it was assumed that selection 
probability will not vary to a large extent. This resulted in a target 3 fold coverage for 
the screening procedure, independently of the number of elements used in the library. 
9.5.2. Size of the target pool 
More than 200 transcription factors had been identified in S. cerevisiae at the time of 
library design267. Assuming a similar profile of these elements in P. pastoris the total 
possible search space for promoter-ORF combinations would exceed 40000 variants.  
Considering that the application of this method for practical purposes would require 
restrictions on the size of the target population, the optimal size for the library would be 
at 50 (2500 variants) to 60 (3600) elements. Above this number issues relating to 
sample handling and storage could severely limit the extent of validation work 
performed as well as quality of the screening procedure. 
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9.5.3. Selection of library elements 
Published work regarding the relevance of specific parameters in the exercise of 
transcriptional regulatory rewiring revealed that affecting hierarchically superior 
regulators would more likely produce relevant effects in phenotypes such as growth 
than attempting to modify lower-level regulators265. 
Taking this into account it was decided that inclusion of a larger number of promoters 
than ORFs should provide more depth to the application of the technique when 
compared to the symmetric use of both promoter and ORF for each selected gene. 
Inclusion of promoters specific to certain cellular processes was also considered 
beneficial as they should provide the more extreme cases of hierarchical 
rearrangement of the transcriptional factors and regulators. 
The UniprotKB repository was chosen as the source of annotation for the selection 
process as it provided access to protein information collected from several sources, 
whilst also providing a simple to use interface for handling large queries.  
While limiting the use of search terms to Gene Ontology may be good practice, it can 
be quite limiting in species where most genes have an ‘Inferred from Electronic 
Annotation’ (IEA) status. This is because no curation has taken place on the entry and 
because it tends to be limited in detail of the annotation. Queries including protein 
name may yield more results of interest as this field will many times mirror the name of 
the gene homologue that was the basis for GO annotation. An example of this is 
protein C4R7K1 of P. pastoris, that was not annotated as a transcription factor for GO 
but is named through its similarity to S. cerevisiae’s MIG1 (“Transcription factor 
involved in glucose repression”), therefore being returned from a general database 
query for the term “Transcription Factor”. 
No specific parameter was defined for inclusion of elements from specific subsets into 
the library – this was left to the analysis of relevant gene/protein entries retrieved from 
database queries. 
Although limited in scope, the resulting set of promoters and ORFs should allow for the 
exploration of relevant changes to the transcriptional regulatory landscape produced 
through rewiring. 
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9.5.4. Library assembly 
Considering an optimal library assembly process, all variants of library and promoter 
elements would have been individually amplified with compatible overhangs. When 
taking into account the workflow requirements set by this option in terms of cloning, 
storage and sample tracking this option was considered overly ambitious and of little 
gain. 
Instead, a combinatorial assembly with a promoter and ORF independent linker was 
used. While inserting a DNA fragment between promoter and coding sequence may 
affect the native mode of regulation associated to the promoter, it was considered that 
it would not impede the exploration of new regulatory spaces and thus the validation of 
the method. This should however be controlled for during characterisation of strains 
showing relevant phenotypes. 
9.5.4.1. Pre-assembly of the AOX terminator 
Inclusion of the AOX terminator in the expression cassette could have been done by 
subcloning of this component into the receiving plasmid. This strategy would have 
prevented the second amplification step of ORF elements, but could prove a challenge 
for assembly considering the formation of possible secondary structures in the already 
large vector: if this was the case it could affect the overall assembly process, leading to 
a low efficiency assembly; or it could lead to issues related to interaction with specific 
ORF coding regions, which would lead to extensive bias in the assembly process. 
Assembly of the terminator with the ORF as a preliminary step allows for the 
identification of ORF specific issues and their troubleshooting, as well as removal of 
bias from 3’ sequence identity. 
9.5.4.2. Vector modifications 
Inclusion of restriction sites in the primers containing homology to the target vector 
allows for both directional assembly of the library through extension based methods 
and non-directional assembly using restriction enzyme based cloning. It also allows for 
isolation of constructs through SmaI digestion when checking vectors containing library 
elements. 
 The positioning of the target site for the library components was considered to be 
optimal at the opposite side of the site used for assembly of the target enzyme/pathway 
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to be tested. As this region of the plasmid was occupied by the 3’ AOX region that was 
not to be used for integration purposes the modification of the plasmid included 
removal of said region. This also allowed for some reduction of vector size. 
9.5.5. Assembly method 
Assembly of the library was performed using the one-pot isothermal assembly method. 
This method was chosen due to its simplicity, specificity, high efficiency and isothermal 
properties.  Considering the complexity of the library, amplification-based methods 
such as CPEC would invariably introduce bias due to different ORF sizes and different 
sequence nature. This could be obviated by producing independent reaction mixes for 
each ORF containing all promoters to be assembled, but could greatly increase 
complexity of the process due to possible issues with some of the components. 
Restriction cloning was excluded due to efficiency concerns, but may be used to 
explore the relevance of rewiring construct directionality by releasing the cloned library 
components of the vector by complete digestion using the added sites (for SmaI) and 
re-ligation. 
The use of separate reactions for intervals of ORF fragment size was also considered 
as it could assist control of bias associated with this parameter. However it was felt that 
it could add variation to the screening procedure in the case of sample isolation from 
different clone pools. 
The assembly mix was incubated for a prolonged period of time (8h) instead of the 
standard hour described in the original protocol. Whilst no test was performed to 
evaluate the impact of this change it should not affect the quality of the library in any 
way considering the reaction should terminate once all available T5 exonuclease 
becomes denatured or all vectors have been re-ligated after gap extension by Phusion 
DNA polymerase. 
9.5.5.1. Transformation and quality control 
Transformation was performed by electroporation of the reaction mix containing the 
assembled library. A clone count was performed on all transformation plates and more 
than 9800 clones were washed into LB medium for plasmid DNA isolation. This 
accounted for a clone pool of slightly more than 3.48 fold the size of the library, which 
should guarantee high variant representation. 
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Sequencing of 10 isolated clones resulted in the identification of the same promoter 
twice and a failed read. Whilst the probability of two clones containing the same 
promoter is low (0.02%), it was considered that variation was enough for the purpose of 
validating the method, and that the process of validation post screening would identify 
any relevant bias. 
Subsequent transformation into P. pastoris produced clones with the expected 
phenotype in large amounts, allowing for an appropriate experimental throughput. 
Amplification of rewiring constructs from gDNA of randomly selected clones revealed 
that integration had been successful and variability was present at the ORF level. 
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10. Rewiring library screening 
 
 
Summary 
Screening was a key step towards the validation of the method: determination of 
screening parameters and protocol would impact severely on the quality and number of 
the candidates obtained at the end of the process, with direct impact in the subsequent 
steps. 
Considerations such as media choice, incubation time and methodology used for 
colony picking are discussed and their impact analysed. 
Considering the number of clones picked and grown for the purposes of screening, 
lycopene production in a substantial number of clones was quantified resulting in a set 
of 1422 candidates identified for validation. 
  
158 
 
10.1. Introduction 
Efficient screening of a moderately large library requires an assay that is compatible 
with the defined search space, while having a good level of precision and low false 
negative rate – accuracy may be achieved with lower throughput methods; false 
positives can be detected throughout the candidate validation phase. 
As P. pastoris mainly recombines DNA through Non-homologous end joining (NHEJ) 
recombination only about 30 to 40% of clones obtained after transformation are 
expected to harbour a fully functional construct217. This issue supports the need for an 
assay capable of identifying non expressers and avoid issues with screening metrics 
such as coverage. 
In order to screen the library at 3 fold coverage at least 8442 clones would have to be 
assessed. For this purpose a colony picker and 96 well plate shaker incubator were 
identified as requirements as colony picking, replication from glycerol stocks and 
sample incubation would be the most apparent experimental bottlenecks. 
The use of lycopene as a target metabolite would allow for the verification of positive 
clones during the picking phase, effectively eliminating issues related of noise vs. basal 
level of expression and allowing for the direct observation of issues related to sample 
handling and maintenance.  
10.2. Aims 
The parameters set for the screening procedure aimed at the (1) complete screening of 
the rewiring library and the (2) isolation of candidates with apparent increase in 
lycopene production for validation. 
10.3. Experimental strategy 
Colonies showing production of lycopene were picked and assayed until a sufficient 
number of clones had been screened to achieve the target screening coverage. 
Conditions during screening were varied producing two separate sets, with incubation 
up to 48 and 72 hours. 
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Issues related to picking, loss of expression and no growth were identified and 
quantified where possible. Considering that samples could still be tested and the issue 
could be corrected by including a larger number of clones in the screening process the 
protocol was deemed appropriate. 
10.4. Results 
10.4.1. Picking of rewiring clones 
In order to evaluate picking efficiency three sets of clones grown for screening were 
assessed after growth in YPD medium. Growth and expression were recorded for all 
plates and results are summarised in Table 10.1. The complete dataset is included in 
Table 16.6. 
10.4.2. Growth of clones in 96 well format 
Due to low signal in MD medium using Breathe-Easy® membranes YPD medium was 
tested as well as White Rayon membranes. 
Change of medium to YPD allowed for production of more lycopene in cultures with the 
same incubation time, although corner effects were still noticeable in plates using 
Breathe-easy membranes. 
Use of white rayon membranes with MD medium allowed for a homogeneous 
improvement of expression levels across plate wells. The resulting cultures at 48h 
displayed a dark pink colour, with some clones showing red colour. 
The combination of YPD medium with white rayon membranes led to homogeneous 
expression across plates with dark red colour being obtained after 48h and very dark 
red at 72h. 
  
Table 10.1 – Picking parameters in relation to picking method. Efficiency measured by the 
percentage of producers in the total of wells picked into. 
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10.4.3. Screening of lycopene production 
Two sets of clones from the library were tested with different periods of growth, while 
maintaining all other parameters stable. Only clones showing a strong red colour were 
selected for analysis. 
10.4.3.1. Incubation for 48h 
Incubation of cultures for this reduced period of time allowed for cultures to reach high 
density with highly variable levels of lycopene production, visually verified through 
variations of tone from light orange to strong red colour. 236 clones were selected for 
quantification, resulting in the distribution seen in Figure 10.1. 
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Figure 10.1 – Distribution of clones selected for quantification after 48h incubation 
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10.4.3.2. Incubation for 72h 
Incubation for an additional 24h led to an increase in the number of clones considered 
as expressing as well as with a strong enough colour to be assayed (1186 clones), 
resulting in the distribution seen in Figure 10.2. 
10.4.4. Screening coverage 
A total of 13152 clones were picked for screening. Of these 24.98% failed to grow 
when replicated onto test plates and 24.92% resulted in colonies not showing visible 
production of lycopene. The screening coverage taking into account all clones that 
have not failed to grow during the screening runs resulted in a final coverage of 3.51 
fold library size. Considering only clones with confirmed production of lycopene via 
visual inspection the coverage would be at 2.34 fold. A summary of the data gathered 
for all runs is shown in Table 10.2. 
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Figure 10.2 – Distribution of clones selected for quantification after 72h incubation 
Table 10.2 – Screening run parameters in relation to lycopene production and growth. Efficiency 
measured by the percentage of producers in the total of wells picked into. Runs 1 and 2 refer to 
48h incubation runs whilst run 3 refers to a 72h incubation run. 
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10.5. Discussion 
10.5.1. Lycopene producing clones in agar plates 
After transformation of P. pastoris through the condensed high-efficiency 
electroporation method, colonies containing rewiring constructs and expressing the 
enzymes for the lycopene pathway were obtained.  
While colonies producing the pigment could be distinguished from others visually they 
required 96 hours of incubation for this to be efficient – identification of clones at the 72 
hour mark is possible but with a large degree of uncertainty seeing that only a pale 
orange colour is observed and can be easily mistaken in smaller colonies under 
suboptimal lighting conditions.  
Considering the use of an auxotrophy marker for selection and thus of a defined 
medium, production of lycopene was limited by nutrient availability. This was 
particularly obvious in transformation plates where high clone density was obtained, as 
the pigment was only present to a degree where a light orange was visible.  
Large amounts of lycopene were detected frequently only on very small size colonies 
(typically 1 to 2 mm in diameter after 96h incubation), but not on larger ones. This could 
be explained through hindered growth due to overproduction. Once these were 
transferred to rich liquid media and incubated for periods up to 72h no difference could 
be observed against large colonies. 
These factors affected severely the possibility of using the QPix2 colony picker that 
was available to ameliorate the task of clone isolation as images gathered by the 
integrated camera were limited to grey-scale, making the task of separating positive 
clones from the whole population dependant on settings such as brightness and 
contrast. 
While the possibility of introducing a filter between the light source and lens could affect 
positively the isolation of clones producing the pigment, it would still require 
transformations to be plated at low densities to allow for good colony separation and 
clean picking by the picking head. Moreover, it would require a level of homogeneity 
between transformation and incubation conditions to produce the desired phenotype to 
an extent that would make picking possible without leading to colony overgrowth.   
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Attempts to use the colony picker with modified camera settings led to limited success 
with just short of 21% of all clones picked showing lycopene production. This resulted 
from light refraction phenomena within large non-expressing colonies that produced 
regions with properties similar to those producing lycopene. Colonies growing in the 
immediate proximity of positive clones would in some occasions also be picked as the 
picking head collected cells from the target colony.  
Seeing that this was the case and that manual picking achieved over 78% efficiency it 
was decided that clones should be picked manually. While the workload of this step 
was greatly increased by this decision it should be noted that it diminished the amount 
of resources necessary during the growth, storage and screening procedures. The 
alternative, combining positive samples after growth in microwell plates would still 
require a great deal of effort and limit the throughput during the sample gathering stage 
as the allocated resources for incubation of samples in the selected format was limited. 
It should be noted that a fraction of the clones that were considered as non-producers 
may have been caused by loss of function. This was impossible to quantify and as 
such included in the failure rate of both approaches. 
10.5.2. Clones producing large amounts of lycopene can be identified visually in 
liquid media 
While growth in minimal media during the initial outgrowth phase produced only 
cultures with orange colour to a light red it became immediately apparent that there 
was a high degree of diversity between clones. This diversity could not be attributed to 
any factor at first, but it soon became noticeable that cultures growing at the outer edge 
of 96 well plates produced larger amounts of lycopene. Although not unexpected efforts 
had been made to deploy breathable membranes homogeneously and so it is possible 
that plate design may have taken part in this issue. 
Replication of the clones and incubation in YPD confirmed sample variability although 
the amount of pigment observed was greatly increased and the positional effect less 
relevant. This observation led to the testing of other types of membrane to attempt to 
minimise this effect. Sealing membranes containing rayon were selected due to their 
high gas exchange which produced the most extensive effect in terms of increase in 
lycopene production of cultures in all wells, decreasing intraplate variability. 
Considering that the initially used membranes (Breathe-easy
®
) were developed to 
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meet the concern of evaporation throughout long incubation periods, the loss of volume 
observed during the use of the more breathable membranes was largely expected. 
In order to compensate for this effect culture volume was slightly increased and 
addition of mH20 was necessary to reconstitute the media. Loss of approximately 60ul 
of volume per 24 hours was consistent across the 96 well plates used for growth during 
screening and allowed for appropriate routines to be setup so as to avoid affecting 
sample growth. This process did increase the workload associated with the screening 
process, but it would not differ extensively from that of an induction based assay due to 
the need of induction and in some cases derepression. 
10.5.3. Screening 
10.5.3.1. Inoculation 
The initial step in the screening process – inoculation – can affect endpoint 
measurements if a large enough difference between samples is imposed. In order to 
regulate this, cultures were allowed to grow for 72h after picking, allowing for saturation 
to be achieved. Although far from the optimal procedure of stocking at mid-log phase to 
ensure viability of the culture, this was the only alternative that could help ensure 
homogeneity in inoculum density for the screening phase. 
10.5.3.2. Number of runs 
Optimally a library should be screened in a single run. Considering current state of the 
art this requires vast amount of resources for libraries with large number of variants 
(fully automated screening platforms). 
Diverging from this optimum, a library screened in multiple parts should have as many 
parameters as possible be maintained constant between runs. With the available 
experimental setup this was not possible, and as such measures had to be taken to 
ensure success of the screening step. 
Multiple screening runs were performed with the largest amount of plates possible. This 
allowed for consistency within sets of forty or more plates at a time, while minimizing 
divergence between similar sets.  
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10.5.3.3. Variation of incubation time 
Cultures on one of the three independent screening runs were incubated for an 
additional 24 hours to allow for further lycopene production. This particular exercise 
was performed to evaluate if candidates with different phenotypical properties would 
rise from the same library, mostly to do with increased opportunity to accumulate 
lycopene rather than possible improved production dynamics. 
This increase in incubation period resulted in a dramatic increase of the percentage of 
cultures displaying a sufficiently strong signal to be included in the candidate set 
(3.56% vs 36.59%). 
The alternative of incubating all samples for the least amount of time could also be 
valid if it is assumed that a phenotype that allows for the fast accumulation of large 
amounts of lycopene is relevant for the purpose of strain improvement. Validation of 
candidates can eliminate those that had produced high signal due to a higher 
inoculation density or that would be otherwise limited with more prolonged incubation 
periods. 
It was considered that the existence of two separate data sets would allow for a more 
complete exploration of diversity within the rewired clones, albeit with a known risk of 
not identifying rewired variants that could have been of interest if screened with the 
alternative set of conditions. 
10.5.3.4. Screening coverage  
The objective set out for the screening procedure was of coverage of 3 fold the library 
size. The total number of clones picked was larger than 13000. However, a large 
number of these clones failed to grow upon inoculation of the test plates, limiting the 
amount of clones effectively screened to 9864. This loss of almost a quarter (24.12%) 
of the library members could be explained through inefficient mechanical picking from 
agar plates, a loss of viability of clones during storage or inefficient replication of the 
stock plates. 
10.5.3.4.1. Failure to pick clones from agar plates 
Use of the QPix2 colony picker produced the highest percentage of wells showing no 
detectable growth after incubation in YPD, with 32% of wells - manual picking resulted 
in 23% in the first set and 16% in the second set. Considering that protocols for initial 
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outgrowth and glycerol stocking remained unchanged through all runs this factor 
explains part of the lack of efficiency, albeit not all. The lack of efficiency in the picking 
process may have had to do with artefacts produced during the image processing 
phase, considering that in order to isolate positive clones the filters applied decreased 
greatly the information contents of images. Alternatively calibration of the picking head 
depth may have been inconsistent with height of some agar plates in spite of the 
attempts to produce uniform surfaces and height in agar plates. 
10.5.3.4.2. Loss of viability during storage 
Loss of viability during storage or the preparation for storage may also have been a 
factor. In sample handling, issues pertaining the large number of samples and 
necessity to process them in batch may have occurred, although it is considered 
unlikely that a large amount of the affected cultures may have risen through this. As for 
issues relating to the equipment used for storage, there were problems with the ultra-
low temperature freezer used that could have impacted the quality of stocks. This said, 
it is questionable whether it would have affected sample viability to such a large extent 
as it would be expected across all plates. 
10.5.3.4.3. Inefficient replication of stock plates 
Consistent replication of the plates was necessary throughout the screening runs. The 
QPix2 colony picker included a replication tool that allowed for this step of the 
screening protocol to be automated. Samples were defrosted on ice and the available 
microwell plate incubator was used to re-suspend cultures, as high density cultures of 
P. pastoris will tend to settle if left unshaken. Variability between plates may have 
occurred due to setting of cultures throughout the replication step. However, this is not 
expected to produce no detectable growth in wells as even a small amount of the 
saturated culture should be viable. Adding to this, the replicating head was calibrated 
so as to lightly touch the side of the v-shaped bottom of the plate while collecting the 
inoculum, which should disturb any pelleted culture and allow for successful sample 
transfer. 
10.5.3.4.4. Residual clone growth 
The incidence of slow growing clones due to the rewiring effect was not expected to be 
high. However, clones containing multiple copies of the pathway may have suffered 
from slow growth and in some cases the inoculation of the initial culture may have been 
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at low enough density to affect the final density of cultures previous to glycerol 
stocking, consequently affecting the inoculation process. Combination of both factors 
may explain a part of the wells considered to have no detectable growth, as visual 
inspection may not have been sufficiently thorough to account for these cases. 
10.5.3.5. Picking efficiency 
The picking efficiency achieved through use of the automated picking platform was 
very low and the great majority of clones that were tested after being picked using this 
method produced no visible amounts of lycopene (64.18%). Manual picking of clones 
greatly reduced the percentage of non-producers (15.96% initially, dropping to 7.31%), 
which may indicate that a significant proportion of clones picked using the colony picker 
were wrongly included. 
One consideration that should be taken into account is that none of the clones picked 
using the automatic platform was included in the prolonged incubation run. Observing 
that the percentage of clones with no detectable lycopene was halved in the case of 
manually picked clones incubated for 72h vs 96h, it can be inferred that a similar (but 
perhaps not as extensive) effect could have been observed in the set picked using the 
colony picker. 
Overall the amount of clones picked should have been enough to produce 4.67 fold 
coverage of the library, while the number of clones with detectable growth was 3.51 
fold library size. 
Taking into account only clones with detected production of lycopene results in a 2.34 
fold coverage. Although calculation of the true library coverage would require further 
testing it was considered that the amount of clones screened was enough for the 
purpose of validating the method, and that any positive result obtained through a 
perhaps under screened library would only help reinforce the applicability of the 
method.  
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11. Candidate validation 
 
 
Summary 
A large number of candidates had been identified through the screening phase. Given 
the nature of the screening procedure, a high potential for the inclusion of false 
positives existed.  
As such, a process of elimination was put in place to bring them to a manageable 
number. Replication of the screening procedure allowed for most of the candidates to 
be eliminated. However, once attempts to validate the resulting subset using single 
rewired clones at various culture scales were made the results were unsatisfactory. 
A test of candidate populations versus control at microwell scale was designed that 
allowed these issues to be overcome and to obtain a set of five candidates to be 
included in further studies.   
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11.1. Introduction 
Validation of samples after a screening or sampling process is generally a step of 
elimination of false positives. In cases where the screening procedure does not 
account for reproducibility this should be tested to ensure specific experimental 
conditions are taken into account.  
In rewiring yeast to produce high titres of lycopene, the phenotypes observed during 
screening could have been produced by a number of underlying factors, particularly 
variations in environmental conditions. Thus, the validation process increases in 
importance and these variations can even be imposed to further select for phenotypical 
maintenance. If re-screened using parameters similar to those used during primary 
screening it would serve for strict identification of false positives. 
A further consideration in this project was the possibility of non-homologous 
recombination into the P. pastoris genome. The production of higher concentrations of 
a product due to integration onto a non-specific site, spontaneous increase in gene 
dosage or through any other sporadic event would be difficult to replicate and although 
of interest for strain improvement purposes it would fail to provide more information on 
the validity of the method in specific.  
In order to account for such effects, a rewiring pair of interest should be isolated from 
the clone used during validation, re-cloned into the integration vector and tested after a 
new transformation. By recovering and testing multiple clones of the rewired strain the 
effects aforementioned can be dismissed and a comparable set of genetic conditions 
can be tested.  
 
11.2. Aims 
Considering the large number of candidates obtained after screening the aims for this 
chapter were defined as (1) the reduction of the candidate set to a manageable 
number, (2) the elimination of false positives and (3) the validation of candidate 
expression levels relative to control strains. 
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11.3. Experimental strategy 
Validation of lycopene-enhanced candidates was performed by: (1) testing 
reproducibility of samples using the same conditions as for the primary screen. 
Candidates showing improved lycopene production during the primary and validation 
runs were selected for further validation; (2) a subset of candidates were then tested in 
96 well and 50mL tube format to confirm robustness of the phenotype to environmental 
variations; and (3) the full set of candidates was also tested at the population scale in 
96 well format in order to identify rewired strains showing consistent and clonally 
independent improvement in lycopene production. 
11.4. Results 
11.4.1. Replication of candidates from the initial screening step 
All 1422 candidates were replicated into new stock plates and subsequently tested in 
similar conditions to those used throughout screening. 
Selection of candidates for absorbance readings took into account only cultures 
showing very strong red colour. This led to the collection of data for 95 clones from the 
48h incubation run (see Figure 11.1) and 74 clones related to the 72h incubation run 
(see Figure 11.2). 
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Figure 11.1 – Distribution of clones replicated from the 48h incubation set. 
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Figure 11.2 - Distribution of clones replicated from the 72h incubation set. 
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Figure 11.3 – Standard scores of candidates in screening and validation runs. Green 
indicates candidates selected for further testing at the end of the validation process; Blue 
– 48 hour incubation set; Red – 72 hour incubation set. 
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11.4.2. Selection of candidates for further testing 
Standard scores (z-scores, number of standard deviations above the mean) were 
calculated for the results obtained on both datasets and were compared with standard 
scores produced for the screening run. Candidates with standard scores higher than 
0.5 on both runs were selected for validation for both the 48h dataset (14 clones) and 
72h dataset (12 clones), as seen in Figure 11.3.  
11.4.3. Sequencing of candidates 
Genomic DNA of candidates was isolated and the promoter-ORF pair was rescued into 
the pathway containing vector. Sequencing followed to allow for the identification of 
candidate rewiring constructs. Result are summarised in Table 11.1. 
Sequencing results were further mapped to the closest homologous proteins that had 
manual curation in the UniProt database after alignment using BLASTp. Mappings can 
be observed in Table 11.2.  
11.4.4. Testing of clones at 5ml volume 
A subset of the candidates was tested using capped 50ml falcon tubes with 5ml total 
YPD volume. The 3 top clones out of 96 tested at microwell scale were used for this 
purpose (see Figure 11.4). 
Most of the clones displayed inferior performance than control and only gap1::mth1 
produced more lycopene than control at a statistically significant level at 48h. 
Although snz3::gst did show apparent increase in production when inspected visually, 
no statistical significance was obtained.  
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Table 11.1 – Identity of promoters and ORFs selected for validation. 
Descriptions provided are as in annotations available at NCBI and UniProt. 
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Table 11.2 – Identity of the rewiring pairs present 
in candidates according to homology with human 
curated S. cerevisiae genes determined by 
BLASTp search at UniProt KB. 
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At the 72h point samples from gap1::mth1, snz3::gst and fum1::mtr2 showed a stronger 
red colour when observed but the results obtained did not result in statistical 
significance. Large variance between replicates was also observed at this time point on 
most samples, with that of control affecting the possibility of obtaining statistical support 
to any claim. 
The positioning in the standard score plot did not appear to correlate with the final 
expression levels under these conditions, with the adr1::zim17 performing worse 
overall than most constructs whilst displaying the best combined score and snz3::gst 
and fum1::mtr2 producing higher levels of lycopene whilst having a low combined 
standard score.  
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Figure 11.4 - Production of lycopene in 5ml YPD in 50ml Falcon tubes by the top 3 clones 
of each candidate. Red – 48 h; Grey – 72h. t-tests: open symbol, mean of candidate less 
than control; closed symbol, mean of candidate greater than control; X, not statistically 
significant. Circle: p<0.05; square: p<0.01. No statistical significance at 72h n=3. Error bars 
– SEM. 
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11.4.5. Flask scale test 
The best clone of each candidate of a reduced subset was tested at flask scale with a 
total culture volume of 50ml YPD in 500ml flasks (see Figure 11.5). The gap1::mth1 
pair was selected due to early high expression levels and higher production at 72h, the 
fum1::mtr2 was selected due to overall higher levels of lycopene at the endpoint and 
dbf2::gis2 was included to observe if lower levels of production were also maintained at 
a larger scale. 
Five experiments with three replicates each were performed independently and 
individual results can be found in Figure 16.18. In these experimental conditions 
fum1::mtr2 showed a statistically significant improved level of lycopene production 
whilst gap1::mth1 showed apparent decreased production. 
11.4.6. Testing of clones at 200µl scale 
Considering the variation of expression levels obtained from the highest producers a 
new approach was attempted. For each candidate a plate was transformed and tested 
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Figure 11.5 - Production of lycopene in 50ml YPD in 500ml flasks by the best clone of each 
candidate. Pink – 24 h; Light red – 48h; Dark red – 72h. One-tailed t-tests: Circle: p<0.05; triangle: 
p<0.1. n=15. Error bars – SEM. 
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using a similar protocol as for screening to isolate high producers and the first 4 clones 
of the third quartile were isolated and compared against non-rewired control without 
technical replicates. This should allow for the comparison of clones with more similar 
properties and avoid inclusion of more unique genetic backgrounds. The same subset 
was used as for the 5ml scale experiment, but samples were tested at 24h and 48h 
due to an observed increase in growth (see Figure 11.6). 
Data obtained for the 48h sampling point did appear to correlate well with samples 
obtained at 72h in the 5ml experiment, with the exception of decreased relative 
production of fum1::mtr2 and higher levels of expression of gap1::mth1. 
All candidates apart from snz3::gst showed statistically significant increase in lycopene 
production at 24h but only gap1::mth1 did so at the 48h point. Indeed all other 
candidates with the exception of snz3::gst showed a statistically significant decrease in 
production of lycopene. 
11.4.7. Inoculation of test plates  
Variable levels of lycopene production were observed after inoculating complete 96-
well plates with clones of the same genetic background. Considering that a number of 
these clones showed no visible production, attempts were made to understand the 
source of variability.  
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Figure 11.6 - Production of lycopene in 200µl YPD in 96 well plate format by 4 clones of each strain. 
Red – 24 h; Grey – 48h. t-tests: open symbol, mean of candidate less than control; closed symbol, 
mean of candidate greater than control; X, not statistically significant. Triangle: p<0.1; circle: 
p<0.05; square: p<0.01.  n=4. Error bars – SEM. 
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11.4.8. Variation of conditions during the outgrowth phase 
Use of minimal medium during the outgrowth phase was replaced by rich medium. This 
led to cultures showing higher levels of lycopene production as expected. Use of white 
rayon membranes also allowed for a larger increase in lycopene production comparing 
to the use of Breathe-Easy® membranes. 
11.4.9. Use of direct inoculation versus use of glycerol stocks 
Considering possible issues with the glycerol stocking or replication procedures (from 
glycerol stocked samples) inoculation was tested directly from the outgrowth stage into 
test plates. Cultures inoculated without an intermediate glycerol stocking stage showed 
a more homogeneous level of lycopene production, but loss of expression was still 
noticeable in some cases. 
11.4.10. Comparison of candidate populations  
In order to further test the candidates population level comparisons were made against 
non-rewired controls. 48 clones of each population were isolated and tested against 48 
clones of a non-rewired control population in 96-well microplates. 
Due to inconsistent production of lycopene observed on control populations filtering of 
non-producing candidates was applied. 
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Initial sets were filtered through an arbitrary OD484/OD660 ratio defined after visual 
observation of wells vs measured absorbance. Later sets were filtered using a SVM 
algorithm trained for distinction of white and red populations from absorbance scan 
data.  
Comparison of means was done using one-tailed t-test, which led to the isolation of the 
candidates in Table 11.3 as those to be further characterized.  
Further detail on the population comparison data can be found in Figure 16.19. 
Candidates selected for validation are also highlighted in green in the aforementioned 
table. 
  
Table 11.3 – Comparison of mean lycopene production between populations of rewired strains and 
control. Green background, p<0.01; Orange background, p<0.1. 
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11.5. Discussion 
11.5.1. Elimination of clones with non-reproducible phenotype  
A large number of clones (1422) were selected for validation after the initial screening 
run. Considering that the screening plates did not contain internal control wells with 
non-rewired clones, it was expected that a large number of candidates would not be of 
interest. Variation in lycopene production in control strains was significant, and thus 
candidates were retested with a new expression run. 96-well plates with YPD medium 
were inoculated with cultures from glycerol stocks and absorbance was measured after 
growth using the same protocol as used for the initial screening run for both screening 
populations. 
While the distribution for clones incubated for 48h was contained within a small interval 
of normalised lycopene production (1.21-1.345) and no clones appeared to show 
improvement that would immediately discriminate them from the rest of the population 
the same did not apply for those incubated for 72h – values spanned a large interval 
(1.28-1.505) and a small number of candidates had a much higher level of lycopene 
production. Considering this a more appropriate parameter had to be used for isolation 
of candidates from both populations.  
Standard scores (z-scores) were used for this purpose and candidates were selected 
where this value was greater than 0.5 on both screening and validation runs, providing 
a means to isolate candidates that had produced larger amounts of lycopene 
consistently. 
Higher efficiency (as in, a larger number of candidates being carried through to later 
stages of validation) in this experimental step could be obtained through more limited 
selection of clones for retesting from the initial screening procedure – as for example 
by defining an arbitrary number of clones to be tested per plate – it was felt that it could 
limit the depth of the selection process in cases where cell density or even 
differentiation by eye could bias judgement.  
A smaller number of candidates would also allow the opportunity for a more extensive 
sequencing profiling of candidates. This should allow for not only the identification of 
highly enriched rewiring variants but also for the inference of possible overlooked 
parameters during the selection process. 
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11.5.2. Identity of isolated candidates 
Validation of candidates required re-cloning and re-transformation of the isolated 
rewiring construct so as to account for clones with advantages due to integration at 
non-specific sites or with multiple copies. This was an opportune moment to sequence 
the candidates and obtain their identity.  
Out of the 26 candidates four were found to be adr1::zim17 constructs, two were 
fum1::mtr2 constructs and two were gap1::nas6 constructs. Encountering multiple 
candidates with similar identities may indicate that there is either (1) bias on the library, 
(2) dominant clones with the desired phenotype or (3) clones with enhanced 
phenotypes in the conditions specific to the experimental parameters. 
As for (1), it would indicate that regardless of the rewiring effect it is still possible to 
obtain highly productive clones for the pathway through natural variability of the 
population or integration process; (2) would indicate that the rewiring constructs 
dominate the regulatory landscape for this process and negate any other effect on 
improvement of yields of single clones, so much so that in the case of the construct 
isolated 4 times the probability (considering equal screening probability) of this event is 
1.53% for 1422 events; (3) would indicate that the rewiring constructs had allowed for 
improvement phenotypes in specific conditions that could have risen throughout both 
screening and validation runs. 
Considering the results observed during testing, adr1::zim17 showed worse than 
control levels of lycopene production at 200µl and 5ml scale using individual clones 
and improved levels of production against a limited control population in one of two 
48vs48 tests. The impact of rewiring a carbon source responsive promoter (adr1) with 
a heat-responsive transcription factor (zim17) could explain improved results during 
screening through adaptation to stresses imposed by inoculation/changeable media 
conditions - however the overall results led to its dismissal through grounds of condition 
specific behaviour. 
11.5.3. Testing of individual clones 
In P. pastoris protein expression, overexpressing clones are typically isolated from 
large populations. This is done by extensive testing of individual colonies after 
transformation and isolation of “jackpot” clones containing multiple copies of the 
expression cassette211. Considering the objective of this project it was felt that such 
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exercise could hinder the validation process as it is questionable whether the multi-
copy integration scenario that is usually brought forward by this type of intensive 
screening could aid in understanding the impact of regulatory rewiring in phenotypes of 
interest. 
As such, 96 clones were picked for candidates in a small subset and the screening 
protocol was applied with a prolonged incubation step (72h).  
The top 3 clones were used to test expression at the millilitre scale using 50ml capped 
tubes. Visual inspection of tubes allowed for the identification of large amounts of 
variability between cultures of the same genetic background, especially at the endpoint 
of the experiment. Consistency was mostly obtained in clones producing less than in 
the control cultures (with the exception of fum1::mtr2) which could indicate that multi-
copy effects may have been present. 
Three of the candidates were selected for further testing at flask scale to verify 
consistency of the results. The best clone was selected for this purpose and five runs 
with three replicates were made. Levels of lycopene production were lower than 
expected, with very slight difference between control and the highest producing clone, 
fum1::mtr2. 
Considering the difficulty of testing at larger scales and possible issues with the use of 
the highest producing clones of each candidate an alternative was sought. While the 
need for testing clones with appropriate levels of expression was considered it also 
became evident that use of the highest producing clones could bias the results and 
therefore the ability to validate the method. 
As a first attempt to resolve this, the first four clones of the 3rd quartile of ranked 
normalised lycopene production were selected for testing at microwell scale. Visual 
inspection of the test plate showed much better agreement between clones of the 
same genetic background, allowing for the discrimination of candidates versus non-
rewired control. Levels of lycopene production were also in line with those expected 
from these populations, supporting an apparent improved rate of production from some 
of the candidates that had all been isolated from the 48h screening runs. Whilst the 
relative levels of expression at endpoint sampling were similar to those obtained at the 
millilitre scale the variation between samples allowed for definitive conclusions to be 
taken regarding improvements. 
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Initial testing of top expressers from each candidate’s 96 picked clones could have 
been enough to isolate candidates for further testing. This could however have limited 
selection to rewired strains where optimal conditions are met in multiple copy clones 
and be biased depending on the existence of controls with similar properties. While this 
may be relevant from the application point of view, it would not allow for the 
identification of strains where the rewiring produced net positive phenotypes at the 
population scale. In fact, instability of high-copy number clones could negate the 
positive effects of rewiring through copy loss in longer incubation periods218, both 
through decreased production of pathway enzymes or through decreased effect of 
rewiring. 
11.5.4. Outgrowth and inoculation conditions 
Considering the variability observed between clones of similar genetic constitution it 
was necessary to understand the source of variation. Furthermore, variability between 
plates inoculated using the same source glycerol stocks was seen when using similar 
incubation parameters. 
Considering previous reports of stability of the pathway in P. pastoris248 it was 
necessary to test elements of the protocol for impact on lycopene production to ensure 
successful population testing.  
After testing of initial growth media (MD vs YPD), glycerol stocking vs direct inoculation 
of test plates and use of Breathe-easy® vs rayon membranes it was found that (1) 
limited aeration during both growth phases and (2) glycerol stocking process were 
factors affecting expression of lycopene across clones.  
It was possible that the period of stable expression reported in the literature - 0.5% loss 
after 3 days of non-selective growth using zeocin as marker - could provide limited 
scope in the analysis of clones using auxotrophic markers cultured for more prolonged 
periods. The limitations imposed by variations of expression levels were considered for 
further validation steps and addressed by use of YPD and rayon membranes during 
both outgrowth and screening incubations and elimination of the glycerol stocking step 
between incubations. This did not ensure that loss of expression was eliminated but 
decreased its scope. 
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11.5.5. Testing of candidate populations 
Due to the observed (and expected, according to the literature) amounts of variation 
within P. pastoris populations, it was decided that this would be a parameter to take 
into account rather than discard.  For this purpose a test that maximized number of 
clones studied and direct comparison versus control populations was required. The 
final design used was a half-plate vs half-plate test using 48 clones for both one of the 
candidates and non-rewired controls.  
The large number of candidates and the requirements involved in the test of 
populations at this scale led to the testing of subsets of candidates at different times. 
Where the number of controls without detectable production of lycopene was excessive 
the test was repeated. In each set of candidates two sub-populations (expressing and 
non-expressing) were present. For statistical analysis, the non-expressing sub-
populations were filtered. This prevented bias in statistical comparison by the non-
expressing clones and was achieved by training a SVM algorithm to identify expressing 
clones based on absorbance data. 
The extensive testing performed at the population level conferred a high level of 
confidence in the final candidate subset, which could not be achieved through testing of 
individual clones from candidate populations. 
The ability to define a candidate as a strain with improved performance at the 
population scale versus a control population of similar size validates the method for the 
isolation of relevant phenotypes. The issue of loss of expression throughout steps of 
the protocol was not taken into account during the initial planning stages of the 
validation phase: it could have been foreseeable through the re-use of genetic 
components, this was initially considered as a non-issue due to the aforementioned 
statement that a similar construct was stable.   
11.5.6. Final considerations 
Overall, extra steps were found to be necessary to understand parameters that played 
a part in productivity of the specific pathway used in this project. This is largely 
attributed to the instability of genetic constructs and protein expression in P. pastoris. 
The aims of this section were achieved, allowing for the further study of 5 selected 
candidates. 
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12. Test of candidates at flask scale 
 
 
Summary 
Isolation of a manageable set of candidates allowed for further testing of the observed 
phenotype. Robustness of an improved phenotype through scale-up is an important 
property of strains used for industrial purposes. Here, initial scale-up procedures were 
used to assess such robustness, with populations of candidate clones being used to 
inoculate flasks to allow for a more clear comparison against non-rewired control 
strains. Confirmation of improved production of lycopene was obtained for all validated 
candidates at the 30-40mL scale and for one of the candidates tested at the 300-
400mL scale. The candidate tested at the larger scale also showed improved 
production of lycopene under suboptimal aeration conditions, a phenotype that was not 
targeted through experimental design. 
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12.1. Introduction 
The conditions used throughout the screening and validation phase were replicated as 
much as possible to allow for the consistent selection of strains with increased 
production of lycopene. As the application rewiring for improvement of industrial strains 
was desired, the next step taken was the scaling of cultures to larger volumes.  
12.2. Aims 
Testing of candidates through scale-up aimed at the (1) verification of phenotype 
consistency at flask scale and (2) isolation of rewired strains with improved lycopene 
production for further scale-up. 
12.3. Experimental strategy 
In order to assess performance of the rewired strains at flask scale 250ml flasks were 
used. This would allow not only for the early observation of possible issues but also for 
adaptation of the protocol for larger scales. 
The use of foam bungs in flasks of this size had already been tested in incubators used 
for general work in the laboratory, with good level of lycopene production having been 
observed. However use of a similar set-up at the fermentation facility led to poor 
lycopene production.  
In order to test if aeration was the issue Breathe-easy® membranes were used on a 
separate run. This resulted in a similar phenotype that could be recovered after 
replacement of the membranes by loosely attached foil. 
Considering the need for consistent aeration a final run was performed using more 
breathable membrane. This resulted in an enhanced level of lycopene production. 
An unexpected phenotype was found in one of the clones during the first two runs - 
improved production in oxygen limited conditions. In order to verify if the phenotype 
was maintained at larger scale the same protocol applied to the Breathe-easy®/foil 
incubation and final incubation run was used in 2L flasks. 
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12.4. Results 
12.4.1. Initial scale up test 
The initial scale up step was performed at flask scale with volumes similar to those 
used during validation. This represented an increase of over 165-fold in volume 
compared to microwell cultures. Considering the previous efforts of selecting 
populations representative of the rewired strains, 60 clones were picked and grown 
independently in 96-well plates and pooled to produce the inoculum culture, which was 
incubated overnight before inoculating test flasks. A dedicated incubator was used for 
these experiments to avoid issues with variability. 
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Figure 12.1 - Production of lycopene using 40ml YPD in 500ml flasks. t-tests: closed symbol, mean 
of candidate greater than control; X, not statistically significant. Triangle: p<0.1; circle: p<0.05; 
square: p<0.01. n=3. Error bars – SEM 
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12.4.2. Variation of aeration conditions 
12.4.2.1. Use of foam bung and foil  
The first run at this scale was performed with 40ml total culture volume in 250ml flasks, 
with only 4 of the candidates taking part in the test (see Figure 12.1). General lack of 
lycopene expression was observed visually in all flasks with the exception of those 
containing snz3::gst populations. Whilst cell density profiles are quite similar the 
noticeable rise of lycopene at the 72h mark was specific of this strain.  
Condensation was observed in flask walls to a significant extent, possible due to bad 
aeration. 
12.4.2.2. Use of Breathe-easy® membranes with exchange to foil 
The second run was performed with the same conditions with the exception of the use 
of Breathe-easy
®
 membranes to seal the flasks up to the 48h sampling point, followed 
by a second period of 48h of incubation using only loose foil (see Figure 12.2). It was 
expected that the use of the membranes would impact positively on aeration and result 
in the expected phenotype. 
A higher than expected normalised production of lycopene was observed at 24h, 
possibly due to a sampling artefact. No relevant amount of lycopene was observed in 
the cultures visually as hinted through the reading at OD484 and as such the sampling 
point may be discarded from analysis.  
Production of lycopene was not observed in relevant amounts in any of the flasks until 
the 48h point, prompting a change to loosely fitted foil. This resulted in overall 
improvement in production of lycopene in cultures, and again snz3::gst showed more 
productivity at the endpoint of the experiment.  
The rewired strain containing gap1::mth1 did also recovered promptly from the hypoxic 
conditions, having reached the highest OD484 by the end of the experiment. This hinted 
at an improved production of lycopene under appropriate aeration conditions, more so 
than in the case of snz3::gst. 
Condensation in flask walls was also observed at the 48h sampling point, but subsided 
after changing to foil. 
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Figure 12.2 - Production of lycopene using 40ml YPD in 500ml flasks. t-tests: closed symbol, mean 
of candidate greater than control; X, not statistically significant. Triangle: p<0.1; circle: p<0.05; 
square: p<0.01. n=3. Error bars – SEM 
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12.4.2.3. Use of white rayon membranes  
The last run was performed with reduced culture volume (30ml) and rayon membranes 
were used to seal flasks (see Figure 12.3). The use of these membranes attempted to 
circumvent issues relating to aeration without adding extra variability that could have 
been caused by the use of foil. 
Lycopene production was visible from the first sampling point and proceeded as 
expected, resulting in cultures with a strong red colour (see Figure 12.4). Whilst the 
rewiring pair snz3::gst outperformed all other candidates in normalized lycopene 
production it did so to a lesser extent and cta1::mbp1 produced very similar results at 
x x ▲ ● 
■ 
x 
▲ x 
● ■ 
▲ ● 
▲ 
x 
▲ 
● 
● ● ● ■ 
0.75
0.8
0.85
0.9
0.95
1
1.05
1.1
1.15
1.2
Control gap1::mth1 snz3::gst kog1::upc2 maf1::mac1 cta1::mbp1
N
o
rm
al
is
e
d
 ly
co
p
e
n
e
 p
ro
d
u
ct
io
n
 (
O
D
4
8
4/
O
D
6
6
0)
 
24h
48h
72h
96h
Figure 12.3 - Production of lycopene using 30ml YPD in 500ml flasks. t-tests: closed symbol, mean 
of candidate greater than control; X, not statistically significant. Triangle: p<0.1; circle: p<0.05; 
square: p<0.01. n=3. Error bars – SEM 
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the endpoint of the experiment. However this rewired strain appears to have grown to a 
lower density.  
Observation of independent wavelengths suggests that gap1::mth1 and kog1::upc2 
may have produced a larger amount of lycopene, with kog1::upc2 achieving slightly 
higher cell density. 
No condensation was observed in flask walls. 
  
Figure 12.4 – Incubation of candidates using white rayon membranes. Left – after 24h; Right – 
after 48h. 
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12.4.3. Further scaling-up  
Testing with a 10-fold increase in volume was performed to verify the results previously 
obtained for candidate snz3::gst. On scale-up the observed phenotype was maintained, 
with cultures achieving lower densities compared to previous tests. 
12.4.3.1. Use of Breathe-easy® membranes with exchange to foil 
Recovery from oxygen limited conditions was tested, with a similar expression profile 
being obtained for the 24h sampling point as seen at smaller scale (see Figure 12.5). 
Cell density and lycopene production did not achieve the same levels, possibly due to 
limited aeration. Growth to lower cell density was observed for snz3::gst with only 
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Figure 12.5 - Production of lycopene using 400ml YPD in 2L flasks. t-tests: closed symbol, mean of 
candidate greater than control; X, not statistically significant. Triangle: p<0.1; circle: p<0.05; 
square: p<0.01. n=3. Error bars – SEM 
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slighter higher values of OD484. It was however visible that rewired cultures produced a 
stronger red colour than controls. 
Condensation in flask walls was observed to a larger extent than when the similar 
experiment was produced with smaller flasks. 
12.4.3.2. Use of white rayon membranes 
Testing of cultures with improved aeration conditions resulted in a similar profile to that 
obtained at smaller scale (see Figure 12.6). Reduction of volume from 400ml to 300ml 
resulted in improved shaking of the cultures due to breaking of the meniscus.  
The most noticeable difference was the increase in cell density for all flasks, with the 
rewired clones reaching higher maximum OD660. Production of lycopene was also 
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Figure 12.6 - Production of lycopene using 300ml YPD in 2L flasks. t-tests: closed symbol, mean of 
candidate greater than control; X, not statistically significant; Circle: p<0.05. n=3. Error bars – SEM 
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higher in the rewired clone and it was visually confirmed. 
No condensation was found in the flask walls. 
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12.5. Discussion 
Considering the number of rewired strains selected for testing and the resources 
necessary for direct comparison between flasks the first scale-up test was limited to 
250ml flasks. This would be appropriate for confirmation of the improved phenotype of 
the selected candidates while allowing for testing at a scale previously seen as valid for 
this purpose. 
Considering the strategy used for validation of candidates, 60 clones of each candidate 
were used for inoculation of the flask cultures. This would allow for the observation of 
reproducible phenotypes, whilst reducing deviation from the protocols used thus far. 
12.5.1. Test at 250ml flask scale 
Cultures of the candidates grown in flasks using foam bungs did not show the expected 
phenotype to the extent that was observed in 96-well plates and previous flask 
cultures. 
While production of lycopene was observed in cultures of candidate snz3::gst by 
means of a strong pink colour, all others were only of a pale orange to light pink colour. 
Cell density at times of sampling was comparable for candidates and control with an 
exception of the 48 hours point of maf1::mac1. Monitoring of lycopene with OD484 
measurements showed differentiation of samples from the 48 hour sampling point 
onwards. 
Normalised OD484 measurements revealed that although all candidates perform better 
than non-rewired control in these conditions, snz3::gst outperforms all with a 26.6% 
increase in normalised absorbance vs control at the 72h point.  
This shows that while other candidates have phenotypes that improve overall 
production of lycopene, the rewiring construct in this candidate offers improved yields 
in very specific conditions that can be correlated with aeration. 
Replacement of foam bungs with a single Breathe-easy® membrane still resulted in 
reduced production of lycopene up to the 48 hour mark. This created some concern as 
it was initially considered that the surface available for gas transfer would be sufficient 
to produce good levels of aeration with these membranes. As no observable difference 
in phenotype could be achieved by maintaining the membranes it was decided that an 
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alternative should be sought resulting in its replacement by loosely fitted foil. Whilst the 
use of foil does not allow for good control of gas transfer across flasks, it allowed for 
good levels of aeration and possible recovery of phenotype. This was confirmed after 
24 hours (72 hours sample) and further improvement until the last sampling point. 
This change in production profile of the clones when compared to the initial run shows 
that the lycopene synthesis process is entirely oxygen dependent against what had 
been described in Bhataya & Schmidt-Dannert (2009)140, where the effect of aeration 
was only considered significant in its impact on cell density. This may have resulted 
from the use of very high shaking speeds (275rpm vs 185rpm in this study), which 
could have allowed for expression at higher levels regardless of volume or geometry 
variations. It should be noted that absence of information on shaking orbit makes any 
comparison of these values susceptible to error. 
While the growth profile was similar across samples, a decrease of absorbance at 
484nm for the non-rewired control at the final sampling point was noticed, which was 
not expected seeing that at this point most cultures still displayed lycopene 
accumulation. This may have been caused by a measurement artefact, but this is 
considered unlikely.  
As for normalised OD484, it is apparent that the control samples do not recover the 
phenotype as efficiently as the candidates, as shown by the 72 hour sample. 
Candidates gap1::mth1 and snz3::gst showed much higher levels of lycopene at the 
experiment’s endpoint with an increase of normalised OD484 of 6.36% and 8.21% 
respectively. 
Considering the use of loose foil as possibly inconsistent in terms of aeration an 
alternative was sought. The solution found was to use a rayon membrane similar to 
those used on 96-well plates over the mouth of each flask. The total culture volume 
was also reduced to 30ml to promote efficient gas exchange. 
The use of this membrane allowed for improved aeration of the cultures resulting in a 
large increase in lycopene production.  
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Cultures achieved high densities within 48 hours with some decrease in OD660 being 
noticeable from 48 hours onwards for most samples. Normalised OD484 showed all 
candidates performing better than control with both snz3::gst and cta1::mbp1 
outperforming the others. It should be noted that cell density on cta1::mbp1 cultures 
was lower than other candidates, which could mean that production of lycopene may 
interfere with growth. The conditions found in cultures during this run are then likely to 
have been more similar to those in 96-well plate format. Improvements observed at 96h 
are summarised in Table 12.1. 
12.5.2. Further scale-up 
Considering the results obtained throughout the flask cultures it was decided that the 
candidate showing more promising results was snz3::gst. This was largely due to the 
exceptional behaviour of the strain in suboptimal aeration conditions. This resulted in 
testing with conditions similar to those found while using 250ml flasks in both 
membrane to foil and white rayon membrane experiments. 
12.5.2.1. Membrane to foil transition 
The same pattern was observed as in smaller cultures albeit the recovery of cultures 
after replacing Breathe-easy® membranes for loose foil did not achieve the same 
extension as seen at the previous scale. A large amount of condensation was visible in 
the flasks during the first 48 hours, with only small amounts being observed after 
change to foil. Even though there was some condensation visible when growing 
cultures in limited aeration conditions, at 250ml flask scale the extent of the 
phenomenon was always reduced. This may indicate that the extent to which cultures 
were deprived of oxygen was much larger in the 2L flasks. It is possible that the 
decrease in headspace to culture ratio (1:6.25 to 1:5) impacted gas exchange to a 
larger extent resulting in down regulation of the precursor pathway. The flask shape 
may also have impacted this parameter as it accommodated media in the lower part of 
the flask and resulted in less being forced to the walls during shaking.  
Table 12.1 – Improvement in lycopene production at 500ml scale. 
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Observation of OD660 measurements up to the 48 hour mark show limited growth of the 
cultures with a similar profile for OD484 measurements. Only during the last sampling 
period did the lycopene production change substantially resulting in an increase in 
normalised absorption of 6.81% over control. It is also relevant to note that this period 
reflects a decrease in cell density for the candidate while the same was not noticeable 
for the control culture. 
Overall the previously observed phenotype and relevance of the aeration conditions 
were confirmed, providing further support to the hypothesis that the isolated rewired 
strain has different production characteristics compared to non-rewired controls 
12.5.2.2. White rayon membrane 
The use of a rayon membrane provided appropriate culture aeration resulting in a 
visible increase in lycopene production (see Figure 12.7). 
Both control and candidate cultures produced a well-defined lycopene production curve 
with the candidate showing an improvement in normalised absorbance of 8.62% at 72h 
and 5.61% at 96h. 
As for cell density and non-normalised OD484 the trends followed a similar pattern of 
values increasing up to 72h and slight decrease to 96h, which may be explained 
through cell death and degradation of lycopene.  
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The results obtained through this run helped confirm the results previously obtained in 
good aeration conditions at smaller scale. 
Considering all of the runs it was apparent that lycopene production was affected by 
culture density and that from approximately 72 hours onwards in a culture inoculated to 
an initial OD660 of 0.01 lycopene production may be insufficient to compensate for 
degradation.  
12.5.3. Candidate identity and inferred rewiring effects  
The results obtained throughout the scale-up tests supported the hypotheses that the 
strains that resulted from screening of this rewired library had improved properties 
towards production of lycopene. 
Initially it was thought that phenotype changes other than improvement in lycopene 
production would not be observed from the library. The fact that such drastic response 
to aeration could be elicited in a rewired strain helps support the concept that complex 
phenotypes may be obtained through this method. 
As a note, the process of inference of the potential effects of the rewiring process on 
the isolated strains was only done post scale-up. Throughout the experiments executed 
after sequencing of the candidates only the sample name allocated pre-sequencing 
was used. Mapping of reference name with rewired pair, in order to produce the figures 
and tables shown in this document was also done after scale-up.  
0.75
0.85
0.95
1.05
1.15
1.25
1.35
24h 48h 72h 96h
N
o
rm
al
is
e
d
 ly
co
p
e
n
e
 p
ro
d
u
ct
io
n
 
(O
D
4
8
4/
O
D
6
6
0)
 
Control
snz3::gst
Control*
snz3::gst*
Figure 12.7 – Comparison of cultures at 2L scale. Experiment using Breathe-easy® 
membranes /foil and white rayon membranes (*) are shown. 
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This was a conscious effort to avoid any potential bias from promising rewiring 
backgrounds in the process of method and candidate validation. 
12.5.3.1. gap1::mth1 
This rewired pair consisted of a negative regulator of glucose-sensing signal 
transduction driven by a general amino acid permease promoter.  
Expression of gap1 is associated with poor nitrogen-supply conditions limiting growth 
and degradation of the protein, being tightly regulated by increased internal amino acid 
pools. Down-regulation occurs in stress response and stability of the protein is 
associated with TORC1 ubiquitylation268.  
MTH1 acts as a regulator by transducing glucose sensing and repressing hexose 
transporters and invertase activity in yeast269, mostly repressing hexose transporters 
under low glucose conditions270. 
 A reverse engineering effort in S. cerevisiae established that deregulation of MTH1 
degradation leads to higher glucose tolerance271. 
It can be hypothesised that the expression of mth1 on conditions of limited nitrogen 
supply may have led to an improved adaptation to general media limitations or that the 
suppression of glucose transport in low nitrogen conditions may elicit a secondary 
stress response resulting in increased flux in the ergosterol pathway, the precursor 
substrate for the engineered lycopene pathway. 
12.5.3.2. snz3::gst 
No confirmed homologue could be identified for the open reading frame, but sequence 
homology suggests glutathione S-transferase and nitrogen catabolite repression 
activities. The promoter drives the expression of a nutrient responsive gene, member of 
a stationary phase-induced gene family. 
snz3 is expressed during exponential growth phase and either actively repressed or is 
expressed at very low levels under starvation conditions272. Absence of thiamine in the 
media also leads to accumulation of the transcript, and strains exposed to 40mM of 
menadione for 3 hours require the presence of the enzyme or its products for 
survival273.  
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Glutathione S-transferases are part of a number of enzyme families responsible for the 
glutathione mediated defence against oxidating species274. The closest homologue in 
S. cerevisiae - Ure2p – has been characterised for its role in nitrogen regulation via 
repression of transcription factors GLN3 and NIL1, regulation of glucose sensitive 
genes and some protection against cellular oxidants and heavy metal ions275,276. 
It has also attracted a great deal attention for its processing into an insoluble prion form 
that modifies behaviour of yeast in specific environmental conditions. This requires a 
90 amino acid N-terminal domain that is absent from alignments with the ORF of the P. 
pastoris homologue and is therefore unlikely to be present in this case277. 
From the regulation standpoint, it has been shown to be regulated by TOR kinase 
phosphorylation278 and by glucose and  glutamine levels276. Within the set of genes 
regulated by Ure2p, GAP1 is included. 
Inference of the effect produced by the rewiring pair on the performance of this strain 
must take into account observations at flask scale of improved production in cultures 
with deficient aeration. The possible oxygen limited/hypoxic conditions present in the 
flasks may have led to expression of gst by releasing repression from the Snz3 
promoter, as it contains a number of recognition sequences for transcription factors 
associated with repression during aerobic growth (MOT3, MCM1, FKH1) as detected 
by profiling binding sites of the -1000 genomic region of C4R0U7 in the YEASTRACT 
database279. 
Increased production of the Ure2p homologue may have led to an improved regulation 
of growth in limited nutrient/cofactor availability through regulation of nitrogen or even 
of glucose use. Limited inference of function can be made from ure2, due to its limited 
homology to the rewired ORF present in this study. 
12.5.3.3. kog1::upc2 
The promoter region of this pair drives the expression of one of the TOR1 subunits and 
should be regulated by a number of cellular processes in response to environmental 
signals in yeast, whilst UPC2 is responsible for regulation of sterol biosynthetic genes.  
Kog1p has been shown to associate with Tor1p in S. cerevisiae280. A specific role has 
not been described in this species but the Schizosaccharomyces pombe homologue is 
responsible for nutrient-responsive sexual development281. 
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UPC2 is responsible for regulation of ergosterol synthesis, the pathway responsible for 
generating the precursor for isoprenoid production and therefore availability of 
precursors for lycopene. The expression of this gene is down-regulated at high levels 
of sterols, and decreased amounts of sterols or low oxygen levels produce a response 
from UPC2 towards the increase in sterol contents and uptake282. One of the HMG-
CoA reductase isozymes coding regions, hmg1 has also been shown to have binding 
sites for UPC2 regulation in C. albicans283, which could indicate there could be 
regulation by this activator.  
Inferring how this rewired strain may be better adapted to lycopene production is 
challenging: considering the possibility of up-regulation of the precursor producing 
enzymes with decreased ergosterol production due to product inhibition may explain 
improved yields, although simple overexpression of upc2 should not result in this, as 
the ergosterol content should be sufficient to limit pathway activity.  Increased flux 
through the pathway in specific conditions may also be an advantage if these 
conditions natively resulted in repression of the pathway through mechanisms that are 
not relevant to strains in laboratory condition. Dissection of the effect of this rewired 
strain should offers many opportunities, as regulation of ergosterol synthesis and TOR 
pathways have been a subject of interest from the community and several inhibitors 
targeting different components of the pathways are available. 
12.5.3.4. maf1::mac1 
The MAC1 copper-sensing TF is responsible for regulation of high affinity copper 
transport needed for response to DNA damage. In this rewiring pair it is regulated by 
the promoter of a negative regulator of RNA polymerase III.  
MAF1 is positively regulated by TORC1 by phosphorylation and expression of its gene 
has been shown to be promoted by conditions that require cells to shift away from 
growth programs284. It has been shown that maf1 mutants with increased tRNA 
expression impact isoprenoid pathway regulation by limiting the amount of DMAPP 
available as substrate for ERG20285. This has also been shown lead to increased erg20 
transcription285. 
The requirement of multiple copper ions bound to maintain MAC1 in an inactive state 
(cellular copper ion satiety) provides a mechanism for control of uptake as the protein 
coordinates this action. It is possible that increased expression of mac1 in stationary 
cultures allows for increased copper intake, allowing for improved production of 
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intermediates in the ergosterol pathway and therefore providing higher levels of 
precursor for lycopene286. 
12.5.3.5. cta1::mbp1 
The final rewiring pair consisted of a TF involved in cell cycle progression regulated by 
the promoter of catalase A which is activated during fatty acid beta-oxidation.  
Activity of catalase is minimal in P. pastoris grown in glucose containing media287, and 
in S. cerevisiae it  is induced in the presence of oleic acid in the media288. Positive 
regulation of this gene in oleate containing media is ADR1 dependant and together with 
OAF1, PIP2 and OAF3 respond to a FFL coherent motif. OAF3 is an inhibitor with 
similar targets to ADR1 and together with the previously mentioned three TFs produces 
a coherent inhibitory feed-forward network motif, overlapping with the first motif. 
Absence of glucose also de-represses cta1 expression by ADR1 activity289, and this TF 
also regulates peroxisome proliferation by controlling pox1 and pex11 expression290. 
Mbp1p is involved in progression of the cell from G1 to S phase and regulates a large 
number of targets responsible for DNA replication and other pathways necessary for 
preparation of the replicative process291. Overexpression leads to a pre-replicative cell 
division arrest and toxicity292. 
The peroxisomal location of CTA1 may help expression of mbp1 at a suitable time for 
the activity of the lycopene pathway enzymes that were also targeted for expression in 
that organelle. This could be caused by arrest of division post glucose depletion, which 
could result in accumulation of lycopene in cells with either active ergosterol synthesis 
or with excess of acetyl-CoA production without appropriate consumption (leading to a 
possible shunting towards the mavalonate pathway). It could also be caused through 
replication being maintained in conditions that would otherwise slow down 
accumulation of mbp1 and triggering of G1 to S transition. The consistently lower levels 
of cell density across experiments would hint at the case being for the arrest of cellular 
division upon glucose depletion.  
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13. Conclusion - rewiring Pichia for lycopene 
production 
 
 
Summary 
The validation of transcriptional regulatory network rewiring for the purpose of strain 
improvement in P. pastoris was described throughout this part. Issues faced and 
decisions made as well as overall accomplishments are described here. 
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Throughout the second part of this thesis the design, assembly, testing and validation 
of a rewiring library has been demonstrated. While principles guiding the development 
of a general strategy for this process could be obtained from literature there were 
several components that had not yet been tested. 
13.1. Selection of lycopene as target metabolite 
The need for an HTS compatible assay for the selected metabolite was one of the 
original concerns, and the attempt to verify suitability of multiple targets was used to 
minimise the risk of overcommitting to a single pathway that could require complex 
assay development. 
Although no such assay had been reported for lycopene, early attempts to correlate 
absorbance with lycopene content yielded positive results and efforts were invested in 
this target as it showed greater potential. The resulting procedure allowed for the in 
vivo quantification of lycopene in stationary phase P. pastoris GS115 expressing the 
crtEBI genes of E. uredovora. 
13.2. Library design, assembly and testing 
Use of combinatorial libraries in P. pastoris had been limited and never produced using 
component pools rather than construct specific assembly. Limitations imposed by the 
selected method of assembly could also have limited the success of the library, and the 
negative impact of some of the decisions could only have been measured after partial 
screening had been performed. 
The gains in efficiency were considered to outweigh these risks. The ability to use an 
absorbance based method for screening provided some assurance that libraries with 
limited phenotype variability could be detected and measures could have been taken to 
redesign and retest the library if issues were indeed present. 
Ultimately, the procedure allowed for the efficient production of a rewiring library with 
no observable over-representation issues. 
13.3. Screening 
The ability to produce consistent screening conditions was a challenge considering the 
number of samples to be assayed, the issues related with picking and loss of 
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expression and the relatively high level of expression of lycopene observed in positive 
clones. The definition of two different sample sets differing in incubation length also led 
to a need for samples to be treated in separate blocks – while this was done in view of 
the opportunity to isolate strains with variable phenotypes, it required an increase in 
complexity of the process. Screening allowed for reduction of sample number for the 
validation step, as required. 
13.4. Validation 
This stage of the project required the isolation of a small number of candidates that 
could be further characterised, with a focus on exclusion of false positive strains. The 
initial step of confirming levels of expression of clones obtained during screening 
allowed for a substantial decrease in number of candidates, but only through the use of 
strict parameters.  
Further validation was revealed to be a challenge due to natural variability in the 
species, and only through direct analysis of variation did isolation of candidates 
become possible.  
13.5. Scale-up 
Even though small-scale cultures of candidates could be used to validate the method to 
a large extent an attempt to scale-up candidate cultures was made. This was 
considered to be the most relevant step to take as it is during this procedure that many 
engineered strains often fail to fulfil their expected performance. 
The results obtained support the notion that the changes made to regulatory networks 
through rewiring can be observed even after the environmental conditions are varied 
and the phenotypes observed can be replicated up to flask scale. 
Results obtained with the snz3::gst strain also seem to reinforce the view that many of 
the phenotypical properties of a strain only become noticeable during the process of 
scaling up. The recognition of an improved performance with limited aeration might 
have been noticed if the conditions were designed into an experiment, but this would 
have required the identification of the parameter as relevant for the process of strain 
improvement. In the case of lycopene and this rewiring strain in particular the change 
was noticeable both through the positive impact on the desired phenotype and the 
opportunity to visualise production of the compound – with a different set of conditions 
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target samples might have been altogether dismissed once the issue of aeration was 
assessed in control cultures and corrected for full-scale experiments. 
Efforts to produce rewired strains should thus take into account as many parameters 
relevant to the scale-up procedure as possible, and embed these into the screening 
procedure. 
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14. Final conclusions and future work 
 
 
Summary 
Final considerations on the choice to interrupt work in M. smegmatis and pursue 
method validation in P. pastoris are made. The use of regulatory rewiring as a method 
for strain improvement is also considered with the inclusion of work done in parallel for 
the validation of the method for improved protein production. Several possible paths for 
exploration into the effect of rewiring on improved strains, characterisation of rewired 
elements and pursuit of variants to the method are also described that could further the 
work described in this thesis. 
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The initial effort to produce an improved M. smegmatis strain with faster growth 
suggested that the method could be applied for this purpose. Issues underlying the 
process of library assembly and experimental design resulted however in a very limited 
support for the use of transcriptional regulatory network rewiring for strain 
improvement. Whilst redesign of experiments allowing for the isolation of fast growing 
strains or the pursuit of other phenotypes of interest could allow for validation of the 
method, issues regarding production of engineered strains and their testing became 
obvious, as well as the impact it could take on candidate validation and further 
exploration of causative agents for phenotypical improvement. 
Higher tractability of P. pastoris laboratory strains, both at the level of genetic 
modification and maintenance were considered as well as mature applications at the 
industrial level. The decisive factor was the observation that a great deal of the 
groundwork towards the understanding of the species’ regulatory networks was still 
missing, and assumption of regulatory components is largely limited to comparison with 
other fungal lineages. This was considered to be an element of relevance towards the 
validation of the method for the phenotype improvement of industrial strains where the 
scenario of limited information of regulatory properties can be complemented with 
expertise and proprietary methods for strain manipulation. 
The work described in this thesis has demonstrated that the improvement in 
experimental throughput provided by P. pastoris allowed for the production of 
conclusive results in the proposed scenario of lycopene production in rich media. 
The isolation of improved strains not only showed that transcriptional regulatory 
network rewiring is a valid method for strain improvement but also that the strategy put 
in place to produce the rewiring library, screen it and select and validate candidates 
was appropriate and could be replicated in future work. 
The scope of applications validated through this project is very specific: production of 
secondary metabolites in a eukaryotic species where limited knowledge of regulatory 
network dynamics exists. It should be noted that the author believes that validation at 
this level strongly supports the general applicability of the method and this belief is 
made stronger by the type of phenotype changes observed. 
Work done in the group by Dr. Oliver Windram has also successfully validated the 
strategy for the improvement of strains producing heterologous proteins. 
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Considering the work here described, the research done in parallel on the use of the 
method in protein production and the work previously reviewed on the use of methods 
suitable for reverse engineering of improved strains, the toolkit available for the 
understanding of cellular regulation and derivation of regulatory engineering rules 
relevant to strain improvement has been expanded with a novel and useful method. 
14.1. Future work 
Considering the early stage of method validation included in this thesis a number of 
experiments to follow up on this work could be identified. 
14.1.1. Dissection of transcriptional changes upon rewiring 
The use of high-throughput transcriptomic analysis of rewired strains is perhaps the 
most obvious next step in measuring the impact of the strategy on transcriptional 
regulation. The use of microarrays or RNA sequencing, as demonstrated in Alper and 
Stephanopoulos (2007)64, Alper et al. (2006)65 and Chen et al. (2012)75, could be used 
to better understand the breadth and scope of changes produced in the strains’ 
transcriptome, and allow for an appropriate rational strategy to be devised in order to 
obtain the same phenotype.  
Better understanding of how the production of lycopene had been affected might also 
uncover new targets for rational engineering not only of novel strains with improved 
phenotype but also for the attempt to translate this new knowledge into strains of other 
species engineered to produce lycopene and/or other carotenoids.  
14.1.2. Cloning of further carotenoid genes 
One of the elements aiding the selection of lycopene as a target was the possibility of 
producing a very diverse set of metabolites that use it as a precursor by including 
carotenoid biosynthesis pathway genes. This would thus be an obvious target for 
further efforts, as it could help test if the changes produced in rewired strains were 
likely to allow for improvement of those producing more complex metabolites. Issues in 
downstream steps, screening of the library with the complete pathway and inclusion of 
stress of different natures could further inform on the suitability of the method when 
only molecular intermediates can be screened and in the nature of the effect of the 
rewiring pair. 
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14.1.3. Higher order rewiring 
Once the rewiring library has been created and a starting set of improved strains has 
been isolated, it could be possible to both produce strains with two or more rewiring 
constructs observed in that same set or to fully re-screen the library to isolate strains 
with further improvements. 
Producing strains with multiple rewiring constructs known to have produced an 
improved phenotype could allow for the identification of additive, subtractive and 
neutral changes to the phenotype. This could elucidate of the relationship between the 
regulators and the nature of the rewiring event. 
Re-screening of the complete library could either result in the repeated isolation of 
already identified rewiring pairs or allow for the identification of new strains with a more 
distinct adaptation to the production of the metabolite. This last element could support 
the use of multiple screening procedures as a simple procedure for strain improvement, 
and would provide support for the development of fully automated rewiring library 
screening protocols. 
14.1.4. Dissection of promoter regions 
It was expected that the expression pattern imposed by the promoter region in rewiring 
pairs would be decisive in the phenotypes observed in this work. In some of the 
promoters isolated there is a potential for information to be gathered by the use of 
signalling cascade inhibitors, which could allow for confirmation that the mode of 
regulation has been maintained when only the 1000bp region was included. 
Experiments limiting nitrogen and carbon sources, aeration, temperature and other 
stresses may also aid the assessment of the impact of these elements in the 
production of lycopene by the isolated strains. 
Analysis of potential TFBSs in the promoter region could also allow for its manipulation 
not only for the improvement of the phenotype but also for a better understanding of 
the dynamics associated with their regulation. 
14.1.5. Use of gTME with isolated regulators 
Considering the nature of strain improvement via gTME, it seems likely that it could be 
applied after targets for diversification are identified using the rewiring approach. 
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However, and to strictly adhere to the method’s principles, a library for the rewiring of 
transcriptional machinery associated elements should be produced. This could then 
allow not only for effects caused by modification of their mode of action but also of their 
transcription dynamics to be assessed, possibly resulting in even more complex 
phenotypical changes. 
14.1.6. Diversification of isolated regulators 
As an alternative to the above mentioned experiments the diversification of rewired 
regulators via error-prone PCR could yield a further level of phenotypical diversity, 
potentiating the observation of trans- element evolution-like events. Whilst the potential 
for novelty is great, this would require the development of protocols that would allow for 
the removal of most of the search space generated, as the number of variants 
produced could potentially result in a very large variant screening effort. 
14.1.7. Expansion of the rewiring library 
Inclusion of new elements in the library could result in further improvement of 
phenotype or in the identification of different pathways affecting the production of the 
target compound. Considering the increase in complexity of the screening procedure, 
use of automated tools would be advised. Taking into account the highly modular 
nature of the strategy and the increased availability of synthetic DNA, it could be 
advantageous to produce a verified and individually constructed library of plasmids or 
strains containing rewiring constructs. This would enable higher throughput screening 
of improved phenotypes specific to compounds of interest. These libraries could also 
be used for other industrially relevant phenotypes and essential research into relevant 
parameters for rational strain engineering. 
14.1.8. Inclusion of non-native regulators 
The use of the non-native, regulator IrrE in E. coli resulted in improved stress response 
of the strain. This supports the concept that inclusion of regulators identified in both 
distant and close species may result in regulatory novelty relevant to strain 
improvement. Inclusion of regulatory elements from species such as Candia albicans, 
S. pombe, Yarrowia lipolytica or S. cerevisiae could lead to very interesting changes in 
the regulatory network of P. pastoris, as the recognition sequences of TFs of these 
species are likely to still be relevant to the species and the mode of regulation may 
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differ substantially. Equally, inclusion of promoter regions with native TF coding regions 
may result in unexpected phenotypical novelty arising. 
Considering the breadth of knowledge existing on S. cerevisiae’s transcriptional 
regulators, this would be a good candidate for the process, providing an extra source of 
information for inference of the mechanism involved in phenotypical change and 
identification of patterns relevant for rational strain improvement.  
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16.1. Primers used for sequencing 
Table 16.1 –Primers used for sequencing purposes 
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16.2. Primers used for assembly 
Table 16.2 – Primers used for construct assembly 
    Name Overhang Annealing sequence Description 
RR_UV15toR_F ATTCCAACCGCTGGCTCTGGCAATT TAATGAATTCGAGCATTTAAATGGC 
Used to amplify pUV15tetORm with overhangs compatible with 
Reductase (Mr.Gene) assembly 
RR_UV15toR_R TCAGATGACCAATCAGGCCGAACAT  ATGTATATCTCCTTCTTAATTAAGCATGC 
Used to amplify pUV15tetORm with overhangs compatible with 
Reductase (Mr.Gene) assembly 
RR_RtoUV15_F GCATGCTTAATTAAGAAGGAGATATACAT ATGTTCGGCCTGATTGGTCATCTGA 
Used to amplify the Reductase gene (Mr. Gene) with overhangs 
compatible with pUV15tetORm assembly 
RR_RtoUV15_R GCCATTTAAATGCTCGAATTCATTA AATTGCCAGAGCCAGCGGTTGGAAT 
Used to amplify the Reductase gene (Mr. Gene) with overhangs 
compatible with pUV15tetORm assembly 
RR_MXNDtorrnBT2_F CAGAAGGCCATCCTGACGGATGGCCTTTTTGCG TTAATATTTTCTAAAAGGAAAGAGAC 
Used to amplify pMEND/pMIND with overhangs compatible with rrnBT2 
terminator assembly into pMEND/pMIND (transcriptional terminator 
underlined) 
RR_MXNDtoR_R GACCAATCAGGCCGAACAT AACATTTCCTCCGGATCCTGT 
Used to amplify pMEND/pMIND with overhangs compatible with 
Reductase gene (Mr.Gene) assembly 
RR_RtoMXND_F GGAATCCTGACAGGATCCGGAGGAAATGTT  ATGTTCGGCCTGATTGGTCATCTGAC 
Used to amplify the Reductase gene (Mr. Gene) with overhangs 
compatible with pMEND/pMIND assembly 
RR_RtorrnBT2toMXND_R 
CTTTTAGAAAATATTAACGCAAAAAGGCCATCCGTCAGGA
TGGCCTTCTGCTT 
TTATTAAATTGCCAGAGCCAGCGGTTG 
Used to amplify the Reductase gene (Mr. Gene) with overhangs 
compatible with rrnBT2 terminator assembly into pMEND/pMIND 
(transcriptional terminator underlined) 
RR_MXNDtoRv2_R GGCCGATCAGACCGAACAT AACATTTCCTCCGGATCCTGTCAGG 
Used to amplify pMEND/pMIND with overhangs compatible with 
Reductase gene (DNA2.0) assembly 
RR_Rv2toMXND_F GGAATCCTGACAGGATCCGGAGGAAATGTT  ATGTTCGGTCTGATCGGCCAC 
Used to amplify the Reductase gene (DNA2.0) with overhangs 
compatible with rrnBT2 terminator assembly into pMEND/pMIND  
(transcriptional terminator underlined) 
RR_Rv2torrnBT2toMXND_R 
CTTTTAGAAAATATTAACGCAAAAAGGCCATCCGTCAGGA
TGGCCTTCTGCTT 
GTTATTAAATCGCCAGCGCCAAC 
Used to amplify the Reductase gene (DNA2.0) with overhangs 
compatible with ttnBT2 terminator assembly (transcriptional terminator 
underlined) 
RR_MXNDtorrnBT1toD_F 
CATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCC
TTTCGTTTTATCTGTTG 
ACTAGTGCATGCGTGACACAAGAA 
Used to amplify pMEND/pMIND with overhangs compatible with the 
rrnBT1 terminator assembly into the Decarbonylase gene 
(transcriptional terminator underlined) 
RR_RtoLinker_R 
CAGTTGTTGCATGTCTCTTTCCTTTTAGAAAATATTAATTAT
TA 
AATTGCCAGAGCCAGCGGTTGG 
Used to amplify the Reductase gene (Mr. Gene) with overhangs 
compatible with linker assembly 
RR_DtoLinker_F 
CTGGCAATTTAATAATTAATATTTTCTAAAAGGAAAGAGA
C 
ATGCAACAACTGACCGACCAATCC 
Used to amplify the Decarbonylase gene with overhangs compatible 
with linker assembly (Mr.Gene) 
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RR_DtorrnBT1toMXND_R 
GATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGT
TTTATTTGATGTTATTA  
TGCTCCAATCAGACCATAGGCC 
Used to amplify the Decarbonylase gene with overhangs compatible 
with rrnBT1 terminator assembly into pMEND/pMIND (Mr.Gene) 
(transcriptional terminator underlined) 
RR_Rv2toLinker_R GTTGTTGCATGTCTCTTTCCTTTTAGAAAATATTAA TTATTAAATCGCCAGCGCCAACGG 
Used to amplify the Reductase gene (DNA2.0) with overhangs 
compatible with linker assembly 
RR_DtoLinkerv2_F GATTTAATAATTAATATTTTCTAAAAGGAAAGAGAC  ATGCAACAACTGACCGACCAATCC 
Used to amplify the Decarbonylase gene with overhangs compatible 
with linker assembly (DNA2.0) 
RR_psmyctoMXND_F TTAATATTTTCTAAAAGGAAAGAGAC 
TTTAATACTGCATGCACTCTAGAAATATTG
GATC 
Used to amplify the psmyc promoter with overhangs compatible with 
pMEND/pMIND assembly 
RR_psmyctoD_R GGATTGGTCGGTCAGTTGTTGCAT TGCGAAGTGATTCCTCCTGATG 
Used to amplify the psmyc promoter with overhangs compatible with 
Decarbonylase assembly 
RR_MXNDLXtoRv2_F GGCCATCACCATCACCATCACTAAT CATGCGTGACACAAGAATCCCTGTTAC 
Used to amplify pMEND/pMIND containing the LuxAB operon with 
overhangs compatible with Reductase gene (DNA2.0) assembly 
RR_MXNDLXtopsmyc_R GATGGCCTTCTGCTTAGCTAATCAGC CATGCACTAGTTTACGAGTGGTATTTG 
Used to amplify pMEND/pMIND containing the LuxAB operon with 
overhangs compatible with psmyc promoter assembly 
RR_Rtopsmyc_F GGTACCATCAGGAGGAATCACTTCGCA ATGTTCGGTCTGATCGGCCACTTGAC 
Used to amplify the Reductase gene (Mr. Gene) with overhangs 
compatible with the promoter psmyc assembly 
RR_RtoMXNDLX_R GTAACAGGGATTCTTGTGTCACGCATG GAAAATATTAACGCAAAAAGGCCATCCG 
Used to amplify the Reductase gene (Mr. Gene) with overhangs 
compatible with pMEND/pMIND containing the LuxAB operon assembly 
RR_psmyctoMXNDLX_F CAAATACCACTCGTAAACTAGTGCATG GCTGATTAGCTAAGCAGAAGGCCATC 
Used to amplify the psmyc promoter with overhangs compatible with 
pMEND/pMIND containing the LuxAB operon assembly 
RR_psmyctoRv2_R GTCAAGTGGCCGATCAGACCGAACATT GCGAAGTGATTCCTCCTGATGGTACC 
Used to amplify the psmyc promoter with overhangs compatible with 
Reductase gene (DNA2.0) assembly 
RR_MXND-Rh_F TCGTCGGGCCATCACCATCACCATCAC TAATAAAAGCAGAAGGCCATCCTGACGG Used to add an hexa-histidine tag to the Reductase gene (DNA2.0) 
RR_MXND-Rh_R GTGATGGTGATGGTGATGGCCCGACGA AATCGCCAGCGCCAACGGC Used to add an hexa-histidine tag to the Reductase gene (DNA2.0) 
RR_MXND-RhD_F TCGTCGGGCCATCACCATCACCATCAC 
TAATAATTAATATTTTCTAAAAGGAAAGA
GAC 
Used to add an hexa-histidine tag to the Reductase gene (DNA2.0) when 
in a operon 
RR_MXND-RhD_R GTGATGGTGATGGTGATGGCCCGACGA AATCGCCAGCGCCAAC 
Used to add an hexa-histidine tag to the Reductase gene (DNA2.0) when 
in a operon 
RR_MXND-RDh_F CATCACCATCACCATCACTCGTCGGGC CAACAACTGACCGACC 
Used to add an hexa-histidine tag to the Decarbonylase gene when in a 
operon 
RR_MXND-RDh_R GTGATGGTGATGGTGATGGCCCGACGA CATGTCTCTTTCCTTTTAGAAAATATTA 
Used to add an hexa-histidine tag to the Decarbonylase gene when in a 
operon 
RR_G_RED_pAO815_Fwd GATCAAAAAACAACTAATTATTCGAAACG  ATGTTTGGGTTAATAGGTCATCTCAC 
Used to amplify the Reductase gene with overhangs compatible with 
pAO815 assembly 
RR_G_RED_pAO815_Rev GAGGAACAGTCATGTCTAAGGC  TTATTAGATTGCCAAAGCCAATGG 
Used to amplify the Reductase gene with overhangs compatible with 
pAO815 assembly 
RR_V_pA0815_RED_Rev GTGAGATGACCTATTAACCCAAACAT  CGTTTCGAATAATTAGTTGTTTTTTGATC 
Used to amplify pAO815 with overhangs compatible with Reductase 
gene assembly 
RR_V_pAO815_RED_Fwd CCATTGGCTTTGGCAATCTAATAA  GCCTTAGACATGACTGTTCCTC 
Used to amplify pAO815 with overhangs compatible with Reductase 
gene assembly 
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RR_G_REDDEC_pAO815_Rev GAGGAACAGTCATGTCTAAGGC  TTATTATGCACCAATCAATCCATAAGC 
Used to amplify the Reductase gene with overhangs compatible with 
Decarbonylase assembly into pAO815 
 
RR_L_RED_DEC_Rev 
 
GCCAGTTTACGTAGTTACGATGGATCTTGCAGCTAACATG  
 
TTATTAGATTGCCAAAGCCAATGG 
 
Used to amplify the Reductase gene with overhangs compatible with 
Decarbonylase assembly into pAO815 
RR_L_DEC_RED_Fwd CATGTTAGCTGCAAGATCCATCGTAACTACGTAAACTGGC  ATGCAACAATTAACAGATCAATCTAAGG 
Used to amplify the Decarbonylase gene with overhangs compatible 
with assembly into pAO815 
RR_V_pAO815_REDDEC_Fwd GCTTATGGATTGATTGGTGCATAATAA  GCCTTAGACATGACTGTTCCTC 
Used to amplify pAO815 with overhangs compatible with  Decarbonylase 
gene assembly 
RR_G_MHT_pSM_F CAACTAATTATTCGAAACGAGGGAA ATGAGCACCGTCGCCAACATCG 
Used to amplify the MHT gene with overhangs compatible with pSM 
assembly 
RR_G_MHT_pSM_R GTCATGTCTAAGGCGAATTTTAAATTTTAGGGGC GTTGTTCATCTTCTTCCAGCGGGCC 
Used to amplify the MHT gene with overhangs compatible with pSM 
assembly 
RR_V_pSM_MHT_F 
GGCCCGCTGGAAGAAGATGAACAACGCCCCTAAAATTTA
A 
AATTCGCCTTAGACATGAC 
Used to amplify pSM with overhangs compatible with MHT gene 
assembly 
RR_V_pSM_MHT_R CGATGTTGGCGACGGTGCTCATtTC CCTCGTTTCGAATAATTAGTTG 
Used to amplify pSM with overhangs compatible with MHT gene 
assembly 
RR_V_pSM_crt_R GACGAGGACACCAAGACATTTCTACAAAAA  CCCGATCTGCGTCTATTTCACAATAC 
Used to amplify pSM with overhangs compatible with carotenoid gene 
assembly 
RR_V_pSM_crt_F GTTTCCAGAGGCCAAACATTCCAC CATGGCGACCACACCCG 
Used to amplify pSM with overhangs compatible with carotenoid gene 
assembly 
RR_G_crt1_pSM_F GTATTGTGAAATAGACGCAGATCGGG TTTTTGTAGAAATGTCTTGGTGTCCTCGTC 
Used to amplify one of the crt genes with overhangs compatible with 
pSM assembly 
RR_G_crt1_ad1_R TCTAGCGCCTATAGTCTAAGCGGGAATTGG CCGCACAAACGAAGGTTTCACTTAATC 
Used to amplify one of the crt genes with overhangs compatible with 
multiple gene assembly (position 1) 
RR_G_crt2_ad1_F CCAATTCCCGCTTAGACTATAGGCGCTAGA TTTTTGTAGAAATGTCTTGGTGTCCTCGTC 
Used to amplify one of the crt genes with overhangs compatible with 
multiple gene assembly (position 2) 
RR_G_crt2_ad2_R ATTAGCACGTGATATGCTGTCTCTGGATTG CCGCACAAACGAAGGTTTCACTTAATC 
Used to amplify one of the crt genes with overhangs compatible with 
multiple gene assembly (position 2) 
RR_G_crt3_ad2_F CAATCCAGAGACAGCATATCACGTGCTAAT TTTTTGTAGAAATGTCTTGGTGTCCTCGTC 
Used to amplify one of the crt genes with overhangs compatible with 
multiple gene assembly (position 3) 
RR_G_crt3_pSM_R CGGGTGTGGTCGCCATG GTGGAATGTTTGGCCTCTGGAAAC 
Used to amplify one of the crt genes with overhangs compatible with 
pSM assembly (position 3) 
RR_yEGFP_cyt_F ACTATCAAAACACAGAATTCAAAACGATG 
TCTAAAGGTGAAGAATTATTCACTGGTGT
TG 
Used to amplify the yEGFP gene with overhangs compatible with pSM 
assembly 
RR_yEGFP_IGLSQMPM_F TGATTGGTCTGTCCTTGCAGATGCCAATG 
TCTAAAGGTGAAGAATTATTCACTGGTGT
TG 
Used to amplify the yEGFP gene with overhangs compatible with pSM 
assembly and inclusion of the IGLSQMPM sequence (underlined) 
RR_yEGFP_QMPM_F CAGAATTCAAAACGATGCAGATGCCAATG 
TCTAAAGGTGAAGAATTATTCACTGGTGT
TG 
Used to amplify the yEGFP gene with overhangs compatible with pSM 
assembly and inclusion of the QMPM sequence (underlined) 
RR_yEGFP_QRLP_F CAGAATTCAAAACGATGCAGATGCCAATG 
TCTAAAGGTGAAGAATTATTCACTGGTGT
TG 
Used to amplify the yEGFP gene with overhangs compatible with pSM 
assembly and inclusion of the QRLP sequence (underlined) 
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RR_GAP1_cyt_R CCAGTGAATAATTCTTCACCTTTAGA 
CATCGTTTTGAATTCTGTGTTTTGATAGTT
GTTC 
Used to amplify the GAP promoter with overhangs compatible with 
yEGFP assembly 
RR_GAP1_IGLSQMPM_R ATTGGCATCTGCAAGGACAGACCAAT 
CATCGTTTTGAATTCTGTGTTTTGATAGTT
GTTC 
Used to amplify the GAP promoter with overhangs compatible with 
yEGFP assembly and inclusion of the IGLSQMPM sequence 
RR_GAP1_QMPM_R TCTTCACCTTTAGACATTGGCATCTG 
CATCGTTTTGAATTCTGTGTTTTGATAGTT
GTTC 
Used to amplify the GAP promoter with overhangs compatible with 
yEGFP assembly and inclusion of the QMPM sequence (underlined) 
RR_GAP1_QRLP_R TCTTCACCTTTAGACAACGGTCTTTG 
CATCGTTTTGAATTCTGTGTTTTGATAGTT
GTTC 
Used to amplify the GAP promoter with overhangs compatible with 
yEGFP assembly and inclusion of the QRLP sequence (underlined) 
RR_AOX_yEGFP_F GTATTACCCATGGTATGGATGAATTGTACAAATAA GCCTTAGACATGACTGTTCCTCAG 
Used to amplify the AOX terminator with overhangs compatible with 
yEGFP assembly 
RR_yEGFP_AOX_R CTGAGGAACAGTCATGTCTAAGGC 
TTATTTGTACAATTCATCCATACCATGGGT
AATAC 
Used to amplify the yEGFP gene with overhangs compatible with AOX 
terminator assembly 
RR_Lib_Prom_F 
GAAGCCGTATTTTTATTATCAGTGAGTCAGTCATCAGGAG
ATCCCGGG  
TCTATTATCCTTAAACGCATATCTCGC 
Used to amplify library promoters with overhangs compatible with 
Library assembly (SmaI site underlined) 
RR_Lib_AOX_F CTTGTTCCTGAGTTTTACCAACATCGTAATAGCCTCCAAG CCTTAGACATGACTGTTCCTCAG 
Used to amplify the AOX terminator with overhangs compatible with 
Library assembly 
RR_Lib_AOX_R 
GTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCG
CCCGGG 
GCACAAACGAACGTCTCAC 
Used to amplify the AOX terminator with overhangs compatible with 
Library assembly (SmaI site underlined) 
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16.3. DNA sequences 
16.3.1. Reductase gene (Mr. Gene version)  
ATGTTCGGCCTGATCGGGCACCTCACCTCGCTGGAGCAGGCCAGGGACGTATCG
CGCCGTATGGGTTACGACGAGTACGCGGATCAGGGCCTGGAGTTCTGGTCGTCC
GCCCCGCCACAGATCGTGGACGAGATCACCGTGACCTCAGCCACCGGCAAGGTC
ATCCACGGCCGCTACATCGAGTCCTGCTTCCTGCCGGAGATGCTGGCGGCGCGC
CGTTTCAAGACCGCGACCCGCAAGGTCCTGAACGCGATGAGCCACGCCCAGAAG
CACGGCATCGACATCAGCGCCCTCGGCGGCTTCACGTCGATCATCTTTGAAAACT
TCGACTTGGCCTCGCTCCGCCAAGTCCGCGACACCACCCTGGAATTCGAACGATT
CACCACGGGGAACACACATACCGCATACGTTATCTGCCGGCAGGTCGAGGCGGC
GGCCAAGACGCTGGGTATCGACATCACACAGGCGACCGTGGCGGTGGTTGGCG
CCACGGGCGACATCGGCTCGGCAGTTTGCCGCTGGCTGGACCTCAAGCTGGGG
GTGGGTGACCTGATCCTGACGGCCCGCAACCAGGAACGCCTGGACAACCTCCAG
GCGGAGCTGGGACGTGGCAAGATCCTGCCGCTGGAGGCGGCCCTGCCGGAGGC
GGACTTCATCGTGTGGGTCGCGTCGATGCCACAAGGCGTCGTCATCGACCCCGC
CACGCTTAAGCAACCTTGTGTTCTGATCGACGGCGGCTATCCGAAGAACCTCGGC
TCCAAGGTGCAGGGGGAAGGTATCTATGTCCTGAACGGCGGCGTCGTGGAGCAC
TGCTTCGACATCGATTGGCAGATCATGAGTGCCGCCGAGATGGCCCGGCCCGAG
CGGCAAATGTTCGCGTGCTTCGCCGAGGCGATGCTGCTGGAATTCGAGGGCTGG
CACACTAACTTCTCGTGGGGCCGCAATCAGATTACCATCGAGAAGATGGAGGCGA
TCGGCGAGGCATCGGTCCGCCACGGCTTCCAGCCCTTGGCCCTGGCCATCTGA 
16.3.2. Reductase gene (DNA2.0 version) 
ATGTTCGGTCTGATCGGCCACTTGACCAGCCTGGAGCAAGCCCGTGATGTTTCTC
GTCGCATGGGTTACGATGAGTATGCGGACCAAGGTCTGGAGTTTTGGTCTAGCGC
ACCGCCGCAGATTGTCGACGAGATCACCGTTACCAGCGCGACCGGCAAAGTCAT
CCACGGTCGTTACATTGAAAGCTGTTTTCTGCCGGAAATGCTGGCCGCTCGCCGC
TTCAAGACCGCGACCCGTAAGGTTTTGAACGCCATGAGCCACGCACAAAAACACG
GTATTGACATTTCCGCGCTGGGTGGCTTCACGAGCATTATCTTTGAGAACTTTGAC
CTGGCAAGCCTGCGTCAAGTGCGTGATACCACGCTGGAGTTCGAGCGTTTCACC
ACGGGTAATACCCATACGGCCTATGTTATCTGCCGCCAGGTCGAGGCGGCAGCG
AAAACCTTGGGCATTGACATCACGCAGGCCACCGTGGCTGTCGTGGGTGCGACC
GGTGATATTGGCTCCGCGGTCTGTCGTTGGTTGGATCTGAAACTGGGTGTTGGTG
ACCTGATTTTGACCGCGCGTAATCAAGAACGTCTGGATAACCTGCAGGCCGAGCT
GGGTCGTGGCAAGATCCTGCCACTGGAAGCAGCTCTGCCGGAGGCGGACTTTAT
CGTGTGGGTCGCGAGCATGCCACAAGGCGTTGTCATCGACCCGGCCACGCTGAA
ACAGCCGTGCGTGCTGATTGATGGTGGTTATCCGAAAAACCTGGGCAGCAAGGTT
CAGGGTGAGGGCATCTACGTGCTGAATGGCGGCGTGGTTGAGCATTGTTTCGAC
ATCGATTGGCAGATCATGAGCGCTGCAGAAATGGCACGTCCGGAACGCCAAATGT
TCGCGTGCTTCGCGGAAGCAATGCTGCTGGAATTTGAAGGTTGGCATACGAACTT
TAGCTGGGGTCGCAATCAGATTACGATCGAAAAGATGGAGGCAATTGGTGAGGC
GTCCGTGCGCCACGGCTTCCAGCCGTTGGCGCTGGCGATTTAA 
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16.4. Analysis of ethyl acetate extractions from cell culture 
samples 
 
 
 
  
Figure 16.1 - GC-MS spectra obtained from ethyl acetate extraction of constructs containing the 
first version of the reductase gene. RED refers to the Reductase gene; OP refers to the pMIND-RD 
construct. Peaks observed in samples at retention times close to standards in pMIND-RED and 
pMIND-OP presented no similarity in the extracted-ion chromatograms (not shown). 
(1)tetradecanal, (2)hexadecanal, (3)octadecanal. 
(1) (2) 
(3) 
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16.5. Detection of aldehydes in two culture systems 
 
All data was obtained over 150 sample points of a single plate taken at regular intervals 
over a 6h30m span. L – reporter cultures in LB media. P – reporter cultures re-
suspended in PBS. I -induced culture. NI – non-induced culture. 
 
  
Figure 16.2 - Luminescence produced by controls 
Figure 16.3 - Luminescence produced by reductase constructs 
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Figure 16.4 - Luminescence produced by operon constructs 
Figure 16.5 - Luminescence produced by reductase constructs 
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Figure 16.6 - Luminescence produced by operon constructs 
Figure 16.7 - Luminescence produced by controls 
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16.6. Identity of M. smegmatis rewiring library elements 
 
Table 16.3 – Identity of genes selected for the full M. smegmatis rewiring library. Cyan background 
indicates ORFs present in the test library. Pink background indicates promoters present in the test 
library. 
ORFs 
  
Gene id Query Description 
MSMEG_0219 Sigma factor 
RNA polymerase factor sigma-70 (EC:2.7.7.6); K03088 RNA 
polymerase sigma-70 factor, ECF subfamily 
MSMEG_0404 Other sigma associated protein 
MSMEG_0405 Sigma factor extra cytoplasmic sigma factor 
MSMEG_0539 
Transcription 
regulator 
transcriptional regulator, Crp/Fnr family protein 
MSMEG_0573 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_0574 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_1348 Sigma factor RNA polymerase ECF-subfamily protein sigma factor 
MSMEG_1349 Other DGPF domain-containing protein 
MSMEG_1418 Sigma factor 
RNA polymerase ECF-type sigma factor; K03088 RNA polymerase 
sigma-70 factor, ECF subfamily 
MSMEG_1486 Sigma factor RNA polymerase sigma factor SigL 
MSMEG_1599 Sigma factor RNA polymerase sigma factor SigD 
MSMEG_1666 Sigma factor RNA polymerase sigma factor SigJ 
MSMEG_1690 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_1747 Sigma factor RNA polymerase sigma-70 factor 
MSMEG_1803 Other RsbW protein 
MSMEG_1804 Sigma factor RNA polymerase sigma factor SigF 
MSMEG_1914 Sigma factor RNA polymerase sigma-70 factor, family protein 
MSMEG_1915 Sigma factor anti-sigma factor, family protein 
MSMEG_1970 Sigma factor sigma factor 
MSMEG_2752 Sigma factor RNA polymerase sigma factor SigB 
MSMEG_2758 Sigma factor RNA polymerase sigma factor 
MSMEG_3008 Regulator putative sigma 54 type regulator 
MSMEG_3275 Sigma factor RNA polymerase sigma factor, sigma-70 family protein 
MSMEG_3296 Sigma factor ECF-family protein sigma factor H 
MSMEG_3485 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_4315 Sigma factor RNA polymerase sigma factor, sigma-70 family protein 
MSMEG_4405 Sigma factor putative ECF sigma factor RpoE1 
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MSMEG_5072 Sigma factor 
RNA polymerase sigma factor SigE; K03088 RNA polymerase sigma-
70 factor, ECF subfamily 
MSMEG_5158 
Transcription 
regulator 
sensor histidine kinase; K02478 two-component system, LytT family, 
sensor kinase [EC:2.7.13.3] 
MSMEG_5159 Regulator DNA-binding response regulator, putative 
MSMEG_5214 Sigma factor RNA polymerase sigma-70 factor 
MSMEG_5243 Oxidoreductase helix-hairpin-helix DNA-binding motif-containing protein 
MSMEG_5244 Regulator two component transcriptional regulatory protein DevR 
MSMEG_5365 Sigma factor RNA polymerase sigma-70 factor 
MSMEG_5444 Sigma factor RNA polymerase sigma-70 factor protein 
MSMEG_6127 Sigma factor anti-anti-sigma factor 
MSMEG_6189 
Transcription 
regulator 
transcriptional regulator, Crp/Fnr family protein 
MSMEG_6383 
Transcription 
regulator 
transcription regulator FurA; K03711 Fur family transcriptional 
regulator, ferric uptake regulator 
MSMEG_6541 Sigma factor anti-sigma factor antagonist 
MSMEG_6682 Sigma factor RNA polymerase sigma-70 factor, putative 
MSMEG_6817 Sigma factor RNA polymerase sigma factor, sigma-70 family protein 
MSMEG_6913 
Transcription 
regulator 
putative transcriptional regulatory protein 
 
 
  
Promoters   
Gene id Query Description 
MSMEG_0219 Sigma factor 
RNA polymerase factor sigma-70 (EC:2.7.7.6); K03088 RNA 
polymerase sigma-70 factor, ECF subfamily 
MSMEG_0404 Other sigma associated protein 
MSMEG_0405 Sigma factor extra cytoplasmic sigma factor 
MSMEG_0539 
Transcription 
regulator 
transcriptional regulator, Crp/Fnr family protein 
MSMEG_0573 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_0574 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_0744 Oxidoreductase 
carbon monoxide dehydrogenase medium chain (EC:1.2.99.2); 
K03519 carbon-monoxide dehydrogenase medium subunit 
[EC:1.2.99.2] 
MSMEG_0965 Other porin 
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MSMEG_1348 Sigma factor RNA polymerase ECF-subfamily protein sigma factor 
MSMEG_1349 Other DGPF domain-containing protein 
MSMEG_1418 Sigma factor 
RNA polymerase ECF-type sigma factor; K03088 RNA polymerase 
sigma-70 factor, ECF subfamily 
MSMEG_1486 Sigma factor RNA polymerase sigma factor SigL 
MSMEG_1599 Sigma factor RNA polymerase sigma factor SigD 
MSMEG_1666 Sigma factor RNA polymerase sigma factor SigJ 
MSMEG_1690 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_1747 Sigma factor RNA polymerase sigma-70 factor 
MSMEG_1803 Other RsbW protein 
MSMEG_1804 Sigma factor RNA polymerase sigma factor SigF 
MSMEG_1914 Sigma factor RNA polymerase sigma-70 factor, family protein 
MSMEG_1915 Sigma factor anti-sigma factor, family protein 
MSMEG_1970 Sigma factor sigma factor 
MSMEG_2752 Sigma factor RNA polymerase sigma factor SigB 
MSMEG_2758 Sigma factor RNA polymerase sigma factor 
MSMEG_3008 Regulator putative sigma 54 type regulator 
MSMEG_3275 Sigma factor RNA polymerase sigma factor, sigma-70 family protein 
MSMEG_3278 Other hypothetical protein 
MSMEG_3296 Sigma factor ECF-family protein sigma factor H 
MSMEG_3485 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_3932 Other 14 kDa antigen 
MSMEG_4290 Other 
glnA; glutamine synthetase, type I (EC:6.3.1.2); K01915 glutamine 
synthetase [EC:6.3.1.2] 
MSMEG_4315 Sigma factor RNA polymerase sigma factor, sigma-70 family protein 
MSMEG_4405 Sigma factor putative ECF sigma factor RpoE1 
MSMEG_5072 Sigma factor 
RNA polymerase sigma factor SigE; K03088 RNA polymerase sigma-
70 factor, ECF subfamily 
MSMEG_5158 
Transcription 
regulator 
sensor histidine kinase; K02478 two-component system, LytT family, 
sensor kinase [EC:2.7.13.3] 
MSMEG_5159 Regulator DNA-binding response regulator, putative 
MSMEG_5214 Sigma factor RNA polymerase sigma-70 factor 
MSMEG_5243 Oxidoreductase helix-hairpin-helix DNA-binding motif-containing protein 
MSMEG_5244 
Transcription 
regulator 
two component transcriptional regulatory protein DevR 
MSMEG_5365 Sigma factor RNA polymerase sigma-70 factor 
MSMEG_5444 Sigma factor RNA polymerase sigma-70 factor protein 
MSMEG_5880 Other nicotine dehydrogenase; K03520 carbon-monoxide dehydrogenase 
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large subunit [EC:1.2.99.2] 
MSMEG_6127 Sigma factor anti-anti-sigma factor 
 
MSMEG_6189 
 
Transcription 
regulator 
 
transcriptional regulator, Crp/Fnr family protein 
MSMEG_6383 
Transcription 
regulator 
transcription regulator FurA; K03711 Fur family transcriptional 
regulator, ferric uptake regulator 
MSMEG_6467 Other 
starvation-induced DNA protecting protein; K04047 starvation-
inducible DNA-binding protein 
MSMEG_6541 Sigma factor anti-sigma factor antagonist 
MSMEG_6682 Sigma factor RNA polymerase sigma-70 factor, putative 
MSMEG_6817 Sigma factor RNA polymerase sigma factor, sigma-70 family protein 
MSMEG_6913 
Transcription 
regulator 
putative transcriptional regulatory protein 
MSMEG_6931 Sigma factor RNA polymerase sigma-70 factor 
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16.7. Testing of the free halide assay in S. cerevisiae 
   
Figure 16.8 – Removal of free halides from media in S. cerevisiae clones. Clones 
expressing the MHT gene under control of the ADH1 promoter were incubated for 72h in 
200µL YPD containing 100mM sodium chloride after an initial outgrowth phase of 24h in 
non-supplemented YPD. Lower absorbance indicates possible removal of free chloride 
and production of methyl chloride. 
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16.8. Determination of absorbance equivalents 
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Figure 16.10 – Correlation between absorbance measurements of P. pastoris cultures at OD600 
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Figure 16.9 – Determination of a second order polynomial for conversion of OD484 values 
obtained in 96-well format using Costar 96-well flat bottom cell culture plates with 200µL of 
sample to 1cm pathlength 
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Figure 16.11 - Determination of a second order polynomial for conversion of OD660 values obtained 
in 96-well format using Costar 96-well flat bottom cell culture plates with 200µL of sample to 1cm 
pathlength. 
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16.9. Determination of in vivo lycopene concentration 
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Figure 16.13 - Absorbance spectra of cultures mixed at the shown ration used to calculate the 
relationship between absorbance at specific wavelengths and lycopene concentration in cultures 
after normalisation with OD660 values 
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Figure 16.12 - Effect of lycopene concentration in absorption spectra. Cultures producing visible 
amounts of lycopene were diluted with wild-type cultures to observe the change in signal with 
varying concentration of lycopene 
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Figure 16.14 – Correlation of single wavelength measurements of cultures in 96 well format with 
absorbance of lycopene extracted from said cultures into hexane and measured at 502nm. 
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Figure 16.15 – Variance of single wavelength measurements across all samples incubated in 96 
well format. 
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Figure 16.16 – Absorbance spectra of extracts obtained from cultures mixed at the shown ratio 
and used to calculate the relationship between absorbance at specific wavelengths and lycopene 
concentration in cultures 
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Figure 16.17 -– Correlation between lycopene concentration (calculated from lycopene extinction 
coefficient at 502nm in hexane) and raw OD484 measurement. 
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16.10. Mapping of library element entries 
 
 
Table 16.4 – Mapping of Entrez geneID to UniprotKB AC used during the library element 
selection procedure 
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16.11. Primers used for P. pastoris library element amplification 
Table 16.5 – Primers used for amplification of ORFs (name starting with “o”) and promoters (name 
starting with “p”). Uppercase - recognition sequence. 
Name Sequence Tm ΔTm 
Target 
Entrez 
Gene ID 
o0275fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGATCATAGTAGACGGCG
AAAAAT 
62.1 
1.6 
8200275 
o0275rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTACAAGGGCAGAGATTTA
CAGGTG 
63.7 8200275 
o0338fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTTCCCCGATAATAAAC
GG 
59.5 
2.5 
8200338 
o0338rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTACAAATCTCTGAAAGAA
GAACCTTTG 
62 8200338 
o0389fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGACATTTCAAGTAGCCTT
ACCGA 
63.5 
1.7 
8200389 
o0389rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTAAAGGTATTCTACATGA
TCTTTTGCATA 
61.8 8200389 
o0775fwd gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGACCACTGCCTATCCCAA 62.3 
2.5 
8200775 
o0775rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCATTTCTTTTCTTGATTTTC
CAGAGAGGT 
64.8 8200775 
o0866fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGAGTGACGTGGTAAACA
AGAGAG 
63.5 
1.4 
8200866 
o0866rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTATTTAAACATGGAAAAA
TCGACAACATC 
62.1 8200866 
o0877fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTCGTCCCCAAGAAAGA
G 
60.8 
0.4 
8200877 
o0877rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTAGTTCTTGAAGCCTTTGG
C 
60.4 8200877 
o0938fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGAATCGACACGAGATCA
GATTG 
61.9 
0.4 
8200938 
o0938rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCATTCAGGGAGTAACTGA
TCAATAATC 
62.3 8200938 
o0968fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGCCTTTCTATCTTCCTGA
AGATG 
61.9 
0.5 
8200968 
o0968rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCACTTCTTGTAATTGTTAA
AAATATGGTC 
61.4 8200968 
o0994fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTTGCCCAGAATTTTAGC
AAG 
61.6 
0.7 
8200994 
o0994rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTATTTATCGGTGTCACTTC
CATCTG 
62.3 8200994 
o1004fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGAACTCAGATCCCACGT
C 
60.5 
0.6 
8201004 
o1004rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTAGAATTCATACACTGACT
TTTCAGG 
61.1 8201004 
o1078fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGATAATCCGTTTGGAC
AGG 
61.6 
0.2 
8201078 
o1078rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTAATGCGTCGAATGTCCTC
G 
61.8 8201078 
o1128fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGCTCGATGAAGAAATTC
TAACAAG 
61.5 
0.5 
8201128 
o1128rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTAGATAACAGGCACAGTT
TTTCG 
61 8201128 
o1180fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGGTAGAAGGAAAATA
GAGATAAATC 
60.7 
0 
8201180 
o1180rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCAGCTCTTCTTAGTCACAC
TG 
60.7 8201180 
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o1433fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGAGCAATCTACCCCCAA
C 
61 
1.1 
8201433 
o1433rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTAGACACCACCATCTAGT
CGG 
62.1 8201433 
o6484fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTCGGAACCAAACACCA
AG 
62.3 
0 
8196484 
o6484rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCATTCTCCCTTGATGGCTT
TTC 
62.3 8196484 
o6642fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGCCCGTAGATTCTTCTCA
TAAGA 
62.7 
3 
8196642 
o6642rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCACCTGATCGCTATGCAT
GTCAAC 
65.7 8196642 
o6675fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTATATCCCACCTACAAG
TTTCAAC 
62.4 
0.8 
8196675 
o6675rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTATATCTTATCTGGCGTCC
AATCC 
61.6 8196675 
o7110fwd gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGACTACTGCTCCCCCAAC 62.6 
0.8 
8197110 
o7110rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCAAGAGTCCGAGTTCATG
ATATTG 
61.8 8197110 
o7136fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTCTCAAAGGAAGTTAC
AACAAG 
61.1 
0.6 
8197136 
o7136rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCAAAGATACAACGTTTCC
AACTTG 
61.7 8197136 
o7166fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGCACAAGAAAGAACAG
AC 
60.3 
1 
8197166 
o7166rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTATGACTCTACTGAATTGG
CTCC 
61.3 8197166 
o7205fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGATAACGACGTATCGA
CA 
60.2 
3.1 
8197205 
o7205rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTATACCCAAATCTCTTTTC
CAGCATTATC 
63.3 8197205 
o7237fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTCTACTCACGGAGTTCA
G 
60.2 
1 
8197237 
o7237rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTAGAGACTCGAAGTTGCG
C 
61.2 8197237 
o7559fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTTTGGAGAAGTGGGTT
CT 
61.1 
0.2 
8197559 
o7559rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTAATTTGAATCAAACTGAT
CAGAAGC 
60.9 8197559 
o7661fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGAGTTCGACTAATCCATC
AGG 
61.1 
0.2 
8197661 
o7661rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTATTTCTGAGGTTGGGTA
GCC 
61.3 8197661 
o7765fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGAAGAAGCGTTGCAAC
C 
62.7 
0.6 
8197765 
o7765rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCATTCATCTGTTATCTCAG
GCTCAG 
63.3 8197765 
o7788fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTCTGCAAGTACTTACA
GTTTTG 
61.3 
0.7 
8197788 
o7788rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCACTGATGTTTCACTAAAC
TCTTT 
60.6 8197788 
o7813fwd gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGACACTCTCCCAGGGG 61.5 
0.3 
8197813 
o7813rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCATTTGATACTGATTTCGT
AGATCATC 
61.2 8197813 
o7959fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGAAGTTCATTGATGAAA
TTGATATAGAGC 
62.7 
1.6 
8197959 
o7959rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTAACTAACCTGCAGGTCTT
CC 
61.1 8197959 
o7996fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGACACAAGCAGAGTTGT
ACAC 
62.2 
0.2 
8197996 
o7996rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTACCAGAAAGAACACCAA
CCG 
62 8197996 
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o8145fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTCGGATTTTCCTAAAGT
CGAAC 
62.6 
1.6 
8198145 
o8145rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTATTTCTTAGCCCTCTTAC
TAGCA 
61 8198145 
o8152fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGATATCCAACCTCTCGGC
AG 
62.8 
2.1 
8198152 
o8152rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTATGTATCACCACGTAGG
GC 
60.7 8198152 
o8177fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGTTCATATCTTACTCGA
TCAACAC 
62.3 
0.9 
8198177 
o8177rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTATGGTACACTCATACCCT
TCTTG 
61.4 8198177 
o8201fwd gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGCTGCTGTATTTTTCCC 60.2 
1.4 
8198201 
o8201rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTAGTTGGCCTCAGCAGTT
G 
61.6 8198201 
o8232fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGACACTTTTTGATAACCT
CAAACAG 
62.2 
0 
8198232 
o8232rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCAGTATTTAGAAGATTGG
TTGACCG 
62.2 8198232 
o8277fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGCAGACCAACGGCTTG
A 
65.7 
2.3 
8198277 
o8277rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCAGTCATCTATGTTCTGAC
CAAGC 
63.4 8198277 
o8289fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGCTGCTAGGTCTAGTA
CTC 
61.7 
0.5 
8198289 
o8289rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCATCGCAGATCTATGTCA
ACC 
61.2 8198289 
o8341fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGTCTACAACAAAACCAA
TGCAGG 
63.5 
1.9 
8198341 
o8341rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCACTGCTTACGGTGAGTA
CGTAGA 
65.4 8198341 
o8430fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGAAGACTCATCCAAGG
C 
61 
4.6 
8198430 
o8430rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTCAGTTGGTCCTCAGAATCT
CCTCA 
65.6 8198430 
o8510fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGCTAACCTAAAGATCC
CTG 
60.9 
0.7 
8198510 
o8510rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTACTCATCATATATACTAC
TGTGCATGA 
61.6 8198510 
o8926fwd gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGCGGCATGGATTTCAAG 60.4 
1.2 
8198926 
o8926rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTAGTAACCATCGTGTTCCT
GC 
61.6 8198926 
o8945fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGGTATACCAATACTCAGT
CTCTC 
60.5 
1.2 
8198945 
o8945rev 
cttggaggctattacgatgttggtaaaactcaggaacaagTTATTCTTCAAACCCTTTGG
TTTCC 
61.7 8198945 
o9654fwd 
gtcgaaacaaagcggtcttacggtcagtcgtatttcaaaaATGACGCTAAAGATGACCA
ACTTC 
62.4 
0.5 
8199654 
o9654rev 
cttggaggctattacgatgttggtaaaactcaggaacaagCTAATAGAGAGTACCAAAA
TGAGTTTGATATC 
61.9 8199654 
p0226fwd 
tctattatccttaaacgcatatctcgcataataactcctcATAATAGTTGGATGGGATCT
GGC 
61.3 
0.4 
8200226 
p0226rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGCTAATGTAAAAAGTAAGAT
TGCTTTCAA 
61.7 8200226 
p0275fwd 
tctattatccttaaacgcatatctcgcataataactcctcCTGTATTTTCAGTCATTTGGTC
G 
59.4 
0.8 
8200275 
p0275rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacAACACTGTATCCCTGTATCCC 60.2 8200275 
p0338fwd tctattatccttaaacgcatatctcgcataataactcctcCATACGTGGTTGCCATGAAC 60.6 
0.1 
8200338 
p0338rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCCTGACTAACGGTGTATGTG
A 
60.5 8200338 
p0362fwd tctattatccttaaacgcatatctcgcataataactcctcATTATGCATTAATCAGGAAAA 61.1 0.8 8200362 
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TTCACAT 
p0362rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTTTTATTTGACGATTCAGATG
GTGC 
61.9 8200362 
p0389fwd 
tctattatccttaaacgcatatctcgcataataactcctcGAAGTATTCAAAATGCTAGCT
CAGTG 
61.7 
1.1 
8200389 
p0389rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGGTTGATGTAGTTTGTAGTG
GATG 
60.6 8200389 
p0775fwd tctattatccttaaacgcatatctcgcataataactcctcTTCTTGGACTTTTATGAGGGC 59.6 
2.6 
8200775 
p0775rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGATAAAAAAAATTTTATGGT
GTTCAGTTTACAG 
62.2 8200775 
p0841fwd 
tctattatccttaaacgcatatctcgcataataactcctcCTTGGGGAACACAGTTGAAA
G 
60.6 
1 
8200841 
p0841rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTTTGGTTTTTACTAGTTTT
CTGGT 
61.6 8200841 
p0866fwd tctattatccttaaacgcatatctcgcataataactcctcCGGACACCATCTATCTCTTCA 60.1 
1 
8200866 
p0866rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGCTGTTTGTGTGATTGTTG 59.1 8200866 
p0877fwd 
tctattatccttaaacgcatatctcgcataataactcctcGAGCAGAGTGATGAAAGTTT
TCAAC 
61.9 
1.7 
8200877 
p0877rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGGTGACTTTTTGTGAAATGA
TCTG 
60.2 8200877 
p0938fwd 
tctattatccttaaacgcatatctcgcataataactcctcGATATAAAATTGGCACCACTT
TCTG 
60.3 
0.7 
8200938 
p0938rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTATGGATAGATTTAGTGACA
GGAGC 
61 8200938 
p0968fwd tctattatccttaaacgcatatctcgcataataactcctcTACCACCTCGTGGTTTGAC 60.6 
0 
8200968 
p0968rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacTCTCTGGAATTCATCTCCGTG 60.6 8200968 
p0994fwd 
tctattatccttaaacgcatatctcgcataataactcctcTCATGATATAATTGATCAAGA
TTTGCG 
60.5 
0.3 
8200994 
p0994rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacCCTGGGGTAATCATTGGGAA 60.8 8200994 
p1004fwd tctattatccttaaacgcatatctcgcataataactcctcAATTTGCCTAAGCCAAGGAC 60.1 
0.4 
8201004 
p1004rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacATTGTGTAAGTAAGATGAAA
AACAATTTC 
60.5 8201004 
p1078fwd 
tctattatccttaaacgcatatctcgcataataactcctcTGAAGAAGAGATTGTTGAGA
TTTTGG 
61.5 
0.7 
8201078 
p1078rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTTGAAGCAAGCTGTAATAGA
AGTG 
60.8 8201078 
p1128fwd 
tctattatccttaaacgcatatctcgcataataactcctcCGGATACAGCTATTGTTACCT
CT 
60.8 
0.2 
8201128 
p1128rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGATTGGGGAGTGGGAATAC
TTA 
60.6 8201128 
p1180fwd 
tctattatccttaaacgcatatctcgcataataactcctcTATTGAAGGAGGTGACAAAG
CTG 
61.9 
1.2 
8201180 
p1180rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTCGATTCTAAAGGTGGTG
T 
60.7 8201180 
p1223fwd 
tctattatccttaaacgcatatctcgcataataactcctcATGTTGGTATTGTGAAATAGA
CGC 
61.2 
0.7 
8201223 
p1223rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCGTTTCGAATAATTAGTTGTT
TTTTGAT 
60.5 8201223 
p1433fwd 
tctattatccttaaacgcatatctcgcataataactcctcAATTGTGGATCTTATCTATAG
CAAGGC 
62.5 
0.9 
8201433 
p1433rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTGCGTGGGATAAAGTCAT
C 
61.6 8201433 
p6441 
fwd 
tctattatccttaaacgcatatctcgcataataactcctcCGGCTCGTTTGATTCTACAAT
C 
60.7 
1.2 
8196441 
p6441rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacCGTTTGACGGAGAAGCTGTT 61.9 8196441 
p6484fwd 
tctattatccttaaacgcatatctcgcataataactcctcCATTCTAAAGGCCGATTTTTT
CAGG 
62.1 
1.3 
8196484 
p6484rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCTCTTTGATGATTGGTGTTG
GG 
60.8 8196484 
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p6606fwd 
tctattatccttaaacgcatatctcgcataataactcctcAGGATAGGAGGGGTGAATTC
C 
61.9 
1.5 
8196606 
p6606rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGATATGGTGGGAGAGCTGA
TAG 
60.4 8196606 
p6642fwd 
tctattatccttaaacgcatatctcgcataataactcctcTTATTGTAAGTGACTAAAGTT
GATTTTCTATTG 
62 
0.1 
8196642 
p6642rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTTTCTGCGATCTGATTCGACT
AAG 
61.9 8196642 
p6675fwd tctattatccttaaacgcatatctcgcataataactcctcCAAGCTTGGCCCGCAC 62.5 
1.9 
8196675 
p6675rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGGGTGATTCTGGTTTGTTT
G 
60.6 8196675 
p6981fwd 
tctattatccttaaacgcatatctcgcataataactcctcTAGTTTAGGCTCGAAATTAAT
TAGTAATTAG 
60.8 
1.4 
8196981 
p6981rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTATCTTAATCTAGCTATTGCT
TTGAAAATGA 
62.2 8196981 
p7066fwd 
tctattatccttaaacgcatatctcgcataataactcctcAATGAGGACGATGGTAACAA
AACTC 
62.6 
1.1 
8197066 
p7066rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGAATAGGATTTGATGGAAAG
AATAAAACTG 
61.5 8197066 
p7110fwd tctattatccttaaacgcatatctcgcataataactcctcAAGGATACTCCGCGCG 60 
1.4 
8197110 
p7110rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGCGAAGTATCTATTGGTGA
CTG 
61.4 8197110 
p7136fwd tctattatccttaaacgcatatctcgcataataactcctcAGACTGCTGCTCAGTTAGTAG 60.2 
2.2 
8197136 
p7136rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGTGTGTGGTGGTTAAGAACT
GTC 
62.4 8197136 
p7166fwd tctattatccttaaacgcatatctcgcataataactcctcGTAACCAACCCGAACGTATCG 61.8 
0.8 
8197166 
p7166rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTTTCTCTATGAATAGGCTAG
GAAAATTC 
61 8197166 
p7205fwd 
tctattatccttaaacgcatatctcgcataataactcctcGGATTCTCCAACCCCTTCAAT
C 
61.9 
0 
8197205 
p7205rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCTATGTTTTAGTGTAAGAAG
GTCTTTGC 
61.9 8197205 
p7237fwd 
tctattatccttaaacgcatatctcgcataataactcctcGAGGTCAATGGTCAGTTTTCT
ATG 
60.7 
0 
8197237 
p7237rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCTGAGACGGCAAAAACTTTT
TTC 
60.7 8197237 
p7559fwd 
tctattatccttaaacgcatatctcgcataataactcctcTATGGCAAAGCGTCAGTAAA
AAG 
61.2 
1.7 
8197559 
p7559rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGAGGGTCTTTTCAAAGGTCC
AATG 
62.9 8197559 
p7661fwd tctattatccttaaacgcatatctcgcataataactcctcAGGGTCTGAGCCAATGG 59.9 
1.9 
8197661 
p7661rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCTAAACGAAAACAAATGAAC
AAACAAATG 
61.8 8197661 
p7683fwd 
tctattatccttaaacgcatatctcgcataataactcctcAGTTTTGTTTGGAGGATAACA
AGTC 
61.4 
0.9 
8197683 
p7683rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCCTATTGGGGGTATCATACA
GAG 
60.5 8197683 
p7738fwd 
tctattatccttaaacgcatatctcgcataataactcctcATACAGTTTGATGATGAAGA
GTTCATAA 
61.2 
0.3 
8197738 
p7738rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTTTGGTGATGAGTTTTTATG
GGG 
60.9 8197738 
p7765fwd 
tctattatccttaaacgcatatctcgcataataactcctcGTCCTGTGTATCCAACCATTG
A 
61.4 
0.2 
8197765 
p7765rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTTCTGTTGCTTTCCTAAAA
CTC 
61.2 8197765 
p7788fwd 
tctattatccttaaacgcatatctcgcataataactcctcGCTTTTTATTGAAAATTGTGT
TGTTAAAATATTC 
62.2 
1.2 
8197788 
p7788rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCACTGATGTTTCACTAAACTC
TTTAAAC 
61 8197788 
p7797fwd 
tctattatccttaaacgcatatctcgcataataactcctcGGTCATGCAGATCCTCATGTT
C 
62 1.6 8197797 
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p7797rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTAACAGGCACCTGAAGATAG
G 
60.4 8197797 
p7813fwd 
tctattatccttaaacgcatatctcgcataataactcctcCTTGAGATCCTTAGTTAGCCA
ATG 
60.3 
0.2 
8197813 
p7813rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacATGGCACGCGGACTAG 60.1 8197813 
p7884fwd tctattatccttaaacgcatatctcgcataataactcctcCACCCGAAGACGAACAGA 60.2 
1.9 
8197884 
p7884rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTCGAATAAAGACGTTATT
AATCGAATG 
62.1 8197884 
p7959fwd tctattatccttaaacgcatatctcgcataataactcctcTTTCCACAAGAACGAAACCC 60.1 
1.6 
8197959 
p7959rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTAGTGAACGTAGCATGCA
C 
61.7 8197959 
p7996fwd 
tctattatccttaaacgcatatctcgcataataactcctcTACTGTGATTGACTCGGGAG
A 
61.5 
0.2 
8197996 
p7996rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacAGGGATACAGCAGAGGACG 61.7 8197996 
p8145fwd 
tctattatccttaaacgcatatctcgcataataactcctcAAAAAAGTTCTGTGTTTATAT
TCAGTTTATG 
61 
0.9 
8198145 
p8145rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTATTGCGGGATTATAATG
TCC 
60.1 8198145 
p8152fwd 
tctattatccttaaacgcatatctcgcataataactcctcTCTTGGTGATATTCTGAGACC
AA 
60.7 
1.6 
8198152 
p8152rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGGGTTTAAATGGAAGCAGA
AAAGTG 
62.3 8198152 
p8174fwd 
tctattatccttaaacgcatatctcgcataataactcctcTGATGATCTTGATTTTCATGTT
TTCC 
60.6 
0.4 
8198174 
p8174rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTATCAGTTGAATAAGTGTCA
GTGAC 
60.2 8198174 
p8177fwd 
tctattatccttaaacgcatatctcgcataataactcctcATTTCAATAACTGACATGTCT
TTAATAATCAAG 
62.2 
1.1 
8198177 
p8177rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacGATTGGGGAGGCGAAGAG 61.1 8198177 
p8201fwd 
tctattatccttaaacgcatatctcgcataataactcctcCCAACTTAGACCTCTCAAACA
AG 
60.2 
1.3 
8198201 
p8201rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCTTGTAAGGGGAAAAAAATT
ATTGGATG 
61.5 8198201 
p8232fwd tctattatccttaaacgcatatctcgcataataactcctcACTTCTGACACACAGTCCTC 60.3 
2.8 
8198232 
p8232rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacAATGAGCCGAATATTCCCTTC
AAATC 
63.1 8198232 
p8267fwd 
tctattatccttaaacgcatatctcgcataataactcctcCTATGTTGACGGAGAGTGTT
GG 
61.6 
0.2 
8198267 
p8267rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTTTAATTGTAAGTCTTGACTA
GAGCAAG 
61.4 8198267 
p8277fwd 
tctattatccttaaacgcatatctcgcataataactcctcGAAAATAGTGACCAATCTGTC
ATACTC 
61.2 
0.4 
8198277 
p8277rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacGTTTACGCTCCGTTCAGGG 61.6 8198277 
p8279fwd tctattatccttaaacgcatatctcgcataataactcctcCTGCGGAAGAGTTGGCG 61.7 
0.7 
8198279 
p8279rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGCTATTAGTTTCTGTGATTC
TGTTC 
61 8198279 
p8289fwd 
tctattatccttaaacgcatatctcgcataataactcctcTCCTGAAAAATGGAAAGGTC
TTC 
60.6 
1.5 
8198289 
p8289rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTTTATTATGGTTCCCTAACAA
ATTCTATGG 
62.1 8198289 
p8341fwd tctattatccttaaacgcatatctcgcataataactcctcGCTCAGTGGCTTTCCATCT 61.1 
0.9 
8198341 
p8341rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCTAGTTAATCGCAAACAAAC
CCAAA 
62 8198341 
p8404fwd 
tctattatccttaaacgcatatctcgcataataactcctcTTGAAAAAGAAGTTTTTTTCT
CACAAG 
60.4 
0.1 
8198404 
p8404rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGGTTTTGTATGATGAAGAGG
TAAAAC 
60.3 8198404 
p8430fwd 
tctattatccttaaacgcatatctcgcataataactcctcTGACATTGCAATTCAATTGGA
CTG 
62.1 0.4 8198430 
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p8430rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacCCTCTGTAGTGGGTAGGTGG 61.7 8198430 
p8510fwd 
tctattatccttaaacgcatatctcgcataataactcctcGGAATTATCATGGAGAGAAT
TGACAAG 
61.5 
1 
8198510 
p8510rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGTATGGTCGTATAGAGATAT
ACGAGAG 
60.5 8198510 
p8785fwd tctattatccttaaacgcatatctcgcataataactcctcCAAAGAAGAAGCCACCATCG 60.3 
1.3 
8198785 
p8785rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGGGAACAATGAAGGAACTG
AAAAG 
61.6 8198785 
p8915fwd tctattatccttaaacgcatatctcgcataataactcctcTTTCCACTGGAGCGTGC 61.2 
0.1 
8198915 
p8915rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCTCGTAGGTGAAAGATCGGA
TG 
61.1 8198915 
p8926fwd tctattatccttaaacgcatatctcgcataataactcctcGGATTTCTTGAGGGGGCT 60.3 
1.3 
8198926 
p8926rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTTCCAATTTTTCTAAATAT
AGGCCA 
61.6 8198926 
p8945fwd tctattatccttaaacgcatatctcgcataataactcctcTAATACGGCACCGATTGTCC 61.1 
1.3 
8198945 
p8945rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCCAGCTGTATATTAAAGGCG
G 
59.8 8198945 
p9273fwd tctattatccttaaacgcatatctcgcataataactcctcCCAATCCAGCAGACACCC 61.3 
0.2 
8199273 
p9273rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTGATTTACCAGAGATAAG
TATGGA 
61.1 8199273 
p9308fwd tctattatccttaaacgcatatctcgcataataactcctcATGTGAAGGCAAGGGGTTC 61.5 
0.7 
8199308 
p9308rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacGATGCGTTTGGAGTTTAGAT
GAA 
60.8 8199308 
p9313fwd tctattatccttaaacgcatatctcgcataataactcctcGTAGCAGACTTTGGGGACC 60.9 
0.7 
8199313 
p9313rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTTTATGGTTGGTGAAGTCTT
GG 
60.2 8199313 
p9654fwd 
tctattatccttaaacgcatatctcgcataataactcctcATGATAACTTTAATTTTTCATC
CTGTTTATATACG 
62.5 
2 
8199654 
p9654rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacAATTCAGTGGTTTGTGAGCA
A 
60.5 8199654 
p9681fwd tctattatccttaaacgcatatctcgcataataactcctcGGCCGCCACTCAGATC 60.6 
0.1 
8199681 
p9681rev ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGGGTTTGAGAGTTGGGG 60.5 8199681 
p9755fwd 
tctattatccttaaacgcatatctcgcataataactcctcACTAATAATGAAACGCCCAAA
CT 
60.6 
0.2 
8199755 
p9755rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCTTGTAGTCTTATTGGGGGG
T 
60.4 8199755 
p9846fwd 
tctattatccttaaacgcatatctcgcataataactcctcGATTGCTCCAGAAAAATGTTG
GAT 
61.7 
0.3 
8199846 
p9846rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacCGTTAAACAAAAAAAATTGT
TTTCAATGAG 
61.4 8199846 
p9939fwd 
tctattatccttaaacgcatatctcgcataataactcctcCATATTCAAATACCAAGCAAA
TAAACGC 
62 
0.6 
8199939 
p9939rev 
ttttgaaatacgactgaccgtaagaccgctttgtttcgacTGTTGTGTACTAGCTAATTGA
TTGATG 
61.4 8199939 
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16.12. Library screening data 
Table 16.6 – Summary of data recorded from individual screening plates 
Plate Producers Non producers No growth 
 
Plate Producers Non producers No growth 
C20 25 12 59 
 
D1 7 24 65 
C21 1 7 88 
 
D2 13 67 16 
C22 3 19 74 
 
D3 2 10 84 
C23 74 18 4 
 
D4 7 16 73 
C24 72 17 7 
 
D5 9 11 76 
C25 68 21 7 
 
D6 8 13 75 
C26 66 19 11 
 
D7 0 25 71 
C27 38 8 50 
 
D8 10 58 28 
C28 69 16 11 
 
D9 33 2 61 
C29 71 19 6 
 
D10 48 44 4 
C30 79 5 12 
 
D11 4 57 35 
C31 54 11 31 
 
D12 47 2 47 
C32 54 17 25 
 
D13 15 52 29 
C33 39 9 48 
 
D14 29 58 9 
C34 41 14 41 
 
D15 14 76 6 
C35 51 13 32 
 
D16 21 67 8 
C36 58 3 35 
 
D17 42 51 3 
C37 52 9 35 
 
D18 20 51 25 
C39 59 11 26 
 
D19 10 58 28 
C40 70 13 13 
 
D20 16 58 22 
C41 60 16 20 
 
D21 25 53 18 
C42 71 11 14 
 
D22 6 44 46 
C43 79 9 8 
 
D23 23 69 4 
C44 72 3 21 
 
D24 61 4 31 
C45 60 10 26 
 
D25 49 39 8 
C46 60 20 16 
 
D26 42 51 3 
C47 59 10 27 
 
D27 47 46 3 
C48 68 9 19 
 
D28 27 61 8 
C49 68 11 17 
 
D29 25 68 3 
C50 77 13 6 
 
D30 17 76 3 
C51 68 7 21 
 
D31 15 63 18 
C52 65 12 19 
 
D32 10 64 22 
C53 53 9 34 
 
D34 14 59 23 
C54 67 14 15 
 
D35 10 69 17 
C55 61 5 30 
 
D36 28 54 14 
C56 63 11 22 
 
D37 36 52 8 
C57 46 8 42 
 
D38 19 49 28 
C220 41 8 47 
 
D39 51 30 15 
C230 34 4 58 
 
D40 31 60 5 
C240 45 11 40 
 
C58 22 69 5 
C250 54 10 32 
 
C59 8 53 35 
C260 57 13 26 
 
C60 8 63 25 
C270 44 11 41 
 
C61 4 77 15 
C280 48 11 37 
 
C62 11 71 14 
C290 45 4 47 
 
C63 4 71 21 
C300 23 16 57 
 
C64 4 53 39 
C310 48 11 37 
 
C65 12 62 22 
     
C66 16 37 43 
     
C67 20 66 10 
     
C68 5 69 22 
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Plate Producers Non producers No growth 
C1 79 4 13 
C2 84 6 6 
C3 86 4 6 
C4 88 0 8 
C5 83 8 5 
C6 83 3 10 
C7 82 2 12 
C8 84 6 6 
C9 80 9 7 
C10 77 4 15 
C11 83 3 10 
C12 83 6 7 
C13 88 2 6 
C14 79 7 10 
C15 78 10 8 
C16 68 4 24 
C17 87 5 4 
C18 73 2 21 
C19 73 3 20 
C200 78 4 14 
C69 71 3 22 
C70 70 3 23 
C71 66 11 19 
C72 73 12 11 
C73 71 2 23 
C74 66 3 27 
C75 84 5 7 
C76 82 5 9 
C77 70 7 19 
C78 79 4 13 
C79 63 5 28 
C80 67 11 18 
C81 70 8 18 
C82 70 15 11 
C83 66 13 17 
C84 71 9 16 
C85 71 6 19 
C86 67 3 26 
C87 53 13 30 
C88 58 7 31 
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16.13. Flask scale cultures of best performing clone of each 
candidate 
 
  
Figure 16.18 – Summary of normalised lycopene production for samples obtained at flask scale in 
five separate experiments 
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16.14. Population tests 
 
 
Figure 16.19 – Distribution of samples’ normalised lycopene production obtained during 
population tests 
